false0000040545December 31Q12021us-gaap:OtherLiabilitiesNoncurrentus-gaap:OtherLiabilitiesNoncurrent000000405452021-01-012021-03-310000040545us-gaap:CommonStockMember2021-01-012021-03-310000040545ge:A0.375NotesDue2022Member2021-01-012021-03-310000040545ge:A1.250NotesDue2023Member2021-01-012021-03-310000040545ge:A0.875NotesDue2025Member2021-01-012021-03-310000040545ge:A1.875NotesDue2027Member2021-01-012021-03-310000040545ge:A1.500NotesDue2029Member2021-01-012021-03-310000040545ge:A7.5GuaranteedSubordinatedNotesDue2035Member2021-01-012021-03-310000040545ge:A2.125NotesDue2037Member2021-01-012021-03-31xbrli:shares00000405452021-03-31iso4217:USD0000040545ge:PowerSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000040545ge:PowerSegmentMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-31xbrli:pure0000040545us-gaap:OperatingSegmentsMemberge:RenewableEnergySegmentMember2021-01-012021-03-310000040545us-gaap:OperatingSegmentsMemberge:RenewableEnergySegmentMember2020-01-012020-03-310000040545ge:AviationSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000040545ge:AviationSegmentMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000040545us-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2021-01-012021-03-310000040545us-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2020-01-012020-03-310000040545ge:CapitalSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000040545ge:CapitalSegmentMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000040545us-gaap:OperatingSegmentsMember2021-01-012021-03-310000040545us-gaap:OperatingSegmentsMember2020-01-012020-03-310000040545ge:CorporateAndEliminationsMember2021-01-012021-03-310000040545ge:CorporateAndEliminationsMember2020-01-012020-03-3100000405452020-01-012020-03-310000040545us-gaap:MaterialReconcilingItemsMember2021-01-012021-03-310000040545us-gaap:MaterialReconcilingItemsMember2020-01-012020-03-310000040545us-gaap:ProductMember2021-01-012021-03-310000040545us-gaap:ProductMember2020-01-012020-03-310000040545us-gaap:ServiceMember2021-01-012021-03-310000040545us-gaap:ServiceMember2020-01-012020-03-310000040545ge:GECapitalRevenueFromServicesMember2021-01-012021-03-310000040545ge:GECapitalRevenueFromServicesMember2020-01-012020-03-31iso4217:USDxbrli:shares0000040545us-gaap:ProductMembersrt:SubsidiariesMember2021-01-012021-03-310000040545us-gaap:ProductMembersrt:SubsidiariesMember2020-01-012020-03-310000040545us-gaap:ProductMemberge:SubsidiariesGeccMember2021-01-012021-03-310000040545us-gaap:ProductMemberge:SubsidiariesGeccMember2020-01-012020-03-310000040545srt:SubsidiariesMemberus-gaap:ServiceMember2021-01-012021-03-310000040545srt:SubsidiariesMemberus-gaap:ServiceMember2020-01-012020-03-310000040545ge:SubsidiariesGeccMemberus-gaap:ServiceMember2021-01-012021-03-310000040545ge:SubsidiariesGeccMemberus-gaap:ServiceMember2020-01-012020-03-310000040545ge:GECapitalRevenueFromServicesMembersrt:SubsidiariesMember2021-01-012021-03-310000040545ge:GECapitalRevenueFromServicesMembersrt:SubsidiariesMember2020-01-012020-03-310000040545ge:GECapitalRevenueFromServicesMemberge:SubsidiariesGeccMember2021-01-012021-03-310000040545ge:GECapitalRevenueFromServicesMemberge:SubsidiariesGeccMember2020-01-012020-03-310000040545srt:SubsidiariesMember2021-01-012021-03-310000040545srt:SubsidiariesMember2020-01-012020-03-310000040545ge:SubsidiariesGeccMember2021-01-012021-03-310000040545ge:SubsidiariesGeccMember2020-01-012020-03-3100000405452020-12-310000040545ge:GECapitalMembersrt:ReportableLegalEntitiesMember2021-03-310000040545ge:GECapitalMembersrt:ReportableLegalEntitiesMember2020-12-310000040545srt:SubsidiariesMember2021-03-310000040545srt:SubsidiariesMember2020-12-310000040545ge:SubsidiariesGeccMember2021-03-310000040545ge:SubsidiariesGeccMember2020-12-3100000405452019-12-3100000405452020-03-310000040545srt:SubsidiariesMember2019-12-310000040545ge:SubsidiariesGeccMember2019-12-310000040545srt:SubsidiariesMember2020-03-310000040545ge:SubsidiariesGeccMember2020-03-310000040545us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000040545us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000040545us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-03-310000040545us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-01-012020-03-310000040545us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-03-310000040545us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-03-310000040545us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-03-310000040545us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-01-012020-03-310000040545us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-03-310000040545us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-03-310000040545us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310000040545us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310000040545us-gaap:AdditionalPaidInCapitalMember2020-12-310000040545us-gaap:AdditionalPaidInCapitalMember2019-12-310000040545us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310000040545us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310000040545us-gaap:AdditionalPaidInCapitalMember2021-03-310000040545us-gaap:AdditionalPaidInCapitalMember2020-03-310000040545us-gaap:RetainedEarningsMember2020-12-310000040545us-gaap:RetainedEarningsMember2019-12-310000040545us-gaap:RetainedEarningsMember2021-01-012021-03-310000040545us-gaap:RetainedEarningsMember2020-01-012020-03-310000040545srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2020-12-310000040545srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2019-12-310000040545us-gaap:RetainedEarningsMember2021-03-310000040545us-gaap:RetainedEarningsMember2020-03-310000040545us-gaap:TreasuryStockMember2020-12-310000040545us-gaap:TreasuryStockMember2019-12-310000040545us-gaap:TreasuryStockMember2021-01-012021-03-310000040545us-gaap:TreasuryStockMember2020-01-012020-03-310000040545us-gaap:TreasuryStockMember2021-03-310000040545us-gaap:TreasuryStockMember2020-03-310000040545ge:BioPharmaBusinessMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2020-03-310000040545ge:BioPharmaBusinessMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2020-01-012020-12-310000040545ge:BioPharmaBusinessMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2020-01-012020-03-310000040545ge:GecasMemberus-gaap:SegmentDiscontinuedOperationsMember2021-03-090000040545ge:GecasMemberge:AerCapHoldingsNVMemberus-gaap:SegmentDiscontinuedOperationsMember2021-03-092021-03-090000040545ge:GecasMemberge:AerCapHoldingsNVMemberus-gaap:SegmentDiscontinuedOperationsMember2021-03-310000040545ge:GecasMemberus-gaap:SegmentDiscontinuedOperationsMember2021-03-092021-03-090000040545ge:GecasMemberus-gaap:SegmentDiscontinuedOperationsMember2021-01-012021-03-310000040545ge:BankBPHMemberge:BankBPHMember2021-03-310000040545ge:BankBPHMemberge:BankBPHMember2021-01-012021-03-310000040545us-gaap:InvesteeMemberge:BakerHughesExcludingAeroderivativeJointVentureMember2021-01-012021-03-310000040545ge:BakerHughesMemberus-gaap:InvesteeMemberge:AeroderivativeJointVentureMember2021-01-012021-03-310000040545ge:BakerHughesMemberus-gaap:InvesteeMemberus-gaap:LoansReceivableMember2021-01-012021-03-310000040545ge:BakerHughesMemberus-gaap:InvesteeMember2021-01-012021-03-310000040545us-gaap:SegmentDiscontinuedOperationsMember2021-01-012021-03-310000040545us-gaap:SegmentDiscontinuedOperationsMember2020-01-012020-03-310000040545ge:GecasMemberus-gaap:SegmentDiscontinuedOperationsMember2020-01-012020-03-310000040545us-gaap:SegmentDiscontinuedOperationsMember2021-03-310000040545us-gaap:SegmentDiscontinuedOperationsMember2020-12-310000040545ge:GecasMemberus-gaap:SegmentDiscontinuedOperationsMember2021-03-310000040545ge:GecasMemberus-gaap:SegmentDiscontinuedOperationsMember2020-12-310000040545ge:GeCapitalExitPlanMemberus-gaap:SegmentDiscontinuedOperationsMember2021-03-310000040545ge:GeCapitalExitPlanMemberus-gaap:SegmentDiscontinuedOperationsMember2020-12-310000040545ge:BakerHughesMember2021-03-310000040545us-gaap:DomesticCorporateDebtSecuritiesMember2021-03-310000040545us-gaap:DomesticCorporateDebtSecuritiesMember2020-12-310000040545us-gaap:ForeignCorporateDebtSecuritiesMember2021-03-310000040545us-gaap:ForeignCorporateDebtSecuritiesMember2020-12-310000040545us-gaap:USStatesAndPoliticalSubdivisionsMember2021-03-310000040545us-gaap:USStatesAndPoliticalSubdivisionsMember2020-12-310000040545us-gaap:AssetBackedSecuritiesMember2021-03-310000040545us-gaap:AssetBackedSecuritiesMember2020-12-310000040545us-gaap:USTreasuryAndGovernmentMember2021-03-310000040545us-gaap:USTreasuryAndGovernmentMember2020-12-310000040545us-gaap:CommercialMortgageBackedSecuritiesMember2021-03-310000040545us-gaap:FairValueInputsLevel3Member2021-03-310000040545us-gaap:FairValueInputsLevel3Member2020-12-310000040545ge:GECapitalMember2021-01-012021-03-310000040545ge:GECapitalMember2020-01-012020-12-310000040545ge:CurrentReceivablesMembersrt:SubsidiariesMember2021-01-012021-03-310000040545ge:CurrentReceivablesMembersrt:SubsidiariesMember2020-01-012020-03-310000040545ge:CurrentReceivablesMemberge:GECapitalMembersrt:SubsidiariesMember2020-12-310000040545ge:OtherThirdPartiesMemberge:CurrentReceivablesMembersrt:SubsidiariesMember2020-12-310000040545ge:CurrentReceivablesMemberge:GECapitalMembersrt:SubsidiariesMember2019-12-310000040545ge:OtherThirdPartiesMemberge:CurrentReceivablesMembersrt:SubsidiariesMember2019-12-310000040545ge:CurrentReceivablesMemberge:GECapitalMembersrt:SubsidiariesMember2021-01-012021-03-310000040545ge:CurrentReceivablesMemberge:GECapitalMembersrt:SubsidiariesMember2020-01-012020-03-310000040545ge:OtherThirdPartiesMemberge:CurrentReceivablesMembersrt:SubsidiariesMember2021-01-012021-03-310000040545ge:OtherThirdPartiesMemberge:CurrentReceivablesMembersrt:SubsidiariesMember2020-01-012020-03-310000040545ge:CurrentReceivablesMemberge:GECapitalMembersrt:SubsidiariesMember2021-03-310000040545ge:OtherThirdPartiesMemberge:CurrentReceivablesMembersrt:SubsidiariesMember2021-03-310000040545ge:CurrentReceivablesMemberge:GECapitalMembersrt:SubsidiariesMember2020-03-310000040545ge:OtherThirdPartiesMemberge:CurrentReceivablesMembersrt:SubsidiariesMember2020-03-310000040545ge:GECapitalMembersrt:SubsidiariesMemberge:CurrentReceivablesWithRecourseMember2021-03-310000040545ge:GECapitalMembersrt:SubsidiariesMemberge:CurrentReceivablesWithRecourseMember2020-03-310000040545ge:OtherThirdPartiesMemberge:CurrentReceivablesMemberge:ReceivablesFacilityOneMember2021-03-310000040545ge:GECapitalMembersrt:SubsidiariesMember2021-03-310000040545ge:GECapitalMembersrt:SubsidiariesMember2020-12-31ge:receivable_facility0000040545ge:GECapitalMember2021-03-310000040545ge:ReceivablesFacilityOneMemberge:GECapitalMember2021-03-31ge:entity0000040545ge:GECapitalMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-01-012021-03-310000040545ge:CurrentReceivablesMemberge:GECapitalMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:AccountsReceivableMember2021-03-310000040545ge:CurrentReceivablesMemberge:GECapitalMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:AccountsReceivableMember2020-12-310000040545ge:NoncurrentReceivablesMemberge:GECapitalMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:AccountsReceivableMember2021-03-310000040545ge:NoncurrentReceivablesMemberge:GECapitalMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:AccountsReceivableMember2020-12-310000040545ge:DebtFacilitiesMemberus-gaap:DebtMemberge:GECapitalMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-03-310000040545ge:DebtFacilitiesMemberus-gaap:DebtMemberge:GECapitalMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2020-12-310000040545ge:GECapitalMember2020-12-310000040545ge:GEIndustrialSegmentMember2021-03-310000040545ge:GEIndustrialSegmentMember2020-12-310000040545ge:PowerSegmentMemberus-gaap:OperatingSegmentsMember2020-12-310000040545ge:PowerSegmentMemberus-gaap:OperatingSegmentsMember2021-03-310000040545us-gaap:OperatingSegmentsMemberge:RenewableEnergySegmentMember2020-12-310000040545us-gaap:OperatingSegmentsMemberge:RenewableEnergySegmentMember2021-03-310000040545ge:AviationSegmentMemberus-gaap:OperatingSegmentsMember2020-12-310000040545ge:AviationSegmentMemberus-gaap:OperatingSegmentsMember2021-03-310000040545us-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2020-12-310000040545us-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2021-03-310000040545us-gaap:CorporateNonSegmentMember2020-12-310000040545us-gaap:CorporateNonSegmentMember2021-01-012021-03-310000040545us-gaap:CorporateNonSegmentMember2021-03-310000040545ge:AdditiveReportingUnitMemberus-gaap:OperatingSegmentsMember2021-03-310000040545ge:GEIndustrialSegmentMemberge:EquipmentProductsMemberus-gaap:OperatingSegmentsMemberge:PowerSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:ServicesMemberus-gaap:OperatingSegmentsMemberge:PowerSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberus-gaap:OperatingSegmentsMemberge:PowerSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:EquipmentProductsMemberus-gaap:OperatingSegmentsMemberge:PowerSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:ServicesMemberus-gaap:OperatingSegmentsMemberge:PowerSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberus-gaap:OperatingSegmentsMemberge:PowerSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:EquipmentProductsMemberge:RenewableEnergySegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:RenewableEnergySegmentMemberge:ServicesMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:RenewableEnergySegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:EquipmentProductsMemberge:RenewableEnergySegmentMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:RenewableEnergySegmentMemberge:ServicesMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:RenewableEnergySegmentMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:EquipmentProductsMemberus-gaap:OperatingSegmentsMemberge:AviationSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:ServicesMemberus-gaap:OperatingSegmentsMemberge:AviationSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberus-gaap:OperatingSegmentsMemberge:AviationSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:EquipmentProductsMemberus-gaap:OperatingSegmentsMemberge:AviationSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:ServicesMemberus-gaap:OperatingSegmentsMemberge:AviationSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberus-gaap:OperatingSegmentsMemberge:AviationSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:EquipmentProductsMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:ServicesMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:EquipmentProductsMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:ServicesMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:EquipmentProductsMemberge:CorporateAndReconcilingItemsMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:ServicesMemberge:CorporateAndReconcilingItemsMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:CorporateAndReconcilingItemsMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:EquipmentProductsMemberge:CorporateAndReconcilingItemsMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:ServicesMemberge:CorporateAndReconcilingItemsMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:CorporateAndReconcilingItemsMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:EquipmentProductsMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:ServicesMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:EquipmentProductsMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:ServicesMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:GasPowerSystemsMemberus-gaap:OperatingSegmentsMemberge:PowerSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:GasPowerSystemsMemberus-gaap:OperatingSegmentsMemberge:PowerSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:PowerPortfolioMemberus-gaap:OperatingSegmentsMemberge:PowerSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:PowerPortfolioMemberus-gaap:OperatingSegmentsMemberge:PowerSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:OnshoreWindMemberge:RenewableEnergySegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:OnshoreWindMemberge:RenewableEnergySegmentMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:RenewableEnergySegmentMemberus-gaap:OperatingSegmentsMemberge:GridSolutionsMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:RenewableEnergySegmentMemberus-gaap:OperatingSegmentsMemberge:GridSolutionsMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:RenewableEnergySegmentMemberge:HydroMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:RenewableEnergySegmentMemberge:HydroMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:RenewableEnergySegmentMemberus-gaap:OperatingSegmentsMemberge:RenewableEnergyOtherMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:RenewableEnergySegmentMemberus-gaap:OperatingSegmentsMemberge:RenewableEnergyOtherMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:CommercialEnginesAndServicesMemberus-gaap:OperatingSegmentsMemberge:AviationSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:CommercialEnginesAndServicesMemberus-gaap:OperatingSegmentsMemberge:AviationSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:MilitaryMemberus-gaap:OperatingSegmentsMemberge:AviationSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:MilitaryMemberus-gaap:OperatingSegmentsMemberge:AviationSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:SystemsAndOtherAviationServicesMemberus-gaap:OperatingSegmentsMemberge:AviationSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:SystemsAndOtherAviationServicesMemberus-gaap:OperatingSegmentsMemberge:AviationSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:HealthcareSystemsMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:HealthcareSystemsMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2020-01-012020-03-310000040545ge:LifeSciencesMemberge:GEIndustrialSegmentMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2021-01-012021-03-310000040545ge:LifeSciencesMemberge:GEIndustrialSegmentMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2020-01-012020-03-310000040545ge:GEIndustrialSegmentMemberge:BioPharmaBusinessMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2021-01-012021-03-310000040545ge:GEIndustrialSegmentMemberge:BioPharmaBusinessMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMember2020-01-012020-03-310000040545srt:ConsolidationEliminationsMember2021-01-012021-03-310000040545srt:ConsolidationEliminationsMember2020-01-012020-03-310000040545ge:EquipmentProductsMember2021-03-310000040545ge:EquipmentProductsMember2021-04-012021-03-310000040545ge:EquipmentProductsMember2022-04-012021-03-3100000405452024-04-01ge:EquipmentProductsMember2021-03-310000040545ge:ServicesMember2021-03-3100000405452021-04-01ge:ServicesMember2021-03-310000040545ge:ServicesMember2022-04-012021-03-3100000405452027-04-01ge:ServicesMember2021-03-310000040545ge:ServicesMember2037-04-012021-03-310000040545ge:ServicesMemberus-gaap:LongTermContractWithCustomerMember2021-01-012021-03-310000040545ge:ServicesMemberge:AviationSegmentMemberus-gaap:LongTermContractWithCustomerMember2021-01-012021-03-310000040545ge:PowerSegmentMemberge:ServicesMemberus-gaap:LongTermContractWithCustomerMember2021-01-012021-03-310000040545ge:PowerSegmentMemberge:ServicesMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545ge:ServicesMemberge:AviationSegmentMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545ge:ServicesMemberus-gaap:OperatingSegmentsMemberge:RenewableEnergySegmentMembersrt:SubsidiariesMember2021-03-310000040545ge:ServicesMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMembersrt:SubsidiariesMember2021-03-310000040545us-gaap:AllOtherSegmentsMemberge:ServicesMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545ge:ServicesMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545ge:PowerSegmentMemberge:ServicesMemberus-gaap:OperatingSegmentsMemberus-gaap:LongTermContractWithCustomerMembersrt:SubsidiariesMember2021-03-310000040545ge:ServicesMemberge:AviationSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:LongTermContractWithCustomerMembersrt:SubsidiariesMember2021-03-310000040545ge:ServicesMemberus-gaap:OperatingSegmentsMemberus-gaap:LongTermContractWithCustomerMemberge:RenewableEnergySegmentMembersrt:SubsidiariesMember2021-03-310000040545ge:ServicesMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMemberus-gaap:LongTermContractWithCustomerMembersrt:SubsidiariesMember2021-03-310000040545us-gaap:AllOtherSegmentsMemberge:ServicesMemberus-gaap:OperatingSegmentsMemberus-gaap:LongTermContractWithCustomerMembersrt:SubsidiariesMember2021-03-310000040545ge:ServicesMemberus-gaap:OperatingSegmentsMemberus-gaap:LongTermContractWithCustomerMembersrt:SubsidiariesMember2021-03-310000040545ge:PowerSegmentMemberge:ServicesMemberus-gaap:ShortTermContractWithCustomerMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545ge:ServicesMemberge:AviationSegmentMemberus-gaap:ShortTermContractWithCustomerMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545ge:ServicesMemberus-gaap:ShortTermContractWithCustomerMemberus-gaap:OperatingSegmentsMemberge:RenewableEnergySegmentMembersrt:SubsidiariesMember2021-03-310000040545ge:ServicesMemberus-gaap:ShortTermContractWithCustomerMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMembersrt:SubsidiariesMember2021-03-310000040545us-gaap:AllOtherSegmentsMemberge:ServicesMemberus-gaap:ShortTermContractWithCustomerMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545ge:ServicesMemberus-gaap:ShortTermContractWithCustomerMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545ge:PowerSegmentMemberge:EquipmentProductsMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545ge:EquipmentProductsMemberge:AviationSegmentMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545ge:EquipmentProductsMemberus-gaap:OperatingSegmentsMemberge:RenewableEnergySegmentMembersrt:SubsidiariesMember2021-03-310000040545ge:EquipmentProductsMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMembersrt:SubsidiariesMember2021-03-310000040545ge:EquipmentProductsMemberus-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545ge:EquipmentProductsMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545ge:PowerSegmentMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545ge:AviationSegmentMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545us-gaap:OperatingSegmentsMemberge:RenewableEnergySegmentMembersrt:SubsidiariesMember2021-03-310000040545us-gaap:OperatingSegmentsMemberge:HealthcareSegmentMembersrt:SubsidiariesMember2021-03-310000040545us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545us-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2021-03-310000040545ge:PowerSegmentMemberge:ServicesMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545ge:ServicesMemberge:AviationSegmentMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545ge:ServicesMemberus-gaap:OperatingSegmentsMemberge:RenewableEnergySegmentMembersrt:SubsidiariesMember2020-12-310000040545ge:ServicesMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMembersrt:SubsidiariesMember2020-12-310000040545us-gaap:AllOtherSegmentsMemberge:ServicesMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545ge:ServicesMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545ge:PowerSegmentMemberge:ServicesMemberus-gaap:OperatingSegmentsMemberus-gaap:LongTermContractWithCustomerMembersrt:SubsidiariesMember2020-12-310000040545ge:ServicesMemberge:AviationSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:LongTermContractWithCustomerMembersrt:SubsidiariesMember2020-12-310000040545ge:ServicesMemberus-gaap:OperatingSegmentsMemberus-gaap:LongTermContractWithCustomerMemberge:RenewableEnergySegmentMembersrt:SubsidiariesMember2020-12-310000040545ge:ServicesMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMemberus-gaap:LongTermContractWithCustomerMembersrt:SubsidiariesMember2020-12-310000040545us-gaap:AllOtherSegmentsMemberge:ServicesMemberus-gaap:OperatingSegmentsMemberus-gaap:LongTermContractWithCustomerMembersrt:SubsidiariesMember2020-12-310000040545ge:ServicesMemberus-gaap:OperatingSegmentsMemberus-gaap:LongTermContractWithCustomerMembersrt:SubsidiariesMember2020-12-310000040545ge:PowerSegmentMemberge:ServicesMemberus-gaap:ShortTermContractWithCustomerMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545ge:ServicesMemberge:AviationSegmentMemberus-gaap:ShortTermContractWithCustomerMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545ge:ServicesMemberus-gaap:ShortTermContractWithCustomerMemberus-gaap:OperatingSegmentsMemberge:RenewableEnergySegmentMembersrt:SubsidiariesMember2020-12-310000040545ge:ServicesMemberus-gaap:ShortTermContractWithCustomerMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMembersrt:SubsidiariesMember2020-12-310000040545us-gaap:AllOtherSegmentsMemberge:ServicesMemberus-gaap:ShortTermContractWithCustomerMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545ge:ServicesMemberus-gaap:ShortTermContractWithCustomerMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545ge:PowerSegmentMemberge:EquipmentProductsMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545ge:EquipmentProductsMemberge:AviationSegmentMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545ge:EquipmentProductsMemberus-gaap:OperatingSegmentsMemberge:RenewableEnergySegmentMembersrt:SubsidiariesMember2020-12-310000040545ge:EquipmentProductsMemberus-gaap:OperatingSegmentsMemberge:HealthcareSegmentMembersrt:SubsidiariesMember2020-12-310000040545ge:EquipmentProductsMemberus-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545ge:EquipmentProductsMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545ge:PowerSegmentMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545ge:AviationSegmentMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545us-gaap:OperatingSegmentsMemberge:RenewableEnergySegmentMembersrt:SubsidiariesMember2020-12-310000040545us-gaap:OperatingSegmentsMemberge:HealthcareSegmentMembersrt:SubsidiariesMember2020-12-310000040545us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545us-gaap:OperatingSegmentsMembersrt:SubsidiariesMember2020-12-310000040545ge:PowerAndRenewableEnergySegmentsMember2021-01-012021-03-310000040545ge:PowerSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembersrt:SubsidiariesMember2021-03-310000040545ge:AviationSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembersrt:SubsidiariesMember2021-03-310000040545us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberge:RenewableEnergySegmentMembersrt:SubsidiariesMember2021-03-310000040545us-gaap:OperatingSegmentsMemberge:HealthcareSegmentMemberus-gaap:ProductAndServiceOtherMembersrt:SubsidiariesMember2021-03-310000040545us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembersrt:SubsidiariesMember2021-03-310000040545us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembersrt:SubsidiariesMember2021-03-310000040545ge:PowerSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembersrt:SubsidiariesMember2020-12-310000040545ge:AviationSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembersrt:SubsidiariesMember2020-12-310000040545us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberge:RenewableEnergySegmentMembersrt:SubsidiariesMember2020-12-310000040545us-gaap:OperatingSegmentsMemberge:HealthcareSegmentMemberus-gaap:ProductAndServiceOtherMembersrt:SubsidiariesMember2020-12-310000040545us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembersrt:SubsidiariesMember2020-12-310000040545us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembersrt:SubsidiariesMember2020-12-310000040545ge:CurrentPortionOfLongTermBorrowingsMemberge:GeneralElectricCompanyMember2021-03-310000040545ge:CurrentPortionOfLongTermBorrowingsMemberge:GeneralElectricCompanyMember2020-12-310000040545ge:CurrentPortionOfLongTermBorrowingsAssumedMemberge:GeneralElectricCompanyMember2021-03-310000040545ge:CurrentPortionOfLongTermBorrowingsAssumedMemberge:GeneralElectricCompanyMember2020-12-310000040545ge:GeneralElectricCompanyMemberge:OtherShortTermBorrowingsMember2021-03-310000040545ge:GeneralElectricCompanyMemberge:OtherShortTermBorrowingsMember2020-12-310000040545ge:GeneralElectricCompanyMember2021-03-310000040545ge:GeneralElectricCompanyMember2020-12-310000040545ge:CurrentPortionOfLongTermBorrowingsMemberge:GECapitalMember2021-03-310000040545ge:CurrentPortionOfLongTermBorrowingsMemberge:GECapitalMember2020-12-310000040545ge:GECapitalMemberge:IntercompanyPayableMember2021-03-310000040545ge:GECapitalMemberge:IntercompanyPayableMember2020-12-310000040545us-gaap:SecuredDebtMemberge:GECapitalMember2021-03-310000040545us-gaap:SecuredDebtMemberge:GECapitalMember2020-12-310000040545ge:GECapitalMemberge:OtherShortTermBorrowingsMember2021-03-310000040545ge:GECapitalMemberge:OtherShortTermBorrowingsMember2020-12-310000040545us-gaap:SeniorNotesMemberge:GeneralElectricCompanyMember2021-03-310000040545us-gaap:SeniorNotesMemberge:GeneralElectricCompanyMember2020-12-310000040545ge:SeniorNotesAssumedMemberge:GeneralElectricCompanyMember2021-03-310000040545ge:SeniorNotesAssumedMemberge:GeneralElectricCompanyMember2020-12-310000040545us-gaap:SeniorSubordinatedNotesMemberge:GeneralElectricCompanyMember2021-03-310000040545us-gaap:SeniorSubordinatedNotesMemberge:GeneralElectricCompanyMember2020-12-310000040545ge:OtherLongTermBorrowingsMemberge:GeneralElectricCompanyMember2021-03-310000040545ge:OtherLongTermBorrowingsMemberge:GeneralElectricCompanyMember2020-12-310000040545us-gaap:SeniorNotesMemberge:GECapitalMember2021-03-310000040545us-gaap:SeniorNotesMemberge:GECapitalMember2020-12-310000040545us-gaap:SeniorSubordinatedNotesMemberge:GECapitalMember2021-03-310000040545us-gaap:SeniorSubordinatedNotesMemberge:GECapitalMember2020-12-310000040545ge:GECapitalMemberge:IntercompanyPayableMember2021-03-310000040545ge:GECapitalMemberge:IntercompanyPayableMember2020-12-310000040545ge:GECapitalMemberus-gaap:SecuredDebtMember2021-03-310000040545ge:GECapitalMemberus-gaap:SecuredDebtMember2020-12-310000040545ge:GECapitalMemberge:OtherLongTermBorrowingsMember2021-03-310000040545ge:GECapitalMemberge:OtherLongTermBorrowingsMember2020-12-310000040545ge:GeCapitalExitPlanMemberge:SubsidiariesGeccMember2021-03-310000040545ge:SubsidiariesGeccMember2021-03-310000040545ge:IntercompanyLoanMembersrt:SubsidiariesMemberge:SubsidiariesGeccMember2021-03-310000040545ge:GEIssuedBorrowingsMembersrt:SubsidiariesMember2021-03-310000040545ge:TrustAssetsUnconditionallyGuaranteedByGEMemberge:SubsidiariesGeccMember2021-03-310000040545ge:TrustAssetsUnconditionallyGuaranteedByGEMemberge:SubsidiariesGeccMember2020-12-310000040545ge:RunoffInsuranceOperationsMemberge:GECapitalMember2021-01-012021-03-310000040545ge:RunoffInsuranceOperationsMemberge:GECapitalMember2020-01-012020-03-310000040545ge:RunoffInsuranceOperationsMemberge:GECapitalMember2021-03-310000040545ge:RunoffInsuranceOperationsMemberge:GECapitalMember2020-12-310000040545ge:LongTermCareInsuranceMember2021-03-310000040545ge:StructuredSettlementAnnuityAndLifeInsuranceMember2021-03-310000040545us-gaap:OtherInsuranceProductLineMember2021-03-310000040545ge:LongTermCareInsuranceMember2020-12-310000040545ge:StructuredSettlementAnnuityAndLifeInsuranceMember2020-12-310000040545us-gaap:OtherInsuranceProductLineMember2020-12-3100000405452020-01-012020-12-31ge:category0000040545us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-03-310000040545us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-03-310000040545ge:PrincipalRetireeBenefitPlansMember2021-01-012021-03-310000040545ge:PrincipalRetireeBenefitPlansMember2020-01-012020-03-310000040545us-gaap:OtherPensionPlansDefinedBenefitMember2021-01-012021-03-310000040545us-gaap:OtherPensionPlansDefinedBenefitMember2020-01-012020-03-310000040545srt:ReportableLegalEntitiesMember2021-01-012021-03-310000040545ge:AlstomLegacyMembersrt:ReportableLegalEntitiesMember2021-01-012021-03-3100000405452019-10-012019-12-310000040545us-gaap:HerMajestysRevenueAndCustomsHMRCMemberus-gaap:ForeignCountryMemberge:SubsidiariesGeccMember2021-03-310000040545us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2020-12-310000040545us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2019-12-310000040545us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2021-01-012021-03-310000040545us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2020-01-012020-03-310000040545us-gaap:AccumulatedNetInvestmentGainLossAttributableToNoncontrollingInterestMember2021-01-012021-03-310000040545us-gaap:AccumulatedNetInvestmentGainLossAttributableToNoncontrollingInterestMember2020-01-012020-03-310000040545us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-03-310000040545us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-03-310000040545us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-12-310000040545us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2019-12-310000040545us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-01-012021-03-310000040545us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-01-012020-03-310000040545us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember2021-01-012021-03-310000040545us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember2020-01-012020-03-310000040545us-gaap:AccumulatedTranslationAdjustmentMember2021-03-310000040545us-gaap:AccumulatedTranslationAdjustmentMember2020-03-310000040545us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2020-12-310000040545us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2019-12-310000040545us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-01-012021-03-310000040545us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2020-01-012020-03-310000040545us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember2021-01-012021-03-310000040545us-gaap:AccumulatedGainLossNetCashFlowHedgeNoncontrollingInterestMember2020-01-012020-03-310000040545us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-03-310000040545us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-03-310000040545us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-12-310000040545us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2019-12-310000040545us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-01-012021-03-310000040545us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-01-012020-03-310000040545us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember2021-01-012021-03-310000040545us-gaap:AccumulatedDefinedBenefitPlansAdjustmentAttributableToNoncontrollingInterestMember2020-01-012020-03-310000040545us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-03-310000040545us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-03-310000040545us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMemberge:BioPharmaBusinessMember2020-01-012020-03-310000040545us-gaap:SeriesDPreferredStockMemberge:GeneralElectricCompanyMember2021-03-310000040545us-gaap:SeriesDPreferredStockMember2021-01-212021-01-210000040545us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:SeriesDPreferredStockMember2021-01-212021-01-210000040545us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-03-310000040545us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-03-310000040545us-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310000040545us-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310000040545us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-03-310000040545us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000040545us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2021-03-310000040545us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2020-12-310000040545us-gaap:DesignatedAsHedgingInstrumentMember2021-03-310000040545us-gaap:DesignatedAsHedgingInstrumentMember2020-12-310000040545us-gaap:InterestRateContractMemberus-gaap:NondesignatedMember2021-03-310000040545us-gaap:InterestRateContractMemberus-gaap:NondesignatedMember2020-12-310000040545us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2021-03-310000040545us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2020-12-310000040545us-gaap:OtherContractMemberus-gaap:NondesignatedMember2021-03-310000040545us-gaap:OtherContractMemberus-gaap:NondesignatedMember2020-12-310000040545us-gaap:NondesignatedMember2021-03-310000040545us-gaap:NondesignatedMember2020-12-310000040545us-gaap:InterestRateContractMemberge:GECapitalMember2021-03-310000040545us-gaap:InterestRateContractMemberge:GECapitalMember2020-12-310000040545us-gaap:CurrencySwapMember2021-03-310000040545us-gaap:CurrencySwapMember2020-03-310000040545us-gaap:SalesMember2021-01-012021-03-310000040545us-gaap:CostOfSalesMember2021-01-012021-03-310000040545us-gaap:InterestExpenseMember2021-01-012021-03-310000040545us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-03-310000040545us-gaap:OtherIncomeMember2021-01-012021-03-310000040545us-gaap:SalesMember2020-01-012020-03-310000040545us-gaap:CostOfSalesMember2020-01-012020-03-310000040545us-gaap:InterestExpenseMember2020-01-012020-03-310000040545us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-03-310000040545us-gaap:OtherIncomeMember2020-01-012020-03-310000040545us-gaap:InterestRateContractMemberus-gaap:SalesMember2021-01-012021-03-310000040545us-gaap:InterestRateContractMemberus-gaap:CostOfSalesMember2021-01-012021-03-310000040545us-gaap:InterestRateContractMemberus-gaap:InterestExpenseMember2021-01-012021-03-310000040545us-gaap:InterestRateContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-03-310000040545us-gaap:InterestRateContractMemberus-gaap:OtherIncomeMember2021-01-012021-03-310000040545us-gaap:InterestRateContractMemberus-gaap:SalesMember2020-01-012020-03-310000040545us-gaap:InterestRateContractMemberus-gaap:CostOfSalesMember2020-01-012020-03-310000040545us-gaap:InterestRateContractMemberus-gaap:InterestExpenseMember2020-01-012020-03-310000040545us-gaap:InterestRateContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-03-310000040545us-gaap:InterestRateContractMemberus-gaap:OtherIncomeMember2020-01-012020-03-310000040545us-gaap:SalesMemberus-gaap:ForeignExchangeContractMember2021-01-012021-03-310000040545us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2021-01-012021-03-310000040545us-gaap:InterestExpenseMemberus-gaap:ForeignExchangeContractMember2021-01-012021-03-310000040545us-gaap:ForeignExchangeContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-03-310000040545us-gaap:ForeignExchangeContractMemberus-gaap:OtherIncomeMember2021-01-012021-03-310000040545us-gaap:SalesMemberus-gaap:ForeignExchangeContractMember2020-01-012020-03-310000040545us-gaap:CostOfSalesMemberus-gaap:ForeignExchangeContractMember2020-01-012020-03-310000040545us-gaap:InterestExpenseMemberus-gaap:ForeignExchangeContractMember2020-01-012020-03-310000040545us-gaap:ForeignExchangeContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-03-310000040545us-gaap:ForeignExchangeContractMemberus-gaap:OtherIncomeMember2020-01-012020-03-310000040545us-gaap:OtherContractMemberus-gaap:SalesMember2021-01-012021-03-310000040545us-gaap:CostOfSalesMemberus-gaap:OtherContractMember2021-01-012021-03-310000040545us-gaap:InterestExpenseMemberus-gaap:OtherContractMember2021-01-012021-03-310000040545us-gaap:OtherContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-03-310000040545us-gaap:OtherContractMemberus-gaap:OtherIncomeMember2021-01-012021-03-310000040545us-gaap:OtherContractMemberus-gaap:SalesMember2020-01-012020-03-310000040545us-gaap:CostOfSalesMemberus-gaap:OtherContractMember2020-01-012020-03-310000040545us-gaap:InterestExpenseMemberus-gaap:OtherContractMember2020-01-012020-03-310000040545us-gaap:OtherContractMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-03-310000040545us-gaap:OtherContractMemberus-gaap:OtherIncomeMember2020-01-012020-03-310000040545ge:CounterpartyCreditConcentrationRiskMember2021-03-310000040545ge:CounterpartyCreditConcentrationRiskMember2020-12-310000040545us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-03-310000040545us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2020-12-310000040545us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-03-310000040545us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2020-12-310000040545ge:EnergyFinancialServicesMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-03-310000040545ge:EnergyFinancialServicesMemberus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2020-12-310000040545us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberge:InsuranceEntitiesMember2021-03-310000040545us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMemberge:InsuranceEntitiesMember2020-12-310000040545ge:GECapitalMemberge:InvestmentCommitmentMember2021-03-310000040545ge:ThermalAndWindEnergyProjectsMemberge:GECapitalMember2021-03-310000040545ge:ThermalAndWindEnergyProjectsUnconsolidatedVIEInvestmentCommitmentMemberge:GECapitalMember2021-03-310000040545ge:RunoffInsuranceOperationsUnconsolidatedVIEInvestmentCommitmentMemberge:GECapitalMember2021-03-310000040545ge:AviationMember2021-03-310000040545ge:GecasMemberge:AircraftMember2021-01-012021-03-31ge:aircraft0000040545ge:GecasMemberge:NewAircraftMember2021-01-012021-03-310000040545ge:GecasMemberge:NewAircraftMember2021-03-310000040545ge:UsedAircraftMemberge:GecasMember2021-01-012021-03-310000040545ge:UsedAircraftMemberge:GecasMember2021-03-310000040545ge:GecasMemberge:AircraftMember2021-03-310000040545us-gaap:IndemnificationGuaranteeMember2021-03-31ge:significant_case0000040545ge:AlstomLegacyMember2015-11-012015-11-30iso4217:EUR0000040545ge:AlstomLegacyMember2007-01-012007-01-310000040545ge:AlstomLegacyMember2014-12-012014-12-310000040545ge:AlstomLegacyMember2015-11-020000040545ge:AlstomLegacyMember2021-03-310000040545ge:AlstomLegacyMember2020-12-3100000405452017-01-012017-01-310000040545ge:AlstomLegacyMember2021-03-012021-03-31ge:claim0000040545ge:ShareholderDerivativeLawsuitsMember2021-03-31ge:plantiff0000040545ge:TouchstoneMember2019-02-012019-02-280000040545ge:BakerHughesCaseMember2019-03-310000040545ge:BakerHughesMemberge:BakerHughesCaseMember2018-11-300000040545ge:BankBPHMemberge:BankBPHMember2020-12-310000040545srt:ReportableLegalEntitiesMember2020-01-012020-03-310000040545ge:CurrentReceivablesSoldToRelatedPartyMembersrt:ReportableLegalEntitiesMember2021-01-012021-03-310000040545ge:CurrentReceivablesSoldToRelatedPartyMembersrt:ReportableLegalEntitiesMember2020-01-012020-03-310000040545ge:LongTermReceivablesSoldToRelatedPartyMembersrt:ReportableLegalEntitiesMember2021-01-012021-03-310000040545ge:LongTermReceivablesSoldToRelatedPartyMembersrt:ReportableLegalEntitiesMember2020-01-012020-03-310000040545ge:SupplyChainFinanceProgramsMembersrt:ReportableLegalEntitiesMember2021-01-012021-03-310000040545ge:SupplyChainFinanceProgramsMembersrt:ReportableLegalEntitiesMember2020-01-012020-03-310000040545ge:EliminationsAndReconcilingItemsMember2021-01-012021-03-310000040545ge:EliminationsAndReconcilingItemsMember2020-01-012020-03-310000040545ge:CurrentReceivablesSoldToRelatedPartyMembersrt:AffiliatedEntityMembersrt:ReportableLegalEntitiesMember2021-01-012021-03-310000040545ge:CurrentReceivablesSoldToRelatedPartyMembersrt:AffiliatedEntityMembersrt:ReportableLegalEntitiesMember2020-01-012020-03-310000040545ge:BakerHughesMember2021-01-012021-03-310000040545ge:BakerHughesMember2020-01-012020-03-31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q

(Mark One)
☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2021
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____ to ____
Commission file number 001-00035
GE-20210331_G1.JPG
GENERAL ELECTRIC COMPANY
(Exact name of registrant as specified in its charter)
New York
14-0689340
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
5 Necco Street
Boston
MA
02210
(Address of principal executive offices) (Zip Code)
(Registrant’s telephone number, including area code) (617) 443-3000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, par value $0.06 per share
GE
New York Stock Exchange
0.375% Notes due 2022
GE 22A
New York Stock Exchange
1.250% Notes due 2023
GE 23E
New York Stock Exchange
0.875% Notes due 2025
GE 25
New York Stock Exchange
1.875% Notes due 2027
GE 27E
New York Stock Exchange
1.500% Notes due 2029
GE 29
New York Stock Exchange
7 1/2% Guaranteed Subordinated Notes due 2035
GE /35
New York Stock Exchange
2.125% Notes due 2037
GE 37
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
☑
Accelerated filer 
☐
Non-accelerated filer 
☐
Smaller reporting company 
☐
Emerging growth company 
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
There were 8,778,641,000 shares of common stock with a par value of $0.06 per share outstanding at March 31, 2021.



TABLE OF CONTENTS
Page
3
4
4
4
7
12
13
14
18
New Accounting Standards
18
19
23
23
23
24
24
26
28
30
30
31
31
33
34
36
Note 6 Inventories, Including Deferred Inventory Costs
36
36
36
37
38
38
39
39
40
40
40
41
42
42
44
45
48
48
49
49
49



FORWARD-LOOKING STATEMENTS. Our public communications and SEC filings may contain statements related to future, not past, events. These forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "estimate," "forecast," "target," "preliminary," or "range." Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the impacts of the COVID-19 pandemic on our business operations, financial results and financial position and on the world economy; our expected financial performance, including cash flows, revenues, organic growth, margins, earnings and earnings per share; macroeconomic and market conditions and volatility; planned and potential business or asset dispositions, including our plan to combine our GE Capital Aviation Services (GECAS) business with AerCap Holdings N.V. (AerCap); our de-leveraging plans, including leverage ratios and targets, the timing and nature of actions to reduce indebtedness and our credit ratings and outlooks; GE's and GE Capital's funding and liquidity; our businesses’ cost structures and plans to reduce costs; restructuring, goodwill impairment or other financial charges; or tax rates.
For us, particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include:
•the continuing severity, magnitude and duration of the COVID-19 pandemic, including impacts of the pandemic, of businesses’ and governments’ responses to the pandemic and of individual factors such as aviation passenger confidence on our operations and personnel, and on commercial activity and demand across our and our customers’ businesses, and on global supply chains;
•the extent to which the COVID-19 pandemic and related impacts will continue to adversely impact our business operations, financial performance, results of operations, financial position, the prices of our securities and the achievement of our strategic objectives;
•our success in executing and completing asset dispositions or other transactions, including our plan to combine our GECAS business with AerCap and our plan to exit our equity ownership position in Baker Hughes, the timing of closing for such transactions, the ability to secure regulatory approvals and satisfy other closing conditions (as applicable), and the expected proceeds, consideration and benefits to GE;
•changes in macroeconomic and market conditions and market volatility (including developments and volatility arising from the COVID-19 pandemic), including interest rates, the value of securities and other financial assets (including our equity ownership position in Baker Hughes and the equity ownership position that we will hold in AerCap after completing our announced plan to combine GECAS with AerCap), oil, natural gas and other commodity prices and exchange rates, and the impact of such changes and volatility on our financial position and businesses;
•our de-leveraging and capital allocation plans, including with respect to actions to reduce our indebtedness, the timing and amount of GE dividends, organic investments, and other priorities;
•further downgrades of our current short- and long-term credit ratings or ratings outlooks, or changes in rating application or methodology, and the related impact on our liquidity, funding profile, costs and competitive position;
•GE’s liquidity and the amount and timing of our GE Industrial cash flows and earnings, which may be impacted by customer, supplier, competitive, contractual and other dynamics and conditions;
•GE Capital's capital and liquidity needs, including in connection with GE Capital’s run-off insurance operations and discontinued operations such as Bank BPH, the amount and timing of any required capital contributions and any strategic actions that we may pursue; the impact of conditions in the financial and credit markets on GE Capital's ability to sell financial assets; the availability and cost of funding; and GE Capital's exposure to particular counterparties and markets, including through GECAS to the aviation sector and adverse impacts related to COVID-19;
•global economic trends, competition and geopolitical risks, including changes in the rates of investment or economic growth in key markets we serve, or an escalation of sanctions, tariffs or other trade tensions between the U.S. and China or other countries, and related impacts on our businesses' global supply chains and strategies;
•market developments or customer actions that may affect levels of demand and the financial performance of the major industries and customers we serve, such as secular, cyclical and competitive pressures in our Power business, pricing and other pressures in the renewable energy market, levels of demand for air travel and other dynamics related to the COVID-19 pandemic, conditions in key geographic markets and other shifts in the competitive landscape for our products and services;
•operational execution by our businesses, including the operations and execution of our Power and Renewable Energy businesses, and the performance of our Aviation business;
•changes in law, regulation or policy that may affect our businesses, such as trade policy and tariffs, regulation related to climate change, and the effects of tax law changes;
•our decisions about investments in new products, services and platforms, and our ability to launch new products in a cost-effective manner;
•our ability to increase margins through implementation of operational changes, restructuring and other cost reduction measures;
•the impact of regulation and regulatory, investigative and legal proceedings and legal compliance risks, including the impact of Alstom and other investigative and legal proceedings;
•the impact of actual or potential failures of our products or third-party products with which our products are integrated, and related reputational effects;
•the impact of potential information technology, cybersecurity or data security breaches at GE or third parties; and
•the other factors that are described in the "Risk Factors" section of this report and of our Annual Report on Form 10-K for the year ended December 31, 2020, as such descriptions may be updated or amended in any future reports we file with the SEC.
These or other uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements. We do not undertake to update our forward-looking statements. This document includes certain forward-looking projected financial information that is based on current estimates and forecasts. Actual results could differ materially.

2021 1Q FORM 10-Q 3


ABOUT GENERAL ELECTRIC. General Electric Company (General Electric, GE or the Company) is a high-tech industrial company that operates worldwide through its four industrial segments, Power, Renewable Energy, Aviation and Healthcare, and its financial services segment, Capital. See the Segment Operations section within Management’s Discussion and Analysis of Financial Condition (MD&A) for segment business descriptions and product and service offerings. See the Consolidated Results section within MD&A and Results of Operations and Note 2 to the consolidated financial statements for information regarding our recent business portfolio actions. Results of businesses reclassified to discontinued operations have been recast for all periods presented.

GE’s Internet address at www.ge.com, Investor Relations website at www.ge.com/investor-relations and our corporate blog at www.gereports.com, as well as GE’s Facebook page, Twitter accounts and other social media, including @GE_Reports, contain a significant amount of information about GE, including financial and other information for investors. GE encourages investors to visit these websites from time to time, as information is updated and new information is posted.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (MD&A). See Note 1 for a discussion of the basis of presentation for our consolidated financial statements and this MD&A. Discussions throughout MD&A are based on continuing operations unless otherwise noted. The MD&A should be read in conjunction with the Financial Statements and Notes to the consolidated financial statements. For purposes of the financial statement display of sales and costs of sales in our consolidated Statement of Earnings (Loss), “goods” is required by SEC regulations to include all sales of tangible products, and "services" must include all other sales, including other services activities. Throughout MD&A we refer to sales under product services agreements and sales of both goods (such as spare parts and equipment upgrades) and related services (such as monitoring, maintenance and repairs) as sales of “services,” which is an important part of our operations.

We believe investors will gain a better understanding of our company if they understand how we measure and talk about our results. Because of the diversity in our businesses, we present our financial statements in a three-column format, which allows investors to see our GE Industrial operations separately from our GE Capital operations. We believe that this provides useful information to investors.

In the accompanying analysis of financial information, we sometimes use information derived from consolidated financial data but not presented in our financial statements prepared in accordance with GAAP. Certain of these data are considered “non-GAAP financial measures” under SEC rules. See the Non-GAAP Financial Measures section for the reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures.

CONSOLIDATED RESULTS
SIGNIFICANT DEVELOPMENTS. Coronavirus Disease 2019 (COVID-19) Pandemic. The COVID-19 pandemic has impacted global economies, resulting in workforce and travel restrictions, supply chain and production disruptions and reduced demand and spending across many sectors. Since the latter part of the first quarter of 2020, these factors have had a material adverse impact on our operations and financial performance, as well as on the operations and financial performance of many of the customers and suppliers in industries that we serve. While factors related directly and indirectly to the COVID-19 pandemic have been impacting operations and financial performance at varying levels across all our businesses, the most significant impact to date has been at our Aviation segment and our GE Capital Aviation Services (GECAS) aircraft leasing business within discontinued operations. For details about impacts related to our businesses and actions we have taken in response, as applicable, refer to the respective segment sections within MD&A. We also continue to evaluate market conditions as they evolve and take precautionary measures to strengthen our financial position. We ended the first quarter of 2021 with $31.8 billion of consolidated cash, cash equivalents and restricted cash, in addition to our available credit lines of $20.2 billion. See the Capital Resources and Liquidity section for further information. We anticipate that our operations and financial performance will continue to be impacted by the COVID-19 pandemic in future periods. These impacts will ultimately depend on many factors that are not within our control, including the severity and duration of the pandemic; governmental, business and individuals’ actions in response to the pandemic; and the development, availability and public acceptance of effective treatments and vaccines.

GECAS. On March 9, 2021, we announced an agreement to combine GECAS with AerCap Holdings N.V. (AerCap), for which the Company expects to receive $23.9 billion in cash, subject to contractual closing adjustments, 111.5 million shares of AerCap common stock (approximately 46% ownership interest) valued at approximately $6.6 billion based on the AerCap’s closing share price on March 31, 2021, and $1 billion in AerCap notes and/or cash upon closing. In connection with the signing of the transaction agreement, GE Capital recorded a non-cash after-tax charge of $2.8 billion in discontinued operations in the first quarter of 2021, partially offset by $0.2 billion of earnings, and the results of GECAS are now presented in discontinued operations. Given the economics of GECAS accrue to AerCap in conjunction with the transaction, the net impact of GECAS (loss on sale and operations) could change materially, mainly due to fluctuations in AerCap's closing share price. Completion of the transaction remains subject to AerCap shareholder approval, regulatory approvals and other customary closing conditions.

After completion of the transaction, we will elect to prospectively measure our investment in AerCap at fair value and expect to have continuing involvement with AerCap, primarily through our ownership interest and ongoing sales or leases of products and services. In addition, we expect to sell our stake in an orderly fashion over time. The remainder of GE Capital, including Energy Financial Services (EFS) and our run-off insurance operations, will be reported within Corporate. This means we will move from three-column to one-column financial statement reporting.


2021 1Q FORM 10-Q 4

FIRST QUARTER 2021 RESULTS. Consolidated revenues were $17.1 billion, down $2.4 billion for the quarter, driven by decreased GE Industrial revenues partially offset by increased GE Capital revenues. GE Industrial revenues decreased $2.5 billion (13%), driven primarily by decreases at Aviation, Healthcare and Power, partially offset by an increase at Renewable Energy. GE Capital revenues increased 5%.

Continuing earnings (loss) per share was $0.00. Excluding realized and unrealized gains (losses), non-operating benefit costs, restructuring and other charges and a GE Capital tax loss, Adjusted earnings per share* was $0.03.

For the three months ended March 31, 2021, GE Industrial profit was $0.4 billion and profit margins were 2.3%, down $6.2 billion, driven primarily by the nonrecurrence of the $12.3 billion gain on the sale of our BioPharma business and lower profit at Aviation, partially offset by a lower net loss on our investment in Baker Hughes of $6.0 billion, a decrease in adjusted total Corporate operating costs* of $0.2 billion, a decrease in non-operating benefit cost of $0.2 billion, and a decrease in interest and other financial charges of $0.1 billion. Adjusted GE Industrial organic profit* increased $0.1 billion, as increases at Healthcare, Renewable Energy and Power, and lower adjusted total Corporate operating costs*, were partially offset by a decrease at Aviation.

GE Industrial cash flows from operating activities (CFOA) were $(0.5) billion and $(1.7) billion for the three months ended March 31, 2021 and 2020, respectively. GE Industrial cash used for operating activities decreased primarily due to a decrease in cash used for working capital, partially offset by an increase in cash used for All other operating activities. GE Industrial free cash flows (FCF)* were $(0.8) billion and $(2.2) billion for the three months ended March 31, 2021 and 2020, respectively. GE Industrial FCF increased primarily due to a decrease in cash used for working capital, and a decrease in additions to property, plant and equipment and internal-use software, partially offset by an increase in cash used for All other operating activities. See the Capital Resources and Liquidity - Statement of Cash Flows section for further information.

Orders are contractual commitments with customers to provide specified goods or services for an agreed upon price.
GE INDUSTRIAL ORDERS Three months ended March 31
2021 2020
Equipment $ 8,208  $ 9,211 
Services 8,800  10,274 
Total orders(a) $ 17,008  $ 19,485 
Total organic orders $ 16,720  $ 18,247 
(a) Orders for the three months ended March 31, 2020 included $1,136 million related to BioPharma.

For the three months ended March 31, 2021, orders decreased $2.5 billion (13%) on a reported basis and decreased $1.5 billion (8%) organically primarily at Aviation, due to decreases in services orders, and at Power, due to decreases in equipment orders, partially offset by increases at Renewable Energy and Healthcare. Equipment orders were down $0.1 billion (1%) organically and services orders were down $1.4 billion (14%) organically.

Backlog is unfilled customer orders for products and product services (expected life of contract sales for product services).
GE INDUSTRIAL BACKLOG March 31, 2021 December 31, 2020 March 31, 2020
Equipment $ 72,272  $ 73,286  $ 76,854 
Services 311,134  313,234  324,216 
Total backlog $ 383,405  $ 386,520  $ 401,070 

As of March 31, 2021, backlog decreased $3.1 billion (1%) from December 31, 2020, primarily at Power, from sales outpacing new orders, and at Aviation, from cancellations of commercial engine and service orders. Renewable Energy decreased due to the effects of foreign currency fluctuations, and Healthcare decreased due to an increase in shorter cycle time products. Backlog decreased $17.7 billion (4%) from March 31, 2020, due to a decrease in equipment backlog of $4.6 billion (6%), primarily at Aviation, Power and Healthcare, and a decrease in services backlog of $13.1 billion (4%), primarily at Aviation, due to a reduction in our Commercial Services backlog and cancellations of commercial engine orders, and at Power, due to sales outpacing new orders. The reduction in Commercial Services at Aviation reflects the cancellation of equipment unit orders, lower anticipated engine utilization, customer fleet restructuring and contract modifications.

Remaining performance obligation (RPO), a defined term under GAAP, is backlog excluding any purchase order that provides the customer with the ability to cancel or terminate without incurring a substantive penalty. In the second quarter of 2021, we expect to replace our quarterly disclosures of backlog with RPO as a key metric, one commonly used across our industries, which will simplify our reporting. Our historical experience indicates the likelihood of cancellation of orders excluded from RPO is remote. See Note 9 for further information.





*Non-GAAP Financial Measure
2021 1Q FORM 10-Q 5

March 31, 2021
Equipment Services Total
Backlog $ 72,272  $ 311,134  $ 383,405 
Adjustments (31,321) (125,122) (156,443)
Remaining performance obligation $ 40,951  $ 186,012  $ 226,962 

Adjustments to reported backlog, primarily related to long-term contracts in excess of one year, of $156.4 billion as of March 31, 2021 are largely driven by adjustments of $145.9 billion in our Aviation segment: (1) backlog includes engine contracts for which we have received purchase orders that are cancelable; (2) our services backlog includes contracts that are cancelable without substantive penalty, primarily time and materials contracts; and (3) backlog includes engines contracted under long-term service agreements, even if the engines have not yet been put into service.
REVENUES Three months ended March 31
2021 2020
Consolidated revenues $ 17,118  $ 19,490 
Equipment 7,971  9,097 
Services 8,358  9,748 
GE Industrial revenues $ 16,329  $ 18,844 
GE Capital revenues $ 878  $ 837 

For the three months ended March 31, 2021, Consolidated revenues were down $2.4 billion, driven by a decrease in GE Industrial revenues of $2.5 billion partially offset by an increase in GE Capital revenues.
GE Industrial revenues decreased $2.5 billion (13%), with decreases in services and equipment. The decrease in services was primarily at Aviation, due to lower commercial spare part shipments and decreased shop visits, partially offset by an increase at Power driven by Gas Power services revenues. The decrease in equipment was primarily at Aviation, due to fewer commercial install and spare engine shipments; at Healthcare, due to the disposition of the BioPharma business; and at Power, due to decreases in Steam Power and Gas Power; partially offset by an increase in Renewable Energy. The decrease in GE Industrial revenues included the net effects of dispositions of $1.1 billion and an increase from foreign currency translation of $0.3 billion. Excluding the effects of acquisitions, dispositions and foreign currency translation, GE Industrial organic revenues* decreased $1.7 billion (10%), with a decrease in services revenues of $1.4 billion (14%) and equipment revenues of $0.4 billion (5%). GE Industrial organic revenues* decreased at Aviation and Power, partially offset by an increase at Healthcare. Healthcare organic revenue* increased $0.3 billion (7%) due to increased demand for Healthcare Systems (HCS) products, and a return to pre-pandemic volume in Pharmaceutical Diagnostics (PDx).
GE Capital revenues increased 5%, primarily as a result of lower marks and impairments primarily in Insurance, partially offset by lower revenue at Working Capital Solutions (WCS) due to lower volume and lower gains and project revenues at EFS.

EARNINGS (LOSS) AND EARNINGS (LOSS) PER SHARE Three months ended March 31
(Per-share in dollars and diluted) 2021 2020
Continuing earnings (loss) $ 20  $ 6,175 
Continuing earnings per share (loss) $ —  $ 0.70 

For the three months ended March 31, 2021, Consolidated continuing earnings decreased $6.2 billion due to a decrease in GE Industrial profit.
GE Industrial profit decreased $6.2 billion driven by the nonrecurrence of the $12.3 billion gain on the sale of our BioPharma business and lower profit at Aviation, partially offset by a lower net loss on our investment in Baker Hughes of $6.0 billion, a decrease in adjusted total Corporate operating costs* of $0.2 billion, a decrease in non-operating benefit cost of $0.2 billion, and a decrease in interest and other financial charges of $0.1 billion. GE Industrial profit margin was 2.3%, a decrease from 34.9%, primarily due to the same net decreases as described above. Adjusted GE Industrial profit* was $0.8 billion, an increase of $0.1 billion organically*, due to increases at Healthcare, Renewable Energy and Power, partially offset by a decrease at Aviation. Adjusted GE Industrial profit margin* was 5.1%, an increase of 110 basis points organically*, primarily due to the same net increases as described above. At Aviation, the primary drivers were lower volume on commercial spare part and commercial spare engine shipments, and decreased shop visits in our service agreements. At Power, the increase was driven by growth in Gas Power services revenues and margins, and continued efforts to streamline the business. At Healthcare, the increase was primarily due to cost reductions and increased demand for HCS products and increases in PDx volume, and at Renewable Energy, the increase was due to product cost deflation, the favorable impact of cost reduction measures and improved project execution.
GE Capital continuing losses decreased 8% as lower claims, improved investment performance and lower marks and impairments in Insurance were partially offset by lower gains and project revenues at EFS and the nonrecurrence of the tax benefit related to the BioPharma sale in the first quarter of 2020.





*Non-GAAP Financial Measure
2021 1Q FORM 10-Q 6

SEGMENT OPERATIONS. Refer to our Annual Report on Form 10-K for the year ended December 31, 2020, for further information regarding our determination of Industrial and Capital segment profit for continuing operations, and for our allocations of corporate costs to our segments.
SUMMARY OF REPORTABLE SEGMENTS Three months ended March 31
2021 2020 V%
Power
$ 3,921  $ 4,025  (3) %
Renewable Energy
3,248  3,194  2  %
Aviation
4,992  6,892  (28) %
Healthcare
4,308  4,727  (9) %
Capital
878  837  5  %
Total segment revenues
17,346  19,675  (12) %
Corporate items and eliminations
(228) (185) (23) %
Consolidated revenues
$ 17,118  $ 19,490  (12) %
Power
$ (87) $ (131) 34  %
Renewable Energy
(234) (327) 28  %
Aviation
641  1,003  (36) %
Healthcare
698  867  (19) %
Capital
(172) (187) 8  %
Total segment profit (loss)
847  1,224  (31) %
Corporate items and eliminations
52  6,123  (99) %
GE Industrial interest and other financial charges (268) (370) 28  %
GE Industrial non-operating benefit costs (433) (616) 30  %
GE Industrial benefit (provision) for income taxes (148) (187) 21  %
Earnings (loss) from continuing operations attributable to GE common shareholders
20  6,175  U
Earnings (loss) from discontinued operations, net of taxes
(2,894) (21) U
Less net earnings (loss) attributable to noncontrolling interests, discontinued operations —  (2) F
Earnings (loss) from discontinued operations, net of tax and noncontrolling interest
(2,894) (19) U
Consolidated net earnings (loss) attributable to the GE common shareholders
$ (2,874) $ 6,156  U

POWER. Power continues to streamline its business to better align with market demand and drive its businesses with an operational rigor and discipline that is focused on its customers’ lifecycle experience. We remain focused on our underwriting discipline and risk management to ensure we are securing deals that meet our financial hurdles and we have a high confidence to deliver for our customers.

Global electricity demand increased during the first quarter of 2021, driving increases in GE gas turbine utilization and long-term service agreement billings. Looking ahead, we anticipate the power market to continue to be impacted by overcapacity in the industry, continued price pressure from competition on servicing the installed base, and the uncertain timing of deal closures due to financing and the complexities of working in emerging markets, as well as the ongoing impacts of COVID-19. Market factors related to the energy transition such as greater renewable energy penetration and the adoption of climate change-related policies continue to impact long-term demand, to differing degrees across markets globally. We believe gas will play a critical role in the energy transition and our view of the market has not materially changed. Our businesses are executing on their turnarounds, including the planned exit of new build coal, and we are encouraged by the growth in Gas Power Services.

We continue to invest in new product development, such as our HA-Turbines. Our fundamentals remain strong with approximately $78 billion in backlog and a gas turbine installed base greater than 7,000 units, including approximately 1,800 units under long-term service agreements.
Three months ended March 31
Orders Sales
(In units) 2021 2020 2021 2020
GE Gas Turbines 18  9  11  7 
Heavy-Duty Gas Turbines(a) 10  6  11  5 
HA-Turbines(b) 2  2  5  4 
Aeroderivatives(a) 8  3  —  2 
GE Gas Turbine Gigawatts(c) 1.7  2.2 
(a) Heavy-Duty Gas Turbines and Aeroderivatives are subsets of GE Gas Turbines.
(b) HA-Turbines are a subset of Heavy-Duty Gas Turbines.
(c) Gigawatts reported associated with orders in the periods presented.

2021 1Q FORM 10-Q 7

March 31, 2021 December 31, 2020 March 31, 2020
Equipment $ 16,563  $ 17,127  $ 18,187 
Services 61,468  62,448  66,921 
Total backlog $ 78,032  $ 79,575  $ 85,108 

Three months ended March 31
2021 2020
Equipment $ 837  $ 1,498 
Services 2,796  2,612 
Total orders $ 3,633  $ 4,111 
Gas Power $ 2,829  $ 2,859 
Power Portfolio 1,091  1,165 
Total segment revenues $ 3,921  $ 4,025 
Equipment $ 1,241  $ 1,506 
Services 2,679  2,518 
Total segment revenues $ 3,921  $ 4,025 
Segment profit (loss) $ (87) $ (131)
Segment profit margin (2.2) % (3.3) %
For the three months ended March 31, 2021, segment orders were down $0.5 billion (12%), segment revenues were down $0.1 billion (3%) and segment profit was up 34%.
Backlog as of March 31, 2021 decreased $1.5 billion (2%) and $7.1 billion (8%) from December 31, 2020 and March 31, 2020, respectively, primarily driven by sales outpacing new orders.
Orders decreased $0.5 billion (12%) organically, primarily due to decreases in Gas Power driven by the nonrecurrence of a large turnkey order and Steam Power equipment orders.
Revenues decreased $0.2 billion (4%) organically*, primarily due to decreased Steam Power equipment and services revenues and decreases in Gas Power equipment revenues, partially offset by an increase in Gas Power services revenues.
Profit increased 35% organically* due to growth in Gas Power services revenues and margins and continued efforts to streamline the business across Gas Power and Power Portfolio, partially offset by unfavorable legacy project arbitration resolutions and Steam project execution.

RENEWABLE ENERGY. Renewable Energy includes a portfolio of businesses comprising Onshore Wind (with our separate LM Wind blades business), Grid Solutions equipment and services, Hydro, Offshore Wind and Hybrid Solutions. These businesses are uniquely positioned to lead the energy transition with products and integrated solutions by growing new renewable energy generation, lowering the cost of electricity and modernizing the grid.

We continue to observe strong demand across the global onshore wind market together with a positive impact on deliveries and installations in the U.S. from the Production Tax Credit (PTC) cycle and customer preference shifting to larger, more efficient units to drive down costs and compete with other power generation options. The Grid and Hydro businesses are executing their turnaround plans and we are expecting improved operating results in 2021.

New product introductions remain important to our onshore and offshore customers who are demonstrating the willingness to adopt the new technology of larger turbines that decrease the levelized cost of energy. We have observed significant market demand for our Onshore 5-6 MW Cypress units and Offshore Haliade-X 12-13 MW units and are preparing for large scale production in response to this market demand.
Three months ended March 31
Orders Sales
Onshore and Offshore (In units)
2021 2020 2021 2020
Wind Turbines 728  738  778  731 
Wind Turbine Gigawatts 2.2  2.3  2.4  2.1 
Repower units 121  6  —  219 

March 31, 2021 December 31, 2020 March 31, 2020
Equipment $ 16,987  $ 17,470  $ 15,799 
Services 12,461  12,531  10,712 
Total backlog $ 29,448  $ 30,001  $ 26,511 


*Non-GAAP Financial Measure
2021 1Q FORM 10-Q 8

Three months ended March 31
2021 2020
Equipment $ 2,954  $ 2,669 
Services 561  399 
Total orders $ 3,515  $ 3,068 
Onshore Wind $ 2,118  $ 2,124 
Grid Solutions equipment and services 795  839 
Hydro 165  179 
Offshore Wind and Hybrid Solutions
169  51 
Total segment revenues $ 3,248  $ 3,194 
Equipment $ 2,844  $ 2,576 
Services 404  618 
Total segment revenues $ 3,248  $ 3,194 
Segment profit (loss) $ (234) $ (327)
Segment profit margin (7.2) % (10.2) %
For the three months ended March 31, 2021, segment orders were up $0.4 billion (15%), segment revenues were up $0.1 billion (2%) and segment profit was up $0.1 billion (28%).
Backlog as of March 31, 2021 decreased $0.6 billion (2%) from December 31, 2020 primarily driven by the effects of foreign currency fluctuations, partially offset by new orders outpacing sales. Backlog increased $2.9 billion (11%) from March 31, 2020 primarily from Offshore Wind due to our first Haliade-X order for the Dogger Bank Wind Farm, new Cypress platform orders in Onshore Wind and an increase in Hydro. These increases were partially offset by sales exceeding new orders at Grid, primarily as a result of increased commercial selectivity in certain product lines.
Orders increased $0.4 billion (13%) organically, primarily due to the Grid high voltage direct current (HVDC) project for the Sofia Offshore Wind Farm and higher services orders at Onshore Wind.
Revenues were flat organically*, as higher revenue at Offshore Wind associated with the EDF’s 6MW PBG project in Saint-Nazaire, France and 30 more Onshore Wind turbine sales on a unit basis and 11% more on a megawatt basis, were offset by lower repower unit deliveries at Onshore Wind and lower revenue at Grid.
Profit increased $0.1 billion (31%) organically*, primarily from improvement in Onshore Wind product cost, the favorable impact of cost reduction measures, primarily at Grid and Hydro, and improved project execution, partially offset by lower margins on new product introductions at Onshore Wind and higher restructuring costs.

AVIATION. The global COVID-19 pandemic continues to have a material adverse effect on the global airline industry. A key underlying driver of Aviation’s commercial engine and services businesses is global commercial air traffic, which in turn is driven by economic activity and consumer and business propensity to travel. Since the beginning of the pandemic in the first quarter of 2020, we have seen varied levels of recovery in global markets. Government travel restrictions, public health advisories, individuals' propensity to travel and continued cases of the virus have all impacted the level of air travel. Aviation regularly tracks global departures, which as of March 31, 2021, were approximately 40% below first quarter 2020. Global departures improved in March 2021 compared to the first two months of the year, but levels of recovery varied across global regions. Aviation is closely monitoring government actions and economic and industry forecasts. Due to the global airline industry contraction, Aviation’s airline and airframe customers are taking measures to address reduced demand, which, in turn, continue to materially impact Aviation’s business operations and financial performance. More broadly, we are in frequent dialogue with our airline and airframe customers about the outlook for commercial air travel, new aircraft production, fleet retirements, and after-market services, including shop visit and spare part demand. Given current trends, we expect domestic travel routes primarily served by narrowbody aircraft to recover before long-haul, international travel routes which are primarily served by widebody aircraft. Consistent with industry projections, Aviation continues to estimate the duration of the market recovery to be prolonged over multiple years dependent on containing the spread of the virus, effective inoculation programs and government collaboration to encourage travel, particularly around reducing quarantine requirements.

Aviation has taken several business actions to respond to the current adverse environment, including a reduction of approximately 25% of its total global workforce since year-end 2019. The business is actively monitoring the pace of demand recovery to ensure the business is appropriately sized for the future. In addition, we continue to partner with our airline and leasing customers and are aligned with our airframe partners on production rates for 2021 and beyond.

As it relates to the military environment, Aviation continues to forecast strong military demand creating future growth opportunities for our Military business as the U.S. Department of Defense and foreign governments have continued flight operations, and have allocated budgets to upgrade and modernize their existing fleets. During the first quarter of 2021, Aviation continued to experience supply chain challenges, which the business is actively addressing.

Total engineering, comprised of company, customer and partner-funded and nonrecurring engineering costs, decreased compared to prior year in line with the changes in the commercial environment. During the first quarter of 2021, company-funded research and development spend decreased compared to the prior year. Customer and partner-funded engineering efforts, primarily in our Military business, decreased compared to the prior year due to the timing of planned program expenditures. Aviation continues to be committed to investment in developing and maturing technology that enables a more sustainable future of flight.
*Non-GAAP Financial Measure
2021 1Q FORM 10-Q 9

Aviation is taking actions to protect its ability to serve its customers now and as the global airline industry recovers. Aviation’s deep history of innovation and technology leadership, commercial engine installed base of approximately 37,700 units, with approximately 12,500 units under long-term service agreements, and military engine installed base of approximately 26,500 units represents strong long-term fundamentals. Aviation seeks to emerge from this crisis stronger and drive long-term cash and profitable growth over time.

Three months ended March 31
Orders Sales
(In units, except where noted) 2021 2020 2021 2020
Commercial Engines(a) 298  168  359  530 
LEAP Engines(b) 141  6  188  272 
Military Engines 181  272  96  146 
Spare Parts Rate(c) $ 13.2  $ 26.9 
(a) Commercial Engines now includes Business and General Aviation and Aeroderivative units for all periods presented.
(b) LEAP engines are subsets of commercial engines.
(c) Commercial externally shipped spare parts and spare parts used in time and material shop visits in millions of dollars per day.

March 31, 2021 December 31, 2020 March 31, 2020
Equipment $ 34,333  $ 34,486  $ 39,154 
Services 225,032  225,927  234,078 
Total backlog $ 259,365  $ 260,412  $ 273,232 
Three months ended March 31
2021 2020
Equipment $ 2,004  $ 2,228 
Services 3,488  5,221 
Total orders $ 5,491  $ 7,448 
Commercial Engines & Services $ 3,354  $ 5,113 
Military 956  960 
Systems & Other 682  820 
Total segment revenues $ 4,992  $ 6,892 
Equipment $ 1,847  $ 2,364 
Services 3,145  4,529 
Total segment revenues $ 4,992  $ 6,892 
Segment profit $ 641  $ 1,003 
Segment profit margin 12.8  % 14.6  %
For the three months ended March 31, 2021, segment orders were down $2.0 billion (26%), segment revenues were down $1.9 billion (28%) and segment profit was down $0.4 billion (36%).
Backlog as of March 31, 2021 decreased $1.0 billion from December 31, 2020, primarily due to approximately 400 LEAP-1B unit order cancellations. Backlog decreased $13.9 billion (5%) from March 31, 2020, primarily due to a reduction in our Commercial Services backlog and cancellations of commercial equipment orders, which included approximately 1,900 LEAP-1B unit order cancellations. The reduction to Commercial Services backlog reflects estimates of lower engine utilization, the partial cancellation of long-term service agreements related to the equipment unit order cancellations, and anticipated customer fleet restructuring and contract modifications.
Orders decreased $1.9 billion (26%) organically, primarily driven by lower commercial equipment and service orders as airline customers have slowed or deferred new engine orders, as well as delayed maintenance and repair operations while existing fleets have lower utilization or been grounded. Military orders decreased 8% compared to the prior year primarily driven by lower spare parts orders.
Revenues decreased $1.9 billion (27%) organically*. Equipment revenues decreased, primarily due to 171 fewer commercial install and spare engine unit shipments, including 84 fewer LEAP units versus the prior year. Commercial Services revenues decreased, primarily due to lower commercial spare part shipments and decreased shop visits. Military revenues were flat with 50 fewer engine shipments due to supply chain challenges, offset by favorable product mix.
Profit decreased $0.4 billion (37%) organically*, primarily due to lower volume on commercial spare part and commercial spare engine shipments, and decreased shop visits in our service agreements. These decreases in profit were partially offset by operational cost reduction from the cost savings actions taken in 2020 and the first quarter of 2021, along with charges related to customer
credit risk and declines in the estimated profitability in long-term service agreements not repeating in the current year.




*Non-GAAP Financial Measure
2021 1Q FORM 10-Q 10

HEALTHCARE. We continue to see an overall recovery in hospital spend and increases in procedure volume; the expectation is that this will continue in line with the worldwide COVID-19 vaccine rollout. PDx demand has largely recovered to pre-COVID levels in line with increases in procedure volume. However, in some markets we expect capital expenditures to remain under pressure from revenue declines related to COVID-19 impacts. The pandemic is still driving additional supply chain and logistics costs, and we expect this to continue. In response to continuing near-term volatility and cost pressures, we have continued to execute on structural cost reductions and cash optimization actions, in order to prioritize spend on growth and research and development.

We continue focusing on creating new products and digital solutions as well as expanding uses of existing offerings that are tailored to the different needs of our global customers. GE Healthcare introduced the latest member of the Venue™ point of care ultrasound family. We also introduced Vscan Air, a cutting edge wireless pocket-sized ultrasound that provides crystal clear image quality, whole-body scanning capabilities, and intuitive software. We received 510(k) clearance for OEC 3D surgical c-arm. OEC 3D sets the standard of interoperative imaging with precise 3D volumetric images for spine and orthopedic procedures combined with 2D imaging for greater everyday efficiency. We remain committed to innovate and invest to create more integrated, efficient, and personalized precision healthcare.
March 31, 2021 December 31, 2020 March 31, 2020
Equipment $ 5,564  $ 5,538  $ 5,957 
Services 11,479  11,562  11,433 
Total backlog $ 17,044  $ 17,100  $ 17,389 

Three months ended March 31
2021 2020
Equipment $ 2,445  $ 3,305 
Services 2,027  1,987 
Total orders(a) $ 4,472  $ 5,292 
Healthcare Systems (HCS) $ 3,825  $ 3,448 
Pharmaceutical Diagnostics (PDx) 482  450 
BioPharma —  830 
Total segment revenues $ 4,308  $ 4,727 
Equipment $ 2,227  $ 2,699 
Services 2,081  2,029 
Total segment revenues $ 4,308  $ 4,727 
Segment profit $ 698  $ 867 
Segment profit margin 16.2  % 18.3  %
(a) Orders for the three months ended March 31, 2020 included $1,136 million related to BioPharma.
For the three months ended March 31, 2021, segment orders were down $0.8 billion (15%), segment revenues were down $0.4 billion (9%) and segment profit was down $0.2 billion (19%).
Backlog as of March 31, 2021 decreased $0.1 billion from December 31, 2020 and $0.3 billion (2%) from March 31, 2020 primarily due to conversion to revenue of shorter cycle time LCS products, offset by increases in orders of longer cycle time imaging products.
Orders increased $0.2 billion (5%) organically, due to increases in Imaging and Ultrasound in HCS, and a return to pre-pandemic volume in PDx, partially offset by lower Life Care Solutions (LCS) orders in HCS as pandemic-related demand softened.
Revenues increased $0.3 billion (7%) organically*, driven by increased demand in Imaging, Ultrasound and Life Care Solutions for HCS products, and a return to pre-pandemic volume in PDx.
Profit increased $0.2 billion (30%) organically*, primarily due to cost reductions and increased demand for HCS products, and increases in PDx volume.

CAPITAL. In the first quarter of 2021, we announced an agreement to combine GECAS with AerCap, for which the Company expects to receive $23.9 billion in cash, subject to contractual closing adjustments, approximately $6.6 billion in shares representing a 46% stake in the combined company, and $1 billion in AerCap notes and/or cash upon closing. The Company expects to transfer GECAS’ net assets, including its engine leasing and Milestone helicopter leasing businesses, as well as GECAS’ more than 400 employees and its current purchase obligations, to AerCap. In addition, upon the closing of the transaction, the remainder of GE Capital will be reported within Corporate.

In connection with the signing of the transaction agreement, GE Capital recorded a non-cash after-tax charge of $2.8 billion in discontinued operations in the first quarter of 2021, and the results of GECAS are now presented in discontinued operations.

In the first quarter of 2021, we announced our intention to discontinue the majority of our factoring programs, which was effective April 1, 2021.

GE Capital made capital contributions to its insurance subsidiaries of $2.0 billion in the first quarters of both 2021 and 2020, and expects to provide further capital contributions of approximately $5.5 billion through 2024.

*Non-GAAP Financial Measure
2021 1Q FORM 10-Q 11

March 31, 2021 December 31, 2020
Energy Financial Services (EFS) $ 2,359  $ 2,385 
Working Capital Solutions (WCS) 4,567 5,884
Insurance 50,353 50,824
Other continuing operations(a) 14,429  18,577 
Total segment assets - continuing operations $ 71,709  $ 77,670 
(a) Included cash, cash equivalents and restricted cash of $9,332 million as of March 31, 2021 and $13,245 million as of December 31, 2020.
Three months ended March 31
2021 2020
EFS $ (3) $ 64 
WCS 55  131 
Insurance 775  616 
Other continuing operations 51  25 
Total segment revenues $ 878  $ 837 
EFS $ (5) $ 53 
WCS 2  24 
Insurance 116  (93)
Other continuing operations(a) (285) (171)
Total segment profit (loss) $ (172) $ (187)
(a) Other continuing operations primarily comprised excess interest costs from debt previously allocated to assets that have been sold, interest costs not allocated to GE Capital businesses, and preferred stock dividend costs prior to January 2021, at which time these became a GE Industrial obligation (see Note 17 for further information). Interest costs are allocated to GE Capital businesses based on the tenor of their assets using the market rate at the time of origination, which differs from the asset profile when the debt was originated. As a result, actual interest expense is higher than interest expense allocated to the remaining GE Capital businesses. We anticipate unallocated interest costs to gradually decline as debt matures and/or is refinanced.

For the three months ended March 31, 2021, segment revenues increased 5% and segment losses decreased 8%.
GE Capital revenues increased 5%, primarily as a result of lower marks and impairments primarily in Insurance, partially offset by lower revenue at WCS due to lower volume and lower gains and project revenues at EFS. GE Capital segment losses decreased 8% as lower claims, improved investment performance and lower marks and impairments in Insurance were partially offset by lower gains and project revenues at EFS and the nonrecurrence of the tax benefit related to the BioPharma sale in the first quarter of 2020.

CORPORATE ITEMS AND ELIMINATIONS. Corporate items and eliminations included the results of our Lighting segment for the three months ended March 31, 2020, and our GE Digital business for all periods presented.
Three months ended March 31
2021 2020
Revenues
Corporate revenues $ 227  $ 377 
Eliminations and other (455) (562)
Total Corporate Items and Eliminations $ (228) $ (185)
Operating profit (cost)
Gains (losses) on disposals and held for sale businesses $ (159) $ 12,439 
Restructuring and other charges (106) (143)
Unrealized gains (losses) 509  (5,794)
Adjusted total corporate operating costs (Non-GAAP) (192) (379)
Total Corporate Items and Eliminations (GAAP) $ 52  $ 6,123 
Less: gains (losses) and restructuring & other 244  6,502 
Adjusted total corporate operating costs (Non-GAAP) $ (192) $ (379)
Functions & operations $ (159) $ (272)
Environmental, health and safety (EHS) and other items (55) (10)
Eliminations 23  (98)
Adjusted total corporate operating costs (Non-GAAP) $ (192) $ (379)
Adjusted total corporate operating costs* excludes gains (losses) on disposals and held for sale businesses, significant, higher-cost
restructuring programs and unrealized gains (losses). We believe that adjusting corporate costs to exclude the effects of items that are not closely associated with ongoing corporate operations provides management and investors with a meaningful measure that increases the period-to-period comparability of our ongoing corporate costs.
*Non-GAAP Financial Measure
2021 1Q FORM 10-Q 12

For the three months ended March 31, 2021, revenues remained relatively flat year over year primarily as a result of a $0.1 billion decrease in revenues due to the sale of our Lighting business in June 2020, offset by $0.1 billion of lower inter-segment eliminations. Corporate operating profit decreased by $6.1 billion due to $12.6 billion of lower net gains, primarily driven by $12.3 billion of gains from the sale of our BioPharma business during the first three months of 2020, as compared to $0.2 billion of realized losses primarily related to our Baker Hughes shares during the first three months of 2021. These decreases were partially offset by a $6.3 billion change in net unrealized gains and losses primarily related to mark-to-market activity on our Baker Hughes shares. Overall, restructuring and other charges remained relatively flat year over year.
Adjusted total corporate operating costs* decreased by $0.2 billion in the first quarter of 2021 primarily as the result of $0.1 billion of cost reductions primarily within our Corporate functions. Costs also decreased by $0.1 billion due to lower intercompany profit eliminations as the result of lower intercompany activity from our Aviation segment to our GECAS business, lower intercompany elimination activity from project financing investments associated with wind energy projects in our Renewable Energy segment and lower GE industrial inter-segment eliminations. Overall, costs associated with EHS matters remained relatively flat year over year.

OTHER CONSOLIDATED INFORMATION
RESTRUCTURING. Restructuring actions are essential to our cost improvement efforts for both existing operations and those acquired. Restructuring and other charges relate primarily to workforce reductions, facility exit costs associated with the consolidation of sales, service and manufacturing facilities, the integration of acquisitions, and certain other asset write-downs such as those associated with product line exits. We also recognize an obligation for severance benefits that vest or accumulate with service. We continue to closely monitor the economic environment and expect to undertake further restructuring actions to more closely align our cost structure with earnings goals. This table is inclusive of all restructuring charges in our segments.
Three months ended March 31
2021 2020
Workforce reductions $ 211  $ 154 
Plant closures & associated costs and other asset write-downs 26  29 
Acquisition/disposition net charges 5  27 
Total restructuring and other charges $ 242  $ 210 
Cost of product/services $ 101  $ 116 
Selling, general and administrative expenses 148  94 
Other income (7) — 
Total restructuring and other charges $ 242  $ 210 
Power $ 49  $ 33 
Renewable Energy 76  26 
Aviation 62  68 
Healthcare 39  30 
Corporate 11  50 
Total GE Industrial restructuring and other charges $ 236  $ 207 
Capital 5  3 
Total restructuring and other charges $ 242  $ 210 
Restructuring and other charges cash expenditures $ 223  $ 210 

Liabilities associated with restructuring activities were approximately $1.3 billion, including actuarial determined post-employment severance benefits of $0.7 billion as of both March 31, 2021 and December 31, 2020.
INTEREST AND OTHER FINANCIAL CHARGES Three months ended March 31
2021 2020
GE Industrial $ 268  $ 370 
GE Capital 291  271 

The decrease in GE Industrial interest and other financial charges for the three months ended March 31, 2021 was primarily due to lower interest expense on debt driven by a lower intercompany loan balance and lower financing costs on sales of receivables. The primary components of GE interest and other financial charges are interest on short- and long-term borrowings and financing costs on sales of receivables. Total GE Industrial interest and other financial charges of $0.2 billion and $0.2 billion was recorded at Corporate and $0.1 billion and $0.1 billion was recorded by Industrial segments for the three months ended March 31, 2021 and 2020, respectively.

The increase in GE Capital interest and other financial charges for the three months ended March 31, 2021 was primarily due to higher average market interest rates and higher interest on assumed debt as a result of the repayments of intercompany loans by GE Industrial (effectively transferring that interest cost back to GE Capital), partially offset by lower average borrowings balances due to maturities and debt purchases.


*Non-GAAP Financial Measure
2021 1Q FORM 10-Q 13

CONSOLIDATED INCOME TAXES. For the three months ended March 31, 2021, the consolidated income tax rate was 59.7% compared to 0.9% for the three months ended March 31, 2020.

The consolidated provision (benefit) for income taxes was $0.1 billion for both the three months ended March 31, 2021 and 2020. The provision increased slightly as there was a tax expense associated with the unrealized gain on our remaining interest in Baker Hughes in the first quarter of 2021 compared to a tax benefit associated with the unrealized loss recorded in the first quarter of 2020. This was largely offset by the nonrecurrence of the tax expense associated with the disposition of the BioPharma business in the first quarter of 2020.

The consolidated tax provision (benefit) includes $0.1 billion and $0.2 billion for GE Industrial for the three months ended March 31, 2021 and 2020, respectively.

DISCONTINUED OPERATIONS. Primarily comprise our GECAS business, our mortgage portfolio in Poland, and other trailing assets and liabilities associated with the dispositions of certain GE Capital and GE Industrial businesses. See Notes 2 and 21 for further financial information regarding our businesses in discontinued operations.

CAPITAL RESOURCES AND LIQUIDITY
FINANCIAL POLICY. We intend to maintain a disciplined financial policy, including maintaining a high cash balance. We are targeting a sustainable long-term credit rating in the Single-A range, achieving a GE Industrial net debt*-to-EBITDA ratio of less than 2.5x over the next few years and a dividend in line with our peers over time. In addition to net debt*-to-EBITDA, we also evaluate other leverage measures, including gross debt-to-EBITDA, and we will ultimately size our deleveraging actions across a range of measures to ensure we are operating the Company based on a strong balance sheet. We intend to continue to decrease our GE Industrial leverage over time as we navigate this period of uncertainty.

Following the closing of the GECAS transaction, the Company intends to use the transaction proceeds and its existing cash sources to significantly reduce debt, and will continue to target achieving a less than 2.5x net debt-to-EBITDA ratio over the next few years.

LIQUIDITY POLICY. We maintain a strong focus on liquidity and define our liquidity risk tolerance based on sources and uses to maintain a sufficient liquidity position to meet our obligations under both normal and stressed conditions. We intend to maintain a high level of cash and maximize flexibility as we navigate the current environment. At both GE Industrial and GE Capital, we manage our liquidity to provide access to sufficient funding to meet our business needs and financial obligations, as well as capital allocation and growth objectives, throughout business cycles.

GE Industrial has continued to enhance its cash management operations, targeting increased linear cash flow, lower factoring, and reducing restricted cash. As a result, GE Industrial's go-forward cash needs are expected to be below $13 billion. We intend to continue holding elevated cash levels through this period of uncertainty.

At GE Capital, we continue to hold cash levels to cover at least 12 months of long-term debt maturities.

We believe that our consolidated liquidity and availability under our revolving credit facilities will be sufficient to meet our liquidity needs.

CONSOLIDATED LIQUIDITY. Following is a summary of cash, cash equivalents and restricted cash at March 31, 2021.
March 31, 2021 March 31, 2021
GE Industrial $ 22,361  U.S. $ 18,115 
GE Capital 9,422  Non-U.S. 13,668 
Consolidated $ 31,783  Consolidated $ 31,783 
Cash held in non-U.S. entities has generally been reinvested in active foreign business operations; however, substantially all of our unrepatriated earnings were subject to U.S. federal tax and, if there is a change in reinvestment, we would expect to be able to repatriate available cash (excluding amounts held in countries with currency controls) without additional federal tax cost. Any foreign withholding tax on a repatriation to the U.S. would potentially be partially offset by a U.S. foreign tax credit.

GE INDUSTRIAL LIQUIDITY. GE Industrial's primary sources of liquidity consist of cash and cash equivalents, free cash flows from our operating businesses, monetization of receivables, and short-term borrowing facilities, including revolving credit facilities. Cash generation can be subject to variability based on many factors, including seasonality, receipt of down payments on large equipment orders, timing of billings on long-term contracts, market conditions and our ability to execute dispositions. Additionally, in connection with the program we launched in 2020 to fully monetize our Baker Hughes position over approximately three years, we received proceeds of $0.7 billion in the first quarter of 2021 and expect to receive approximately $1.0 billion in the second quarter of 2021.

GE Industrial cash, cash equivalents and restricted cash totaled $22.4 billion at March 31, 2021, including $2.1 billion of cash held in countries with currency control restrictions and $0.4 billion of restricted use cash. Cash held in countries with currency controls represents amounts held in countries that may restrict the transfer of funds to the U.S. or limit our ability to transfer funds to the U.S. without incurring substantial costs. Restricted use cash represents amounts that are not available to fund operations, and primarily comprised funds restricted in connection with certain ongoing litigation matters.

*Non-GAAP Financial Measure
2021 1Q FORM 10-Q 14

In the first quarter of 2021, we announced our intention to discontinue the majority of our factoring programs, which was effective April 1, 2021. The estimated adverse impact to GE Industrial CFOA is expected to be approximately $3.5 to $4 billion primarily in the second quarter of 2021, which will be excluded from GE Industrial free cash flows*.

During 2021, GE Capital’s liquidity and capital needs will be evaluated based on the anticipated timing of the closing of the GECAS transaction, as well as GE Capital’s overall performance, to determine if additional capital contributions to GE Capital are necessary.

Additionally, we do not anticipate any further funding requirements for the GE Pension Plan in the foreseeable future, potentially until the end of the decade. This is due to our $2.5 billion prefunding in 2020 and portfolio performance, as well as the recently enacted American Rescue Plan Act.

GE CAPITAL LIQUIDITY. GE Capital’s primary sources of liquidity consist of cash and cash equivalents, cash generated from asset sales (including the expected proceeds from the GECAS transaction) and cash flows from our businesses, as well as GE Industrial repayments of intercompany loans and capital contributions from GE Industrial. We expect to maintain a sufficient liquidity position to fund our insurance obligations, debt maturities and other obligations. See the Segment Operations - Capital section for further information regarding allocation of GE Capital interest expense to the GE Capital businesses.

GE Capital cash, cash equivalents and restricted cash totaled $9.4 billion at March 31, 2021, excluding $1.7 billion of cash in Insurance, which was classified as All other assets on the GE Capital Statement of Financial Position.

GE Capital provided capital contributions to its insurance subsidiaries of $2.0 billion, $2.0 billion, $1.9 billion and $3.5 billion in the first quarters of 2021, 2020, 2019 and 2018, respectively, and expects to provide further capital contributions of approximately $5.5 billion through 2024. These contributions are subject to ongoing monitoring by Kansas Insurance Department (KID), and the total amount to be contributed could increase or decrease, or the timing could be accelerated, based upon the results of reserve adequacy testing or a decision by KID to modify the schedule of contributions set forth in January 2018. GE is required to maintain specified capital levels at these insurance subsidiaries under capital maintenance agreements. Going forward, we anticipate funding any capital needs for Insurance through a combination of GE Capital liquidity, GE Capital asset sales, GE Capital future earnings and capital contributions from GE Industrial.

BORROWINGS. Consolidated total borrowings were $71.4 billion and $74.9 billion at March 31, 2021 and December 31, 2020, respectively, a decrease of $3.5 billion ($3.9 billion excluding intercompany eliminations). See the following table for a summary of GE Industrial and GE Capital borrowings.
GE Industrial March 31, 2021 December 31, 2020 GE Capital March 31, 2021 December 31, 2020
GE Industrial senior notes $ 18,753  $ 18,994  Senior and subordinated notes $ 29,144  $ 30,987 
Senior and subordinated notes assumed by GE Industrial 21,538  22,390 
Intercompany loans from
GE Capital 		3,177  3,177  Intercompany loans to
GE Industrial 		(3,177) (3,177)
Other GE Industrial borrowings 956  1,352  Other GE Capital
borrowings 		1,244  1,779 
Total GE Industrial Total GE Capital
adjusted borrowings(a) $ 22,886  $ 23,523  adjusted borrowings(a)(b) $ 48,749  $ 51,979 
(a) Consolidated total borrowings of $71,358 million and $74,902 million at March 31, 2021 and December 31, 2020, respectively, are net of intercompany eliminations of $277 million and $600 million, respectively, of other GE Industrial borrowings from GE Capital, primarily related to timing of cash settlements associated with GE Industrial receivables monetization programs.
(b) Included $3,826 million and $5,687 million at March 31, 2021 and December 31, 2020, respectively, of fair value adjustments for debt in fair value hedge relationships. See Note 19 for further information.

The reduction in GE Industrial adjusted borrowings at March 31, 2021 compared to December 31, 2020 was driven by net repayments and maturities of other debt of $0.4 billion and $0.2 billion related to changes in foreign exchange rates.

GE Industrial net debt* was $32.3 billion and $32.3 billion at March 31, 2021 and December 31, 2020, respectively, as debt reductions of $0.6 billion were offset by a decrease in the net cash deduction of $0.6 billion due to a lower cash balance.

The reduction in GE Capital adjusted borrowings at March 31, 2021 compared to December 31, 2020 was driven primarily by long-term debt maturities of $0.9 billion, lower non-recourse borrowings of $0.3 billion, lower short-term borrowings of $0.2 billion, and $1.9 billion of fair value adjustments for debt in fair value hedge relationships.


2021 1Q FORM 10-Q 15

The following table provides a reconciliation of total short- and long-term borrowings as reported on the respective GE Industrial and GE Capital Statements of Financial Position to borrowings adjusted for assumed debt and intercompany loans:
March 31, 2021
GE Industrial GE Capital Consolidated
Total short- and long-term borrowings $ 41,247  $ 30,388  $ 71,358 
Debt assumed by GE Industrial from GE Capital(a) (21,538) 21,538  — 
Intercompany loans with right of offset(a) 3,177  (3,177) — 
Total intercompany payable (receivable) between GE Industrial and GE Capital (18,361) 18,361  — 
Total borrowings adjusted for assumed debt and intercompany loans $ 22,886  $ 48,749  $ 71,358 
(a) See the Capital Resources and Liquidity section of our Annual Report on Form 10-K for the year ended December 31, 2020 for further details on the assumed debt and intercompany loans with right of offset.

The intercompany loans from GE Capital to GE Industrial bear the right of offset against amounts owed by GE Capital to GE Industrial under the assumed debt agreement and can be prepaid by GE Industrial at any time, in whole or in part, without premium or penalty. These loans are priced at market terms and have a collective weighted average interest rate of 3.7% and term of approximately 15.2 years at March 31, 2021.

GE Industrial has in place committed revolving credit facilities totaling $20.2 billion at March 31, 2021, comprised of a $15.0 billion unused back-up revolving syndicated credit facility and a total of $5.2 billion of bilateral revolving credit facilities.

Under the terms of an agreement between GE Capital and GE Industrial, GE Capital has the right to compel GE Industrial to borrow under the $15.0 billion unused back-up revolving syndicated credit facility. Under this agreement, GE Industrial would transfer the proceeds to GE Capital as intercompany loans, which would be subject to the same terms and conditions as those between GE Industrial and the lending banks. GE Capital has not exercised this right.

CREDIT RATINGS AND CONDITIONS. We have relied, and may continue to rely, on the short- and long-term debt capital markets to fund, among other things, a significant portion of our operations. The cost and availability of debt financing is influenced by our credit ratings. Moody’s Investors Service (Moody’s), Standard and Poor’s Global Ratings (S&P), and Fitch Ratings (Fitch) currently issue separate ratings on GE Industrial and GE Capital short- and long-term debt. The credit ratings of GE Industrial and GE Capital as of the date of this filing are set forth in the table below.
Moody's S&P Fitch
GE Industrial Outlook Negative CreditWatch Negative Stable
Short term P-2 A-2 F3
Long term Baa1 BBB+ BBB
GE Capital Outlook Negative CreditWatch Negative Stable
Short term P-2 A-2 F3
Long term Baa1 BBB+ BBB
On March 10, 2021, Moody’s and Fitch affirmed their respective credit ratings, and S&P announced that they have placed us on CreditWatch with negative implications and currently expect to lower our credit ratings by one notch upon the closing of the GECAS transaction.

We are disclosing our credit ratings and any current quarter updates to these ratings to enhance understanding of our sources of liquidity and the effects of our ratings on our costs of funds and access to liquidity. Our ratings may be subject to a revision or withdrawal at any time by the assigning rating organization, and each rating should be evaluated independently of any other rating. For a description of some of the potential consequences of a reduction in our credit ratings, see the Financial Risks section of Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2020.

Substantially all of the Company's debt agreements in place at March 31, 2021 do not contain material credit rating covenants. GE’s unused back-up revolving syndicated credit facility and certain of our bilateral revolving credit facilities contain a customary net debt-to-EBITDA financial covenant, which GE satisfied at March 31, 2021.

The Company may from time to time enter into agreements that contain minimum ratings requirements. The following table provides a summary of the maximum estimated liquidity impact in the event of further downgrades below each stated ratings level.

Triggers Below
At March 31, 2021
BBB+/A-2/P-2 $ 277 
BBB/A-3/P-3 621 
BBB- 1,429 
BB+ and below 468 


2021 1Q FORM 10-Q 16

Our most significant contractual ratings requirements are related to ordinary course commercial activities, our receivables sales programs, and our derivatives portfolio. The timing within the quarter of the potential liquidity impact of these areas may differ, as can the remedies to resolving any potential breaches of required ratings levels.

FOREIGN EXCHANGE. As a result of our global operations, we generate and incur a significant portion of our revenues and expenses in currencies other than the U.S. dollar. Such principal currencies include the euro, the Chinese renminbi, the British pound sterling and the Indian rupee, among others. The effects of foreign currency fluctuations on earnings, excluding the earnings impact of the underlying hedged item, was less than $0.1 billion for both the three months ended March 31, 2021 and 2020. This analysis excludes any offsetting effect from the forecasted future transactions that are economically hedged.

See Note 19 for further information about our risk exposures, our use of derivatives, and the effects of this activity on our financial statements.

STATEMENT OF CASH FLOWS – THREE MONTHS ENDED MARCH 31, 2021 VERSUS 2020. We manage the cash flow performance of our industrial and financial services businesses separately, in order to enable us and our investors to evaluate the cash from operating activities of our industrial businesses separately from the cash flows of our financial services business.

Transactions between GE Industrial and GE Capital are reported in the respective columns of our statement of cash flows, but are eliminated in deriving our consolidated statement of cash flows. See the GE Industrial working capital transactions section and Notes 4 and 22 for further information regarding certain transactions affecting our consolidated Statement of Cash Flows.

GE INDUSTRIAL CASH FLOWS FROM CONTINUING OPERATIONS. The most significant source of cash in GE Industrial CFOA is customer-related activities, the largest of which is collecting cash resulting from product or services sales. The most significant operating use of cash is to pay our suppliers, employees, tax authorities, contribute to post retirement plans and pay others for a wide range of material, services and taxes.

GE Industrial cash used for operating activities was $0.5 billion in 2021, a decrease of $1.2 billion compared with 2020, primarily due to: a decrease in cash used for working capital of $1.6 billion; partially offset by an increase in cash used for All other operating activities of $0.2 billion primarily due to increases in Aviation-related customer allowance accruals of $0.4 billion in 2020 and the settlement of an Alstom legacy legal matter of $0.2 billion in 2021, partially offset by lower net cash used for employee benefit liabilities of $0.3 billion. There was an insignificant decrease in Aviation-related customer allowance accruals in 2021.

The decrease in cash used for working capital was due to: a decrease in cash used for accounts payable and equipment project accruals of $1.0 billion, which was primarily as a result of lower disbursements related to purchases of materials in prior periods; a decrease in cash used for inventories, including deferred inventory, of $0.4 billion, which was primarily driven by lower material purchases, partially offset by lower liquidations; an increase in cash from current receivables of $0.2 billion, which was primarily driven by lower volume; and lower net liquidations of progress collections and current deferred income of $0.2 billion, which included a partial offset due to early payments received at our Aviation Military equipment business of $0.3 billion from a foreign government. These decreases were partially offset by changes in current contract assets of $0.2 billion, primarily due to a net unfavorable change in estimated profitability at Aviation in 2020.

GE Industrial cash from investing activities was $0.5 billion in 2021, a decrease of $19.5 billion compared with 2020, primarily due to: the nonrecurrence of proceeds from the sale our BioPharma business of $20.3 billion; partially offset by proceeds from the sales of a portion of our retained ownership interest in Baker Hughes of $0.7 billion. Cash used for additions to property, plant and equipment and internal-use software, which are components of GE Industrial free cash flows*, was $0.4 billion in 2021, down $0.2 billion compared with 2020.

GE Industrial cash used for financing activities was $0.8 billion in 2021, a decrease of $1.2 billion compared with 2020, primarily due to the non-recurrence of repayments of commercial paper of $1.1 billion in 2020.

GE CAPITAL CASH FLOWS FROM CONTINUING OPERATIONS. GE Capital cash used for operating activities was $2.5 billion in 2021, an increase of $3.0 billion compared with 2020, primarily due to: cash collateral paid, which is a standard market practice to minimize derivative counterparty exposures, and settlements paid on derivative contracts (components of All other operating activities) of $1.7 billion in 2021, compared with collateral and settlements received on derivative contracts of $1.4 billion in 2020.

GE Capital cash from investing activities was $1.2 billion in 2021, an increase of $0.5 billion compared with 2020, primarily due to: higher net collections of financing receivables of $1.1 billion partially offset by a decrease in cash related to our current receivables and supply chain finance programs with GE Industrial of $0.6 billion.

GE Capital cash used for financing activities was $1.4 billion in 2021, a decrease of $5.1 billion compared with 2020, primarily due to: lower net repayments of borrowings of $4.8 billion and lower cash settlements on derivatives hedging foreign currency debt of $0.3 billion.

GE CAPITAL CASH FLOWS FROM DISCONTINUED OPERATIONS. GE Capital cash from operating activities relates primarily to cash generated from earnings (loss) from discontinued operations in our GECAS business. GE Capital cash from investing activities increased by $0.2 billion primarily due to higher net collections of financing receivables of $0.3 billion.
*Non-GAAP Financial Measure
2021 1Q FORM 10-Q 17

GE INDUSTRIAL WORKING CAPITAL TRANSACTIONS. Sales of Receivables. In order to manage short-term liquidity and credit exposure, GE Industrial may sell current customer receivables to GE Capital and other third parties. These transactions are made on arms-length terms and any discount related to time value of money is recognized within the respective GE Industrial business in the period these receivables were sold to GE Capital or third parties. See Note 4 for further information.

Supply Chain Finance Programs. GE Industrial facilitates voluntary supply chain finance programs with third parties, which provide participating GE Industrial suppliers the opportunity to sell their GE Industrial receivables to third parties at the sole discretion of both the suppliers and the third parties.

At March 31, 2021 and December 31, 2020, included in GE Industrial's accounts payable was $3.0 billion and $2.9 billion, respectively, of supplier invoices that are subject to the third-party programs. Total GE Industrial supplier invoices paid through these third-party programs were $1.6 billion and $1.1 billion for the three months ended March 31, 2021 and 2020, respectively.

Previously, GE Capital operated a supply chain finance program for suppliers to GE's Industrial businesses. The remaining GE Industrial liability associated with the funded participation in the GE Capital program was insignificant at March 31, 2021.

INTERCOMPANY TRANSACTIONS BETWEEN GE INDUSTRIAL AND GE CAPITAL. Transactions between related companies are made on arms-length terms and are reported in the GE Industrial and GE Capital columns of our financial statements, which we believe provide useful supplemental information to our consolidated financial statements. See Note 22 for further information.

GE Capital Finance Transactions. During the three months ended March 31, 2021 and 2020, GE Capital acquired from third parties three aircraft with a list price totaling $0.2 billion and five aircraft with a list price totaling $0.6 billion, respectively, that will be leased to others and are powered by engines manufactured by GE Aviation and affiliates. GE Capital made no payments to GE Aviation and affiliates related to spare engines and engine parts during the three months ended March 31, 2021 and $0.1 billion during the three months ended March 31, 2020, which included $0.1 billion to CFM International. Additionally, GE Capital had $2.0 billion and $2.1 billion of net book value of engines, originally manufactured by GE Aviation and affiliates and subsequently leased back to GE Aviation and affiliates at March 31, 2021 and December 31, 2020, respectively.

Also, during the three months ended March 31, 2021 and 2020, GE Industrial recognized equipment revenues of $0.4 billion and $0.5 billion, respectively, from customers within our Power and Renewable Energy segments in which GE Capital is an investee or is committed to be an investee in the underlying projects. At March 31, 2021, GE Capital had funded related investments of $0.1 billion.

For certain of these investments, in order to meet its underwriting criteria, GE Capital may obtain a direct guarantee from GE Industrial related to the performance of the third party. GE Industrial guarantees include direct performance or payment guarantees, return on investment guarantees and asset value guarantees. As of March 31, 2021, GE Industrial had outstanding guarantees to GE Capital on $0.8 billion of funded exposure and an insignificant amount on unfunded commitments, which included guarantees issued by industrial businesses. The recorded contingent liability for these guarantees was insignificant as of March 31, 2021 and is based on individual transaction level defaults, losses and/or returns.

CRITICAL ACCOUNTING ESTIMATES. Please refer to the Critical Accounting Estimates and Other Items sections within MD&A and Note 1 to the consolidated financial statements of our Annual Report on Form 10-K for the year ended December 31, 2020 for a discussion of our accounting policies and critical accounting estimates.

NEW ACCOUNTING STANDARDS. The Financial Accounting Standards Board issued new guidance on accounting for long-duration insurance contracts that is effective January 1, 2023. Early adoption is permitted, and if elected, the transition date can be either the beginning of the prior period or the earliest prior period presented. We are evaluating the effect of the new guidance on our consolidated financial statements and anticipate that its adoption will significantly change the accounting for measurements of our long-duration insurance liabilities. The new guidance requires cash flow assumptions used in the measurement of various insurance liabilities to be reviewed at least annually and updated if actual experience or other evidence indicates previous assumptions need to be revised with any required changes recorded in earnings. Under the current accounting guidance, the discount rate is based on expected investment yields, while under the new guidance the discount rate will be equivalent to the upper-medium grade (i.e., single A) fixed-income instrument yield reflecting the duration characteristics of the liability and is required to be updated in each reporting period with changes recorded in other comprehensive income. In measuring the insurance liabilities under the new guidance, contracts shall not be grouped together from different issue years. These changes result in the elimination of premium deficiency testing and shadow adjustments. While we continue to evaluate the effect of the new guidance on our ongoing financial reporting, we anticipate that its adoption will materially affect our financial statements. As the new guidance is only applicable to the measurements of our long-duration insurance liabilities under GAAP, it will not affect the accounting for our insurance reserves or the levels of capital and surplus under statutory accounting practices.

2021 1Q FORM 10-Q 18

NON-GAAP FINANCIAL MEASURES. We believe that presenting non-GAAP financial measures provides management and investors useful measures to evaluate performance and trends of the total company and its businesses. This includes adjustments in recent periods to GAAP financial measures to increase period-to-period comparability following actions to strengthen our overall financial position and how we manage our business.

In addition, management recognizes that certain non-GAAP terms may be interpreted differently by other companies under different circumstances. In various sections of this report we have made reference to the following non-GAAP financial measures in describing our (1) revenues, specifically GE Industrial organic revenues by segment; GE Industrial organic revenues, and GE Industrial equipment and services organic revenues, (2) profit, specifically GE Industrial organic profit and profit margin by segment; Adjusted GE Industrial profit and profit margin (excluding certain items); Adjusted GE Industrial organic profit and profit margin; Adjusted earnings (loss); and Adjusted earnings (loss) per share (EPS), (3) cash flows, specifically GE Industrial free cash flows (FCF), and (4) debt balances, specifically GE Industrial net debt.

The reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures follow.
GE INDUSTRIAL ORGANIC REVENUES, PROFIT (LOSS) AND PROFIT MARGIN BY SEGMENT (NON-GAAP)
Revenues Segment profit (loss) Profit margin
Three months ended March 31 2021 2020 V% 2021 2020 V% 2021 2020 V pts
Power (GAAP) $ 3,921  $ 4,025  (3) % $ (87) $ (131) 34  % (2.2) % (3.3) % 1.1pts
Less: acquisitions —  —  —  — 
Less: business dispositions —  15  —  2 
Less: foreign currency effect 63  —  (1) — 
Power organic (Non-GAAP) $ 3,858  $ 4,009  (4) % $ (86) $ (133) 35  % (2.2) % (3.3) % 1.1pts
Renewable Energy (GAAP) $ 3,248  $ 3,194  2  % $ (234) $ (327) 28  % (7.2) % (10.2) % 3.0pts
Less: acquisitions —  —  —  — 
Less: business dispositions —  24  —  (4)
Less: foreign currency effect 90  —  (10) — 
Renewable Energy organic (Non-GAAP) $ 3,157  $ 3,169  —  % $ (224) $ (323) 31  % (7.1) % (10.2) % 3.1pts
Aviation (GAAP) $ 4,992  $ 6,892  (28) % $ 641  $ 1,003  (36) % 12.8  % 14.6  % (1.8)pts
Less: acquisitions —  —  —  — 
Less: business dispositions —  25  —  (17)
Less: foreign currency effect 10  —  —  — 
Aviation organic (Non-GAAP) $ 4,982  $ 6,868  (27) % $ 641  $ 1,020  (37) % 12.9  % 14.9  % (2.0)pts
Healthcare (GAAP) $ 4,308  $ 4,727  (9) % $ 698  $ 867  (19) % 16.2  % 18.3  % (2.1)pts
Less: acquisitions 18  (21) 8  (6)
Less: business dispositions —  865  —  380 
Less: foreign currency effect 120  —  48  — 
Healthcare organic (Non-GAAP) $ 4,170  $ 3,884  7  % $ 643  $ 493  30  % 15.4  % 12.7  % 2.7pts
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, as these activities can obscure underlying trends. We also believe presenting organic revenues* and organic profit* separately for our industrial businesses provides management and investors with useful information about the trends of our industrial businesses and enables a more direct comparison to other non-financial companies.
GE INDUSTRIAL ORGANIC REVENUES (NON-GAAP) Three months ended March 31
2021 2020 V%
GE Industrial revenues (GAAP) $ 16,329  $ 18,844  (13) %
Less: acquisitions 18  (21)
Less: business dispositions(a) —  1,095 
Less: foreign currency effect(b) 288  — 
GE Industrial organic revenues (Non-GAAP) $ 16,023  $ 17,770  (10) %
(a) Dispositions impact in 2020 primarily related to our BioPharma business, with revenues of $830 million.
(b) Foreign currency impact in 2021 was primarily driven by U.S. Dollar appreciation against euro, Brazilian real, and Chinese renminbi.
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, as these activities can obscure underlying trends.


*Non-GAAP Financial Measure
2021 1Q FORM 10-Q 19

GE INDUSTRIAL EQUIPMENT AND SERVICES Three months ended March 31
ORGANIC REVENUES (NON-GAAP) 2021 2020 V%
GE Industrial equipment revenues (GAAP) $ 7,971  $ 9,097  (12) %
Less: acquisitions —  — 
Less: business dispositions —  948 
Less: foreign currency effect 189  — 
GE Industrial equipment organic revenues (Non-GAAP) $ 7,782  $ 8,149  (5) %
GE Industrial services revenues (GAAP) $ 8,358  $ 9,748  (14) %
Less: acquisitions 18  (21)
Less: business dispositions —  147 
Less: foreign currency effect 99  — 
GE Industrial services organic revenues (Non-GAAP) $ 8,241  $ 9,622  (14) %
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, as these activities can obscure underlying trends.

ADJUSTED GE INDUSTRIAL PROFIT AND PROFIT MARGIN Three months ended March 31
(EXCLUDING CERTAIN ITEMS) (NON-GAAP) 2021 2020 V%
GE Industrial total revenues (GAAP) $ 16,329  $ 18,844  (13) %
Costs
GE Industrial total costs and expenses (GAAP) $ 16,574  $ 19,133  (13) %
Less: GE Industrial interest and other financial charges 268  370 
Less: non-operating benefit costs 433  616 
Less: restructuring & other(a) 113  143 
Add: noncontrolling interests 7  36 
Adjusted GE Industrial costs (Non-GAAP) $ 15,767  $ 18,040  (13) %
Other Income
GE Industrial other income (GAAP) $ 623  $ 6,874  (91) %
Less: unrealized gains (losses)(a) 509  (5,794)
Less: restructuring & other 7  — 
Less: gains (losses) and impairments for disposed or held for sale businesses(a) (159) 12,439 
Adjusted GE Industrial other income (Non-GAAP) $ 266  $ 228  17  %
GE Industrial profit (GAAP) $ 378  $ 6,585  (94) %
GE Industrial profit margin (GAAP) 2.3  % 34.9  % (32.6)pts
Adjusted GE Industrial profit (Non-GAAP) $ 828  $ 1,032  (20) %
Adjusted GE Industrial profit margin (Non-GAAP) 5.1  % 5.5  % (0.4)pts
(a) See the Corporate Items and Eliminations section for further information.
We believe that adjusting industrial profit to exclude the effects of items that are not closely associated with ongoing operations provides management and investors with a meaningful measure that increases the period-to-period comparability. Gains (losses), unrealized gains (losses) and restructuring and other items are impacted by the timing and magnitude of gains associated with dispositions, and the timing and magnitude of costs associated with restructuring and other activities.

ADJUSTED GE INDUSTRIAL ORGANIC PROFIT
Three months ended March 31
 (NON-GAAP)
2021 2020 V%
Adjusted GE Industrial profit (Non-GAAP) $ 828  $ 1,032  (20) %
Less: acquisitions 8  9 
Less: business dispositions —  366 
Less: foreign currency effect 43  — 
Adjusted GE Industrial organic profit (Non-GAAP) $ 777  $ 657  18  %
Adjusted GE Industrial profit margin (Non-GAAP) 5.1  % 5.5  % (0.4)pts
Adjusted GE Industrial organic profit margin (Non-GAAP) 4.8  % 3.7  % 1.1pts
We believe these measures provide management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, dispositions and foreign currency, as these activities can obscure underlying trends.

2021 1Q FORM 10-Q 20

ADJUSTED EARNINGS (LOSS) (NON-GAAP) Three months ended March 31
2021 2020 V%
Consolidated earnings (loss) from continuing operations attributable to GE common shareholders (GAAP)(a) $ 18  $ 6,158  (100) %
Add: Accretion of redeemable noncontrolling interests (RNCI) 2  — 
Less: GE Capital earnings (loss) from continuing operations attributable to GE common shareholders (GAAP) (172) (187)
GE Industrial earnings (loss) (Non-GAAP) $ 192  $ 6,345  (97) %
Non-operating benefits costs (pre-tax) (GAAP) (433) (616)
Tax effect on non-operating benefit costs 91  129 
Less: non-operating benefit costs (net of tax) (342) (487)
Gains (losses) and impairments for disposed or held for sale businesses (pre-tax)(b) (159) 12,439 
Tax effect on gains (losses) and impairments for disposed or held for sale businesses 33  (1,265)
Less: gains (losses) and impairments for disposed or held for sale businesses (net of tax) (126) 11,174 
Restructuring & other (pre-tax)(b) (106) (143)
Tax effect on restructuring & other 22  30 
Less: restructuring & other (net of tax) (84) (114)
Unrealized gains (losses) (pre-tax)(b) 509  (5,794)
Tax on unrealized gains (losses) (152) 1,096 
Less: unrealized gains (losses) (net of tax) 357  (4,697)
Accretion of RNCI (pre-tax) 2  — 
Tax effect on accretion of RNCI —  — 
Less: Accretion of RNCI (net of tax) 2  — 
Adjusted GE Industrial earnings (loss) (Non-GAAP) $ 384  $ 469  (18) %
GE Capital earnings (loss) from continuing operations attributable to GE common shareholders (GAAP) $ (172) $ (187) 8  %
Less: GE Capital tax benefit related to BioPharma sale —  88 
Less: GE Capital tax loss related to GECAS sale (44) — 
Adjusted GE Capital earnings (loss) (Non-GAAP) $ (129) $ (275) 53  %
Adjusted GE Industrial earnings (loss) (Non-GAAP) $ 384  $ 469  (18) %
Add: Adjusted GE Capital earnings (loss) (Non-GAAP) (129) (275) 53  %
Adjusted earnings (loss) (Non-GAAP) $ 256  $ 194  32  %
(a) See Note 18 for further information.
(b) See the Corporate Items and Eliminations section for further information.
2021 1Q FORM 10-Q 21

ADJUSTED EARNINGS (LOSS) PER SHARE (EPS) Three months ended March 31
(NON-GAAP) 2021 2020 V%
Consolidated EPS from continuing operations attributable to GE common shareholders (GAAP) $ —  $ 0.70  U
Add: Accretion of redeemable noncontrolling interests (RNCI) —  — 
Less: GE Capital EPS from continuing operations attributable to GE common shareholders (GAAP) (0.02) (0.02)
GE Industrial EPS (Non-GAAP) $ 0.02  $ 0.73  (97) %
Non-operating benefits costs (pre-tax) (GAAP) (0.05) (0.07)
Tax effect on non-operating benefit costs 0.01  0.01 
Less: non-operating benefit costs (net of tax) (0.04) (0.06)
Gains (losses) and impairments for disposed or held for sale businesses (pre-tax) (0.02) 1.42 
Tax effect on gains (losses) and impairments for disposed or held for sale businesses —  (0.14)
Less: gains (losses) and impairments for disposed or held for sale businesses (net of tax) (0.01) 1.28 
Restructuring & other (pre-tax) (0.01) (0.02)
Tax effect on restructuring & other —  — 
Less: restructuring & other (net of tax) (0.01) (0.01)
Unrealized gains (losses) (pre-tax) 0.06  (0.66)
Tax on unrealized gains (losses) (0.02) 0.13 
Less: unrealized gains (losses) (net of tax) 0.04  (0.54)
Accretion of RNCI (pre-tax) —  — 
Tax effect on accretion of RNCI —  — 
Less: Accretion of RNCI (net of tax) —  — 
Less: GE Industrial U.S. tax reform enactment adjustment —  — 
Adjusted GE Industrial EPS (Non-GAAP) $ 0.04  $ 0.05  (20) %
GE Capital EPS from continuing operations attributable to GE common shareholders (GAAP) $ (0.02) $ (0.02) —  %
Less: GE Capital tax benefit related to BioPharma sale —  0.01 
Less: GE Capital tax loss related to GECAS sale —  — 
Adjusted GE Capital EPS (Non-GAAP) $ (0.01) $ (0.03) 67  %
Adjusted GE Industrial EPS (Non-GAAP) $ 0.04  $ 0.05  (20) %
Add: Adjusted GE Capital EPS (Non-GAAP) (0.01) (0.03) 67  %
Adjusted EPS (Non-GAAP) $ 0.03  $ 0.02  50  %
Earnings-per-share amounts are computed independently. As a result, the sum of per-share amounts may not equal the total.
The service cost of our pension and other benefit plans are included in adjusted earnings (loss)*, which represents the ongoing cost of providing pension benefits to our employees. The components of non-operating benefit costs are mainly driven by capital allocation decisions and market performance, and we manage these separately from the operational performance of our businesses. Gains (losses), unrealized gains (losses) and restructuring and other items are impacted by the timing and magnitude of gains associated with dispositions, and the timing and magnitude of costs associated with restructuring and other activities. We believe that the retained costs in Adjusted earnings (loss)* provides management and investors a useful measure to evaluate the performance of the total company, and increases period-to-period comparability. We believe that presenting Adjusted Industrial earnings (loss)* separately for our financial services businesses also provides management and investors with useful information about the relative size of our industrial and financial services businesses in relation to the total company.

GE INDUSTRIAL FREE CASH FLOWS (FCF) (NON-GAAP) Three months ended March 31
2021 2020
GE Industrial CFOA (GAAP) $ (491) $ (1,662)
Add: gross additions to property, plant and equipment (332) (504)
Add: gross additions to internal-use software (23) (58)
Less: taxes related to business sales —  (17)
GE Industrial free cash flows (Non-GAAP) $ (845) $ (2,207)
We believe investors may find it useful to compare GE's Industrial free cash flows* performance without the effects of cash used for taxes related to business sales. We believe this measure will better allow management and investors to evaluate the capacity of our industrial operations to generate free cash flows.







*Non-GAAP Financial Measure
2021 1Q FORM 10-Q 22

GE INDUSTRIAL NET DEBT (NON-GAAP) March 31, 2021 December 31, 2020
Total GE Industrial short- and long-term borrowings (GAAP) $ 41,247  $ 42,736 
Less: GE Capital short- and long-term debt assumed by GE Industrial 21,538  22,390 
Add: intercompany loans from GE Capital 3,177  3,177 
Total adjusted GE Industrial borrowings $ 22,886  $ 23,523 
Pension and principal retiree benefit plan liabilities (pre-tax)(a) 25,492  25,492 
Less: taxes at 21% 5,353  5,353 
Pension and principal retiree benefit plan liabilities (net of tax) $ 20,139  $ 20,139 
GE Industrial operating lease liabilities 3,083  3,133 
GE Industrial preferred stock 5,930  5,918 
Less: 50% of GE Industrial preferred stock 2,965  2,959 
50% of preferred stock $ 2,965  $ 2,959 
Deduction for total GE Industrial cash, cash equivalents and restricted cash (22,361) (23,209)
Less: 25% of GE Industrial cash, cash equivalents and restricted cash (5,590) (5,802)
Deduction for 75% of GE Industrial cash, cash equivalents and restricted cash $ (16,771) $ (17,407)
Total GE Industrial net debt (Non-GAAP) $ 32,302  $ 32,347 
(a) Represents the sum of the net deficit of principal pension, other pension, and principal retiree benefit plans at December 31, 2020. The funded status of our benefit plans is updated annually in the fourth quarter.
In this document we use GE Industrial net debt*, which is calculated based on rating agency methodologies. We are including the calculation of GE Industrial net debt* to provide investors more clarity regarding how the credit rating agencies measure GE Industrial leverage.

CONTROLS AND PROCEDURES. Under the direction of our Chief Executive Officer and Chief Financial Officer, we evaluated our disclosure controls and procedures and internal control over financial reporting and concluded that (i) our disclosure controls and procedures were effective as of March 31, 2021, and (ii) no change in internal control over financial reporting occurred during the quarter ended March 31, 2021, that has materially affected, or is reasonably likely to materially affect, such internal control over financial reporting.

OTHER FINANCIAL DATA. GE did not repurchase any equity securities during the three months ended March 31, 2021.

RISK FACTORS. The risk factor set forth below updates the corresponding risk factor in our Annual Report on Form 10-K for the year ended December 31, 2020. In addition to the risk factor below, you should carefully consider the risk factors discussed in our most recent Form 10-K report, which could have a material adverse effect on our business, reputation, financial position, results of operations, cash flows and stock price, and they could cause our future results to be materially different than we presently anticipate.
Business portfolio - Our success depends on achieving our strategic and financial objectives, including through dispositions, acquisitions, integrations and joint ventures. Over the past several years we have been pursuing a variety of dispositions, including the ongoing monetization of our remaining equity ownership position in Baker Hughes, and in March 2021 we announced a new plan to combine our GECAS business with AerCap. The proceeds from dispositions have been an important source of cash flow for the Company as part of our strategic and financial planning. When we seek to sell certain businesses, equity interests or assets, we may encounter difficulties in finding buyers or in market conditions that could delay or prevent the accomplishment of our objectives, and declines in the values of equity interests (such as our remaining interest in Baker Hughes, or the equity ownership position that we will hold in AerCap after completing our announced plan to combine GECAS with AerCap) or other assets that we sell can diminish the cash proceeds that we realize. We may dispose of businesses or assets at a price or on terms that are less favorable than we had anticipated, or with purchase price adjustments or the exclusion of assets or liabilities that must be divested, managed or run off separately. We can also be subject to limitations in the form of regulatory or governmental approvals that may prevent certain prospective counterparties from completing transactions with us or delay us from executing transactions on our preferred timeline, or arising from our debt or other contractual obligations that limit our ability to complete certain transactions. For example, the planned transaction to combine GECAS with AerCap is subject to closing conditions, including regulatory approvals in multiple jurisdictions, and accordingly there are risks that one or more closing conditions may not be satisfied or waived, on a timely basis or otherwise, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the proposed transaction, may require conditions, limitations or restrictions in connection with such approvals or that the required approval by the shareholders of AerCap may not be obtained. Moreover, dispositions have the effect of reducing the Company’s cash flow and earnings capacity, resulting in a less diversified portfolio of businesses and increasing our dependency on remaining businesses for our financial results from ongoing operations. Dispositions or other business separations also often involve continued financial involvement in the divested business, such as through continuing equity ownership, retained assets or liabilities, transition services agreements, commercial agreements, guarantees, indemnities or other current or contingent financial obligations or liabilities. Under these arrangements, performance by the divested businesses or other conditions outside our control could materially affect our future financial results. With respect to acquisitions, joint ventures and business integrations, we may not achieve expected returns and other benefits on a timely basis or at all as a result of changes in strategy or separation/integration challenges related to personnel, IT systems or other factors. Executing on all types of portfolio transactions can divert senior management time and resources from other pursuits. In addition, in connection with acquisitions over time, we have recorded significant goodwill and other intangible assets on our balance sheet, and if we are not able to realize the value of these assets, we may be required to incur charges relating to the impairment of these assets. We also participate in a number of joint ventures with other companies or government enterprises in various markets around the world, including joint ventures where we have a lesser degree of control over the business operations, which may expose us to additional operational, financial, reputational, legal or compliance risks.

*Non-GAAP Financial Measure
2021 1Q FORM 10-Q 23

STATEMENT OF EARNINGS (LOSS) Three months ended March 31
(UNAUDITED) Consolidated
(In millions; per-share amounts in dollars) 2021 2020
Sales of goods $ 10,349  $ 12,339 
Sales of services 5,967  6,452 
GE Capital revenues from services 803  699 
Total revenues (Note 9) 17,118  19,490 
Cost of goods sold 8,679  9,930 
Cost of services sold 3,859  4,497 
Selling, general and administrative expenses 2,891  3,061 
Research and development 561  723 
Interest and other financial charges 500  561 
Insurance losses and annuity benefits 555  636 
Non-operating benefit costs 430  618 
Other costs and expenses 32  25 
Total costs and expenses 17,506  20,051 
Other income (Note 23) 626  6,869 
Earnings (loss) from continuing operations before income taxes 238  6,308 
Benefit (provision) for income taxes (142) (54)
Earnings (loss) from continuing operations 97  6,254 
Earnings (loss) from discontinued operations, net of taxes (Note 2) (2,894) (21)
Net earnings (loss) (2,798) 6,233 
Less net earnings (loss) attributable to noncontrolling interests 5  34 
Net earnings (loss) attributable to the Company (2,802) 6,199 
Preferred stock dividends (72) (43)
Net earnings (loss) attributable to GE common shareholders $ (2,874) $ 6,156 
Amounts attributable to GE common shareholders
Earnings (loss) from continuing operations
$ 97  $ 6,254 
Less net earnings (loss) attributable to noncontrolling interests,
   continuing operations
5  36 
Earnings (loss) from continuing operations attributable to the Company
92  6,218 
Preferred stock dividends
(72) (43)
Earnings (loss) from continuing operations attributable
   to GE common shareholders
20  6,175 
Earnings (loss) from discontinued operations, net of taxes
(2,894) (21)
Less net earnings (loss) attributable to
   noncontrolling interests, discontinued operations
—  (2)
Net earnings (loss) attributable to GE common shareholders $ (2,874) $ 6,156 
Earnings (loss) per share from continuing operations (Note 18)
Diluted earnings (loss) per share
$ —  $ 0.70 
Basic earnings (loss) per share
$ —  $ 0.70 
Net earnings (loss) per share (Note 18)
Diluted earnings (loss) per share
$ (0.33) $ 0.70 
Basic earnings (loss) per share
$ (0.33) $ 0.70 







2021 1Q FORM 10-Q 24

STATEMENT OF EARNINGS (LOSS) (CONTINUED) Three months ended March 31
(UNAUDITED) GE Industrial GE Capital
(In millions) 2021 2020 2021 2020
Sales of goods $ 10,349  $ 12,359  $ —  $ — 
Sales of services 5,980  6,486  —  — 
GE Capital revenues from services —  —  878  837 
Total revenues 16,329  18,844  878  837 
Cost of goods sold 8,679  9,949  —  — 
Cost of services sold 3,867  4,526  5  5 
Selling, general and administrative expenses 2,766  2,949  116  149 
Research and development 561  723  —  — 
Interest and other financial charges 268  370  291  271 
Insurance losses and annuity benefits —  —  567  653 
Non-operating benefit costs 433  616  (3) 2 
Other costs and expenses —  —  42  33 
Total costs and expenses 16,574  19,133  1,018  1,113 
Other income (Note 23) 623  6,874  —  — 
Earnings (loss) from continuing operations before income taxes 378  6,585  (140) (277)
Benefit (provision) for income taxes (148) (187) 6  133 
Earnings (loss) from continuing operations 230  6,398  (134) (144)
Earnings (loss) from discontinued operations, net of taxes (Note 2) —  (14) (2,894) (7)
Net earnings (loss) 230  6,384  (3,028) (151)
Less net earnings (loss) attributable to noncontrolling interests 7  34  (2) — 
Net earnings (loss) attributable to the Company 223  6,350  (3,025) (151)
Preferred stock dividends (31) —  (41) (43)
Net earnings (loss) attributable to GE common shareholders $ 192  $ 6,350  $ (3,066) $ (194)
Amounts attributable to GE common shareholders:
   Earnings (loss) from continuing operations $ 230  $ 6,398  $ (134) $ (144)
   Less net earnings (loss) attributable to noncontrolling interests,
      continuing operations 7  36  (2) — 
   Earnings (loss) from continuing operations attributable to the Company
223  6,362  (131) (144)
   Preferred stock dividends (31) —  (41) (43)
   Earnings (loss) from continuing operations attributable
      to GE common shareholders 192  6,362  (172) (187)
   Earnings (loss) from discontinued operations, net of taxes —  (14) (2,894) (7)
   Less net earnings (loss) attributable to
      noncontrolling interests, discontinued operations —  (2) —  — 
Net earnings (loss) attributable to GE common shareholders $ 192  $ 6,350  $ (3,066) $ (194)


2021 1Q FORM 10-Q 25

STATEMENT OF FINANCIAL POSITION (UNAUDITED) Consolidated
(In millions, except share amounts) March 31, 2021 December 31, 2020
Cash, cash equivalents and restricted cash(a) $ 31,783  $ 36,530 
Investment securities (Note 3)
6,741  7,319 
Current receivables (Note 4)
15,381  16,691 
Financing receivables – net (Note 5)
306  326 
Inventories, including deferred inventory costs (Note 6) 16,530  15,890 
Other GE Capital receivables
1,339  1,549 
Receivable from GE Capital
—  — 
Current contract assets (Note 10) 5,821  5,764 
All other current assets (Note 11) 1,376  1,109 
Assets of discontinued operations (Note 2) 33,922  — 
  Current assets 113,198  85,180 
Investment securities (Note 3) 40,786  42,549 
Financing receivables – net (Note 5) —  — 
Other GE Capital receivables 4,634  4,661 
Property, plant and equipment – net (Note 7) 16,296  16,699 
Receivable from GE Capital —  — 
Goodwill (Note 8)
25,320  25,524 
Other intangible assets – net (Note 8)
9,395  9,671 
Contract and other deferred assets (Note 10)
5,985  5,888 
All other assets (Note 11) 12,308  11,038 
Deferred income taxes (Note 16) 14,232  14,253 
Assets of discontinued operations (Note 2)
3,009  40,749 
Total assets
$ 245,164  $ 256,211 
Short-term borrowings (Note 12) $ 4,468  $ 4,713 
Short-term borrowings assumed by GE (Note 12) —  — 
Accounts payable and equipment project accruals 16,090  16,458 
Progress collections and deferred income (Note 10) 17,993  18,371 
All other current liabilities (Note 15) 14,139  15,071 
Liabilities of discontinued operations (Note 2) 4,991  — 
  Current liabilities 57,681  54,613 
Deferred income (Note 10) 1,748  1,801 
Long-term borrowings (Note 12) 66,890  70,189 
Long-term borrowings assumed by GE (Note 12) —  — 
Insurance liabilities and annuity benefits (Note 13) 39,562  42,191 
Non-current compensation and benefits
29,104  29,677 
All other liabilities (Note 15) 14,821  15,484 
Liabilities of discontinued operations (Note 2)
204  5,182 
Total liabilities
210,011  219,138 
Preferred stock (5,939,875 shares outstanding at both March 31, 2021
and December 31, 2020)
6  6 
Common stock (8,778,641,000 and 8,765,493,000 shares outstanding
at March 31, 2021 and December 31, 2020, respectively)
702  702 
Accumulated other comprehensive income (loss) – net attributable to GE
(8,893) (9,749)
Other capital
34,042  34,307 
Retained earnings
89,276  92,247 
Less common stock held in treasury
(81,548) (81,961)
Total GE shareholders’ equity
33,585  35,552 
Noncontrolling interests
1,568  1,522 
Total equity 35,153  37,073 
Total liabilities and equity
$ 245,164  $ 256,211 
(a) Excluded $1,707 million and $455 million at March 31, 2021 and December 31, 2020, respectively, in Insurance, which is subject to regulatory restrictions. This balance is included in All other assets. See Note 11 for further information.

2021 1Q FORM 10-Q 26

STATEMENT OF FINANCIAL POSITION (CONTINUED) GE Industrial GE Capital
(UNAUDITED) (In millions, except share amounts)
March 31, 2021 December 31, 2020 March 31, 2021 December 31, 2020
Cash, cash equivalents and restricted cash $ 22,361  $ 23,209  $ 9,422  $ 13,322 
Investment securities (Note 3) 6,741  7,319  —  — 
Current receivables (Note 4) 12,418  13,442  —  — 
Financing receivables – net (Note 5) —  —  3,738  4,172 
Inventories, including deferred inventory costs (Note 6) 16,530  15,890  —  — 
Other GE Capital receivables —  —  2,260  3,280 
Receivable from GE Capital 1,784  2,432  —  — 
Current contract assets (Note 10) 5,821  5,764  —  — 
All other current assets (Note 11) 1,062  835  518  543 
Assets of discontinued operations (Note 2) —  —  33,922  — 
  Current assets 66,716  68,892  49,860  21,317 
Investment securities (Note 3) 32  36  40,756  42,515 
Financing receivables – net (Note 5) —  —  —  — 
Other GE Capital receivables —  —  5,077  5,076 
Property, plant and equipment – net (Note 7) 16,039  16,433  261  271 
Receivable from GE Capital 16,577  16,780  —  — 
Goodwill (Note 8) 25,320  25,524  —  — 
Other intangible assets – net (Note 8) 9,358  9,632  37  39 
Contract and other deferred assets (Note 10) 5,985  5,921  —  — 
All other assets (Note 11) 7,952  7,948  4,617  3,354 
Deferred income taxes (Note 16) 9,209  9,154  5,023  5,099 
Assets of discontinued operations (Note 2) 132  144  2,876  40,587 
Total assets $ 157,321  $ 160,462  $ 108,507  $ 118,257 
Short-term borrowings (Note 12) $ 535  $ 918  $ 2,426  $ 1,963 
Short-term borrowings assumed by GE (Note 12) 1,784  2,432  1,784  2,432 
Accounts payable and equipment project accruals 15,839  16,380  841  918 
Progress collections and deferred income (Note 10) 17,993  18,371  —  — 
All other current liabilities (Note 15) 13,508  14,131  1,507  2,288 
Liabilities of discontinued operations (Note 2) —  —  4,991  — 
  Current liabilities 49,659  52,232  11,549  7,602 
Deferred income (Note 10) 1,748  1,801  —  — 
Long-term borrowings (Note 12) 19,174  19,428  27,962  30,803 
Long-term borrowings assumed by GE (Note 12) 19,754  19,957  16,577  16,780 
Insurance liabilities and annuity benefits (Note 13) —  —  40,004  42,565 
Non-current compensation and benefits 28,769  29,291  327  379 
All other liabilities (Note 15) 14,586  15,072  363  539 
Liabilities of discontinued operations (Note 2) 125  139  79  5,058 
Total liabilities 133,815  137,921  96,861  103,726 
Preferred stock (5,939,875 shares outstanding at both
     March 31, 2021 and December 31, 2020)
6  6  —  6 
Common stock (8,778,641,000 and 8,765,493,000 shares outstanding at
     March 31, 2021 and December 31, 2020, respectively)
702  702  5  — 
Accumulated other comprehensive income (loss) – net attributable to GE (8,108) (8,945) (786) (804)
Other capital 16,055  16,466  17,982  17,835 
Retained earnings 95,006  94,910  (5,730) (2,663)
Less common stock held in treasury (81,548) (81,961) —  — 
Total GE shareholders’ equity 22,113  21,179  11,472  14,373 
Noncontrolling interests 1,393  1,363  175  159 
Total equity 23,506  22,542  11,646  14,531 
Total liabilities and equity $ 157,321  $ 160,462  $ 108,507  $ 118,257 


2021 1Q FORM 10-Q 27

STATEMENT OF CASH FLOWS Three months ended March 31
(UNAUDITED) Consolidated
(In millions) 2021 2020
Net earnings (loss) $ (2,798) $ 6,233 
(Earnings) loss from discontinued operations 2,894  21 
Adjustments to reconcile net earnings (loss)
   to cash provided from operating activities
Depreciation and amortization of property, plant and equipment (Note 7) 452  461 
Amortization of intangible assets (Note 8) 301  318 
(Gains) losses on purchases and sales of business interests (Note 23) (3) (12,372)
(Gains) losses on equity securities (Note 23) (296) 5,873 
Principal pension plans cost (Note 14) 658  877 
Principal pension plans employer contributions (74) (70)
Other postretirement benefit plans (net) (289) (254)
Provision (benefit) for income taxes 142  54 
Cash recovered (paid) during the year for income taxes (322) (310)
Changes in operating working capital:
Decrease (increase) in current receivables 946  (503)
Decrease (increase) in inventories, including deferred inventory costs (722) (1,077)
Decrease (increase) in current contract assets (35) 145 
Increase (decrease) in accounts payable and equipment project accruals (349) (617)
Increase (decrease) in progress collections and current deferred income (425) (590)
All other operating activities (2,719) 892 
Cash from (used for) operating activities – continuing operations (2,640) (919)
Cash from (used for) operating activities – discontinued operations 680  686 
Cash from (used for) operating activities (1,959) (233)
Additions to property, plant and equipment (332) (504)
Dispositions of property, plant and equipment 34  28 
Additions to internal-use software (24) (60)
Net decrease (increase) in financing receivables 21  (103)
Proceeds from principal business dispositions 1  20,505 
Net cash from (payments for) principal businesses purchased —  (6)
Sales of retained ownership interests 735  — 
Net (purchases) dispositions of GE Capital investment securities (709) (1,289)
All other investing activities 1,121  1,455 
Cash from (used for) investing activities – continuing operations 847  20,025 
Cash from (used for) investing activities – discontinued operations (646) (920)
Cash from (used for) investing activities 202  19,105 
Net increase (decrease) in borrowings (maturities of 90 days or less) (319) (1,905)
Newly issued debt (maturities longer than 90 days) 314  125 
Repayments and other debt reductions (maturities longer than 90 days) (1,513) (5,867)
Dividends paid to shareholders (148) (89)
All other financing activities 57  (226)
Cash from (used for) financing activities – continuing operations (1,608) (7,962)
Cash from (used for) financing activities – discontinued operations 3  43 
Cash from (used for) financing activities (1,605) (7,919)
Effect of currency exchange rate changes on cash, cash equivalents and restricted cash (131) (256)
Increase (decrease) in cash, cash equivalents and restricted cash (3,494) 10,697 
Cash, cash equivalents and restricted cash at beginning of year 37,608  37,077 
Cash, cash equivalents and restricted cash at March 31
34,115  47,774 
Less cash, cash equivalents and restricted cash of discontinued operations at March 31
625  584 
Cash, cash equivalents and restricted cash of continuing operations at March 31
$ 33,490  $ 47,190 
2021 1Q FORM 10-Q 28

STATEMENT OF CASH FLOWS (CONTINUED) Three months ended March 31
(UNAUDITED) GE Industrial GE Capital
(In millions) 2021 2020 2021 2020
Net earnings (loss) $ 230  $ 6,384  $ (3,028) $ (151)
(Earnings) loss from discontinued operations —  14  2,894  7 
Adjustments to reconcile net earnings (loss)
   to cash provided from operating activities
Depreciation and amortization of property, plant and equipment (Note 7) 446  453  6  7 
Amortization of intangible assets (Note 8) 297  315  3  3 
(Gains) losses on purchases and sales of business interests (Note 23) (3) (12,372) —  — 
(Gains) losses on equity securities (Note 23) (293) 5,789  (4) 85 
Principal pension plans cost (Note 14) 658  877  —  — 
Principal pension plans employer contributions (74) (70) —  — 
Other postretirement benefit plans (net) (275) (247) (14) (8)
Provision (benefit) for income taxes 148  187  (6) (133)
Cash recovered (paid) during the year for income taxes (336) (278) 14  (32)
Changes in operating working capital:
Decrease (increase) in current receivables 691  487  —  — 
Decrease (increase) in inventories, including deferred inventory costs (681) (1,065) —  — 
Decrease (increase) in current contract assets (35) 145  —  — 
Increase (decrease) in accounts payable and equipment project accruals (449) (1,475) 14  (18)
Increase (decrease) in progress collections and current deferred income (425) (590) —  — 
All other operating activities (390) (215) (2,359) 763 
Cash from (used for) operating activities – continuing operations (491) (1,662) (2,479) 524 
Cash from (used for) operating activities – discontinued operations —  29  681  658 
Cash from (used for) operating activities (491) (1,633) (1,798) 1,181 
Additions to property, plant and equipment (332) (504) —  — 
Dispositions of property, plant and equipment 34  29  —  — 
Additions to internal-use software (23) (58) (1) (1)
Net decrease (increase) in financing receivables —  —  575  (559)
Proceeds from principal business dispositions 1  20,505  —  — 
Net cash from (payments for) principal businesses purchased —  (6) —  — 
Sales of retained ownership interests 735  —  —  — 
Net (purchases) dispositions of GE Capital investment securities —  —  (709) (1,289)
All other investing activities 133  81  1,334  2,579 
Cash from (used for) investing activities – continuing operations 548  20,046  1,199  730 
Cash from (used for) investing activities – discontinued operations —  (33) (646) (887)
Cash from (used for) investing activities 549  20,013  553  (157)
Net increase (decrease) in borrowings (maturities of 90 days or less) (655) (1,881) (223) (514)
Newly issued debt (maturities longer than 90 days) —  1  315  124 
Repayments and other debt reductions (maturities longer than 90 days) (20) (64) (1,493) (5,804)
Dividends paid to shareholders (118) (89) (41) (42)
All other financing activities
(27) (12) 84  (214)
Cash from (used for) financing activities – continuing operations (820) (2,045) (1,358) (6,450)
Cash from (used for) financing activities – discontinued operations —  —  3  43 
Cash from (used for) financing activities (820) (2,045) (1,355) (6,406)
Effect of currency exchange rate changes on cash, cash equivalents and restricted cash (85) (143) (46) (113)
Increase (decrease) in cash, cash equivalents and restricted cash (848) 16,193  (2,646) (5,495)
Cash, cash equivalents and restricted cash at beginning of year 23,209  17,617  14,400  19,460 
Cash, cash equivalents and restricted cash at March 31
22,361  33,810  11,754  13,964 
Less cash, cash equivalents and restricted cash of discontinued operations at March 31
—  —  625  584 
Cash, cash equivalents and restricted cash of continuing operations at March 31
$ 22,361  $ 33,810  $ 11,129  $ 13,380 
2021 1Q FORM 10-Q 29

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) Three months ended March 31
(In millions, net of tax) 2021 2020
Net earnings (loss) $ (2,798) $ 6,233 
Less net earnings (loss) attributable to noncontrolling interests 5  34 
Net earnings (loss) attributable to the Company $ (2,802) $ 6,199 
Investment securities
$ (18) $ (41)
Currency translation adjustments
110  135 
Cash flow hedges
62  (211)
Benefit plans
705  1,035 
Other comprehensive income (loss) 859  918 
Less: other comprehensive income (loss) attributable to noncontrolling interests
3  5 
Other comprehensive income (loss) attributable to the Company $ 856  $ 913 
Comprehensive income (loss) $ (1,939) $ 7,152 
Less: comprehensive income (loss) attributable to noncontrolling interests
8  39 
Comprehensive income (loss) attributable to the Company $ (1,947) $ 7,113 

CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) Three months ended March 31
(In millions) 2021 2020
Preferred stock issued $ 6  $ 6 
Common stock issued $ 702  $ 702 
Beginning balance (9,749) (11,732)
Investment securities (18) (41)
Currency translation adjustments 108  133 
Cash flow hedges 62  (211)
Benefit plans 704  1,032 
Accumulated other comprehensive income (loss) ending balance $ (8,893) $ (10,819)
Beginning balance 34,307  34,405 
Gains (losses) on treasury stock dispositions (384) (249)
Stock-based compensation 106  105 
Other changes 14  35 
Other capital ending balance $ 34,042  $ 34,296 
Beginning balance 92,247  87,732 
Net earnings (loss) attributable to the Company (2,802) 6,199 
Dividends and other transactions with shareholders (168) (142)
Changes in accounting (Note 1) —  (175)
Retained earnings ending balance $ 89,276  $ 93,615 
Beginning balance (81,961) (82,797)
Purchases (38) (14)
Dispositions 450  295 
Common stock held in treasury ending balance $ (81,548) $ (82,516)
GE shareholders' equity balance 33,585  35,284 
Noncontrolling interests balance (Note 17) 1,568  1,575 
Total equity balance at March 31
$ 35,153  $ 36,859 





2021 1Q FORM 10-Q 30

NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES. We present our financial statements in a three-column format, which allows investors to see our GE industrial operations separately from our financial services operations. We believe that this provides useful supplemental information to our consolidated financial statements. To the extent that we have transactions between GE Industrial and GE Capital, these transactions are made on arms-length terms, are reported in the respective columns of our financial statements and are eliminated in consolidation. See Note 22 for further information.

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on assumptions about current and, for some estimates, future economic and market conditions which affect reported amounts and related disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations and financial position. In particular, a number of estimates have been and will continue to be affected by the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. The severity, magnitude and duration, as well as the economic consequences, of the COVID-19 pandemic, are uncertain, rapidly changing and difficult to predict. As a result, our accounting estimates and assumptions may change over time in response to COVID-19. Such changes could result in future impairments of goodwill, intangibles, long-lived assets and investment securities, revisions to estimated profitability on long-term product service agreements, incremental credit losses on receivables and debt securities, a decrease in the carrying amount of our tax assets, or an increase in our insurance liabilities and pension obligations as of the time of a relevant measurement event.

In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses, businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet reclassifications.

We have reclassified certain prior-period amounts to conform to the current-period’s presentation. Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net earnings. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to the consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for held for sale, are sold, or spun-off. See Note 2 for further information.

The accompanying consolidated financial statements and notes are unaudited. The results reported in these consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for the entire year. These consolidated financial statements should be read in conjunction with the financial statements and notes included in our Annual Report on Form 10-K for the year ended December 31, 2020.

Our significant accounting policies are described in Note 1 of our aforementioned Annual Report.

ACCOUNTING CHANGES. On January 1, 2021, we adopted ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. The ASU removes certain exceptions from the guidance in ASC 740 related to intra-period tax allocations, interim calculations and the recognition of deferred tax liabilities for outside basis differences and clarifies and simplifies several other aspects of accounting for income taxes. Different transition methods apply to the various income tax simplifications. For the changes requiring a retrospective or modified retrospective transition, the adoption of the new standard did not have a material impact to our financial statements.

NOTE 2. BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS. On March 31, 2020, we completed the sale of our BioPharma business within our Healthcare segment for total consideration of $21,112 million (after certain working capital adjustments) and incurred $185 million of cash payments directly associated with the transaction. In the first quarter of 2020, we recognized a pre-tax gain of $12,292 million ($11,145 million after-tax) in our consolidated Statement of Earnings (Loss).

DISCONTINUED OPERATIONS. Primarily comprise our GE Capital Aviation Services (GECAS) business, our mortgage portfolio in Poland, and other trailing assets and liabilities associated with the dispositions of certain GE Capital and GE Industrial businesses. Results of operations, financial position and cash flows for these businesses are reported as discontinued operations for all periods presented.

GECAS. On March 9, 2021 we entered into an agreement with AerCap Holdings N.V. (AerCap) to combine our GECAS business with AerCap. GE will receive total consideration consisting of $23,905 million cash subject to contractual closing adjustments, 111.5 million shares of AerCap common stock (approximately 46% ownership interest) valued at $6,550 million based on the AerCap’s closing share price of $58.74 on March 31, 2021 and $1,000 million paid in AerCap notes and/or cash upon closing at AerCap's option. As a result, we have reclassified GECAS' results to discontinued operations for all periods presented and recognized a non-cash after-tax loss of $2,755 million in discontinued operations in the first quarter of 2021. Given the economics of GECAS accrue to AerCap in conjunction with the transaction, the net impact of GECAS (loss on sale and operations) could change materially, mainly due to fluctuations in AerCap's closing share price. Completion of the transaction remains subject to AerCap shareholder approval, regulatory approvals and other customary closing conditions.

2021 1Q FORM 10-Q 31

After completion of the transaction, we will elect to prospectively measure our investment in AerCap at fair value and expect to have continuing involvement with AerCap, primarily through our ownership interest and ongoing sales or leases of products and services.

Bank BPH. The mortgage portfolio in Poland (Bank BPH) comprises floating rate residential mortgages, 86% of which are indexed to or denominated in foreign currencies (primarily Swiss francs). At March 31, 2021, the total portfolio had a carrying value of $1,986 million with a 1.67% 90-day delinquency rate and an average loan to value ratio of approximately 61.6%. The portfolio is recorded at the lower of cost or fair value, less cost to sell, which reflects market yields as well as estimates with respect to ongoing litigation in Poland related to foreign currency-denominated mortgages and other factors. Earnings from discontinued operations for the three months ended March 31, 2021 included $282 million non-cash pre-tax charges, reflecting estimates with respect to ongoing litigation as well as market yields. Future changes in the estimated legal liabilities or market yields could result in further losses related to these loans in future reporting periods. See Note 21 for further information.

Baker Hughes (BKR). We have continuing involvement with BKR primarily through our remaining interest, ongoing purchases and sales of products and services, transition services that we provide to BKR, as well as an aeroderivative joint venture (JV) we formed with BKR in the fourth quarter of 2019. The JV is jointly controlled by GE and BKR and is consolidated by GE due to the significance of our investment in BKR.

For the three months ended March 31, 2021, we had sales of $166 million and purchases of $61 million with BKR for products and services outside of the JV. We collected net cash of $131 million from BKR related to sales, purchases and transition services.

In the first quarter of 2021, we had sales of $119 million to BKR for products and services from the JV, and we collected cash of $161 million. When our investment in BKR is reduced to below 20%, we will deconsolidate the JV. A deconsolidation of the JV is not expected to have a material impact on GE Industrial Cash from operating activities (CFOA).

In addition, we received $28 million of repayments on the promissory note receivable from BKR and dividends of $56 million on our investment.
RESULTS OF DISCONTINUED OPERATIONS Three months ended March 31
2021 2020
Operations
GE Capital revenues from services $ 633  $ 1,010 
Cost of goods and services sold (368) (547)
Other income, costs and expenses (386) (462)
Earnings (loss) of discontinued operations before income taxes (121) 2 
Benefit (provision) for income taxes (29) (19)
Earnings (loss) of discontinued operations, net of taxes(a)(b) $ (149) $ (17)
Disposal
Gain (loss) on disposal before income taxes (2,702) (4)
Benefit (provision) for income taxes (43) — 
Gain (loss) on disposal, net of taxes $ (2,745) $ (4)
Earnings (loss) from discontinued operations, net of taxes $ (2,894) $ (21)
(a) Earnings (loss) of discontinued operations attributable to the Company after income taxes was $(149) million and $(15) million for the three months ended March 31, 2021 and 2020, respectively.
(b) Included $177 million and $155 million from GECAS operations, including $(359) million and $(545) million of depreciation and amortization, for the three months ended March 31, 2021 and 2020, respectively. Depreciation and amortization ceased on March 10, 2021.
2021 1Q FORM 10-Q 32

ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONS March 31, 2021 December 31, 2020
Cash, cash equivalents and restricted cash
$ 142  $ — 
Financing receivables - net
2,095  — 
Other GE Capital receivables 2,122  — 
 Property, plant, and equipment - net 28,143  — 
Valuation allowance on disposal group classified as discontinued operations (2,536) — 
All other current assets
3,957  — 
Total current assets of discontinued operations
33,922  — 
Cash, cash equivalents and restricted cash
483  623 
Financing receivables - net —  2,710 
Other GE Capital receivables 49  1,844 
Financing receivables held for sale (Polish mortgage portfolio)
1,986  2,461 
 Property, plant, and equipment - net 102  28,429 
All other assets
389  4,683 
Assets of discontinued operations(a) $ 36,931  $ 40,749 
Deferred income taxes $ 2,268  $ — 
Accounts payable and all other liabilities 2,723  — 
Total current liabilities of discontinued operations
4,991  — 
Deferred income taxes —  2,172 
Accounts payable and all other liabilities(b)
204  3,010 
Liabilities of discontinued operations(a)
$ 5,195  $ 5,182 
(a) Included $33,922 million and $37,199 million of assets and $4,991 million and $4,997 million of liabilities for GECAS as of March 31, 2021 and December 31, 2020, respectively.
(b) Included within All other liabilities of discontinued operations at March 31, 2021 and December 31, 2020 are intercompany tax receivables in the amount of $657 million and $704 million, respectively, primarily related to previously disposed financial services businesses, which are eliminated upon consolidation.

NOTE 3. INVESTMENT SECURITIES. All of our debt securities are classified as available-for-sale and substantially all are investment-grade supporting obligations to annuitants and policyholders in our run-off insurance operations. We have adopted the fair value option for our investment in BKR (comprising 311.4 million shares with approximately 30% ownership and a promissory note receivable as of March 31, 2021), which is recorded as Equity securities with readily determinable fair values. We classify investment securities as current or non-current based on our intent regarding the usage of proceeds from those investments. Investment securities held within insurance entities are classified as non-current as they support the long-duration insurance liabilities.
March 31, 2021 December 31, 2020
Amortized
cost 		Gross
unrealized
gains 		Gross
unrealized
losses 		Estimated
fair value 		Amortized
cost 		Gross
unrealized
gains 		Gross
unrealized
losses 		Estimated
fair value
Equity (Baker Hughes) $ 6,741  $ —  $ —  $ 6,741  $ 7,319  $ —  $ —  $ 7,319 
Current investment securities $ 6,741  $ —  $ —  $ 6,741  $ 7,319  $ —  $ —  $ 7,319 
Debt
U.S. corporate $ 24,159  $ 4,616  $ (79) $ 28,695  $ 23,604  $ 6,651  $ (26) $ 30,230 
Non-U.S. corporate 2,456  273  (5) 2,724  2,283  458  (1) 2,740 
State and municipal 3,409  648  (19) 4,038  3,387  878  (9) 4,256 
Mortgage and asset-backed 3,725  153  (63) 3,815  3,652  171  (71) 3,752 
Government and agencies 1,166  112  (3) 1,275  1,169  184  —  1,353 
Other equity 239  —  —  239  218  —  —  218 
Non-current investment securities $ 35,152  $ 5,801  $ (168) $ 40,786  $ 34,313  $ 8,342  $ (106) $ 42,549 
Total $ 41,893  $ 5,801  $ (168) $ 47,527  $ 41,632  $ 8,342  $ (106) $ 49,868 

The amortized cost of debt securities as of March 31, 2021 excludes accrued interest of $438 million, which is reported in current Other GE Capital receivables.

The estimated fair value of investment securities at March 31, 2021 decreased since December 31, 2020, primarily due to higher market yields and the sale of BKR shares, partially offset by new investments in our Insurance business and the mark-to-market effect on our remaining interest in BKR. 

2021 1Q FORM 10-Q 33

Total estimated fair value of debt securities in an unrealized loss position were $3,732 million and $1,765 million, of which $644 million and $165 million had gross unrealized losses of $(56) million and $(20) million and had been in a loss position for 12 months or more at March 31, 2021 and December 31, 2020, respectively. Gross unrealized losses of $(168) million at March 31, 2021 included $(79) million related to U.S. corporate securities and $(57) million related to commercial mortgage-backed securities (CMBS). Primarily all of our CMBS in an unrealized loss position have received investment-grade credit ratings from the major rating agencies and are collateralized by pools of commercial mortgage loans on real estate.

Net unrealized gains (losses) for equity securities with readily determinable fair values, which are recorded in Other income within continuing operations, were $238 million and $(5,772) million for the three months ended March 31, 2021 and 2020, respectively.

Proceeds from debt and equity securities sales, early redemptions by issuers and principal payments on the BKR promissory note totaled $1,333 million and $1,250 million for the three months ended March 31, 2021 and 2020, respectively. Gross realized gains on investment securities were $30 million and $46 million and gross realized losses and impairments were $(60) million and $(17) million for the three months ended March 31, 2021 and 2020, respectively.

Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at March 31, 2021 are as follows:
Amortized
cost 		Estimated
fair value
Within one year $ 613  $ 622 
After one year through five years 3,111  3,396 
After five years through ten years 6,579  7,626 
After ten years 20,886  25,088 
We expect actual maturities to differ from contractual maturities because borrowers have the right to call or prepay certain obligations.

Substantially all our equity securities are classified within Level 1 and substantially all our debt securities are classified within Level 2, as their valuation is determined based on significant observable inputs. Investments with a fair value of $5,641 million and $5,866 million are classified within Level 3, as significant inputs to the valuation model are unobservable at March 31, 2021 and December 31, 2020, respectively. During the three months ended March 31, 2021 and 2020, there were no significant transfers into or out of Level 3.

In addition to the equity securities described above, we hold $291 million and $274 million of equity securities without readily determinable fair values at March 31, 2021 and December 31, 2020, respectively, that are classified within non-current All other assets in our consolidated Statement of Financial Position. Fair value adjustments, including impairments, recorded in earnings were an insignificant amount and $(93) million for the three months ended March 31, 2021 and 2020, respectively.

NOTE 4. CURRENT AND LONG-TERM RECEIVABLES
CURRENT RECEIVABLES Consolidated GE Industrial
March 31, 2021 December 31, 2020 March 31, 2021 December 31, 2020
Customer receivables $ 12,441  $ 13,459  $ 9,307  $ 9,841 
Sundry receivables(a)(b) 4,106  4,395  4,274  4,763 
Allowance for credit losses(c) (1,165) (1,164) (1,163) (1,161)
Total current receivables $ 15,381  $ 16,691  $ 12,418  $ 13,442 
(a) Includes supplier advances, revenue sharing programs receivables in our Aviation business, other non-income based tax receivables, primarily value-added tax related to our operations in various countries outside of the U.S., receivables from disposed businesses, including receivables for transactional services agreements and certain intercompany balances that eliminate upon consolidation. Revenue sharing program receivables in Aviation are amounts due from third parties who participate in engine programs by developing and supplying certain engine components through the life of the program. The participants share in program revenues, receive a share of customer progress payments and share costs related to discounts and warranties.
(b) Consolidated current receivables included a deferred purchase price receivable, which represents our retained risk with respect to current customer receivables sold to third parties through one of the receivable facilities. The balance of the deferred purchase price held by GE Capital as of March 31, 2021 and December 31, 2020 was $461 million and $413 million, respectively.
(c) GE Industrial allowance for credit losses primarily increased due to net new provisions of $39 million offset by write-offs and foreign currency impact.


2021 1Q FORM 10-Q 34

Sales of GE Industrial current customer receivables. When GE Industrial sells customer receivables to GE Capital or third parties, it accelerates the receipt of cash that would otherwise have been collected from customers. In any given period, the amount of cash received from sales of customer receivables compared to the cash GE Industrial would have otherwise collected had those customer receivables not been sold represents the cash generated or used in the period relating to this activity. GE Industrial sales of customer receivables to GE Capital or third parties are made on arms-length terms and any discount related to time value of money is recognized by GE Industrial when the customer receivables are sold. In our Statement of Cash Flows, receivables purchased and retained by GE Capital are reflected as cash from operating activities at GE Industrial, primarily as cash used for investing activities at GE Capital and are eliminated in consolidation. Collections on receivables purchased by GE Capital are reflected primarily as cash from investing activities at GE Capital and are reclassified to cash from operating activities in consolidation. As of March 31, 2021 and 2020, GE Industrial sold approximately 38% and 49%, respectively, of its gross customer receivables to GE Capital or third parties. Effective April 1, 2021, the Company discontinued the majority of its factoring programs. Activity related to customer receivables sold by GE Industrial is as follows:
2021 2020
GE Capital Third Parties GE Capital Third Parties
Balance at January 1 $ 3,618  $ 2,992  $ 3,087  $ 6,757 
GE Industrial sales to GE Capital 7,044  —  9,225  — 
GE Industrial sales to third parties —  124  —  307 
GE Capital sales to third parties (3,826) 3,826  (5,253) 5,253 
Collections and other (3,765) (4,360) (3,224) (7,797)
Reclassification from long-term customer receivables 63  —  123  — 
Balance at March 31
$ 3,134  (a) $ 2,582  (b) $ 3,958  (a) $ 4,519 
(a) At March 31, 2021 and 2020, $526 million and $557 million, respectively, of the current receivables purchased and retained by GE Capital had been sold by GE Industrial to GE Capital with recourse (i.e., GE Industrial retains all or some risk of default). The effect on GE Industrial CFOA of claims by GE Capital on receivables sold with recourse was insignificant for the three months ended March 31, 2021 and 2020.
(b) Included $1,863 million in our active unconsolidated receivables facility at March 31, 2021, under which we currently expect to continue sales of GE Industrial receivables in the future.

LONG-TERM RECEIVABLES Consolidated GE Industrial
March 31, 2021 December 31, 2020 March 31, 2021 December 31, 2020
Long-term customer receivables(a) $ 638  $ 585  $ 601  $ 474 
Long-term sundry receivables(b) 1,656  1,748  1,928  2,097 
Allowance for credit losses (136) (142) (136) (142)
Total long-term receivables $ 2,158  $ 2,191  $ 2,392  $ 2,430 
(a) As of March 31, 2021 and December 31, 2020, GE Capital held $37 million and $111 million, respectively, of GE Industrial long-term customer receivables, substantially all of which are with recourse (i.e. GE Industrial retains all or some risk of default).
(b) Includes supplier advances, revenue sharing programs receivables, other non-income based tax receivables and certain intercompany balances that eliminate upon consolidation.

UNCONSOLIDATED RECEIVABLES FACILITIES. GE Capital has one active revolving receivables facility, under which customer receivables purchased from GE Industrial are sold to third parties. In this facility, which has a program size of $2,000 million as of March 31, 2021, upon the sale of receivables, we receive proceeds of cash and deferred purchase price and the Company’s remaining risk with respect to the sold receivables is limited to the balance of the deferred purchase price.

Activity related to our unconsolidated receivables facilities is included in the GE Capital sales to third parties line in the sales of GE Industrial current customer receivables table above and is as follows:
Three months ended March 31
2021 2020
Customer receivables sold to receivables facilities $ 2,605  $ 4,307 
Total cash purchase price for customer receivables 2,479  4,120 
Cash collections re-invested to purchase customer receivables 2,274  3,723 
Non-cash increases to deferred purchase price $ 116  $ 160 
Cash payments received on deferred purchase price 68  78 

CONSOLIDATED SECURITIZATION ENTITIES. GE Capital consolidates three variable interest entities (VIEs) that purchased customer receivables and long-term customer receivables from GE Industrial. At March 31, 2021 and December 31, 2020, these VIEs held current customer receivables of $1,133 million and $1,489 million and long-term customer receivables of $29 million and $93 million, respectively. At March 31, 2021 and December 31, 2020, the outstanding non-recourse debt under their respective debt facilities was $624 million and $892 million, respectively. 

2021 1Q FORM 10-Q 35

NOTE 5. FINANCING RECEIVABLES AND ALLOWANCES
Consolidated GE Capital
March 31, 2021 December 31, 2020 March 31, 2021 December 31, 2020
Loans, net of deferred income
$ 337  $ 359  $ 3,749  $ 4,182 
Allowance for losses (31) (32) (11) (10)
Current financing receivables - net $ 306  $ 326  $ 3,738  $ 4,172 

We manage our GE Capital financing receivables portfolio using delinquency data as key performance indicators. At March 31, 2021 and December 31, 2020, financing receivables over 30 days past due were 3.7% and 2.8% and 90 days past due were 1.6% and 1.7%, respectively.

GE Capital financing receivables that comprise receivables purchased from GE Industrial are reclassified to either Current receivables or All other assets in our consolidated Statement of Financial Position. To the extent these receivables are purchased with full or limited recourse, they are excluded from the delinquency above. See Note 4 for further information.

NOTE 6. INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS
March 31, 2021 December 31, 2020
Raw materials and work in process
$ 8,013  $ 7,937 
Finished goods 6,057  5,654 
Deferred inventory costs(a) 2,460  2,299 
Inventories, including deferred inventory costs $ 16,530  $ 15,890 
(a) Represents cost deferral for shipped goods (such as components for wind turbine assemblies within our Renewable Energy segment) and labor and overhead costs on time and material service contracts (primarily originating in Power and Aviation) and other costs for which the criteria for revenue recognition has not yet been met.

NOTE 7. PROPERTY, PLANT AND EQUIPMENT
March 31, 2021 December 31, 2020
Original cost $ 31,893  $ 32,098 
Less accumulated depreciation and amortization (18,405) (18,251)
Right-of-use operating lease assets 2,808  2,852 
Property, plant and equipment – net $ 16,296  $ 16,699 

Consolidated depreciation and amortization on property, plant and equipment was $452 million and $461 million for the three months ended March 31, 2021 and 2020, respectively.

Operating Lease Liabilities. Our consolidated operating lease liabilities, included in All other liabilities in our Statement of Financial Position, were $3,143 million and $3,195 million, as of March 31, 2021 and December 31, 2020, respectively, which included GE Industrial operating lease liabilities of $3,083 million and $3,133 million, respectively. Expense on our operating lease portfolio, primarily from our long-term fixed leases, was $281 million and $294 million for the three months ended March 31, 2021 and 2020, respectively.

NOTE 8. GOODWILL AND OTHER INTANGIBLE ASSETS
GOODWILL January 1, 2021 Currency exchange
and other 		Balance at
March 31, 2021
Power $ 146  $ —  $ 145 
Renewable Energy 3,401  (88) 3,313 
Aviation 9,247  (103) 9,144 
Healthcare 11,855  (15) 11,840 
Corporate 876  1  877 
Total $ 25,524  $ (204) $ 25,320 

In assessing the possibility that a reporting unit’s fair value has been reduced below its carrying amount due to the occurrence of events or circumstances between annual impairment testing dates, we consider all available evidence, including (i) the results of our impairment testing from the most recent testing date, (ii) downward revisions to internal forecasts or decreases in market multiples, if any, and (iii) declines in market capitalization. In the first quarter of 2021, we did not identify any reporting units that required an interim impairment test. However, we continue to monitor the operating results and cash flow forecasts of our Additive reporting unit in our Aviation segment as the fair value of this reporting unit was not significantly in excess of its carrying value. At March 31, 2021, our Additive reporting unit had goodwill of $236 million.

2021 1Q FORM 10-Q 36

All other intangible assets of $9,395 million and $9,671 million at March 31, 2021 and December 31, 2020, respectively, are subject to amortization. Intangible assets decreased in the first quarter of 2021, primarily as a result of amortization. Consolidated amortization expense was $301 million and $318 million in the three months ended March 31, 2021 and 2020, respectively.

NOTE 9. REVENUES. The equipment and services revenues classification in the table below is consistent with our segment MD&A presentation.
EQUIPMENT & SERVICES REVENUES
Three months ended March 31 2021 2020
Equipment Services Total Equipment Services Total
Power $ 1,241  $ 2,679  $ 3,921  $ 1,506  $ 2,518  $ 4,025 
Renewable Energy 2,844  404  3,248  2,576  618  3,194 
Aviation 1,847  3,145  4,992  2,364  4,529  6,892 
Healthcare 2,227  2,081  4,308  2,699  2,029  4,727 
Corporate items and industrial eliminations (188) 49  (139) (48) 54  6 
Total GE Industrial revenues $ 7,971  $ 8,358  $ 16,329  $ 9,097  $ 9,748  $ 18,844 
REVENUES
Three months ended March 31
2021 2020
Gas Power
$ 2,829  $ 2,859 
Power Portfolio 1,091  1,165 
Power
$ 3,921  $ 4,025 
Onshore Wind
$ 2,118  $ 2,124 
Grid Solutions equipment and services 795  839 
Hydro 165  179 
Offshore Wind and Hybrid Solutions 169  51 
Renewable Energy
$ 3,248  $ 3,194 
Commercial Engines & Services $ 3,354  $ 5,113 
Military 956  960 
Systems & Other 682  820 
Aviation $ 4,992  $ 6,892 
Healthcare Systems $ 3,825  $ 3,448 
Pharmaceutical Diagnostics 482  450 
BioPharma —  830 
Healthcare $ 4,308  $ 4,727 
Corporate items and industrial eliminations
(139) 6 
Total GE Industrial revenues
$ 16,329  $ 18,844 
Capital
878  837 
GE Capital-GE Industrial eliminations $ (89) $ (191)
Consolidated revenues
$ 17,118  $ 19,490 

REMAINING PERFORMANCE OBLIGATION. As of March 31, 2021, the aggregate amount of the contracted revenues allocated to our unsatisfied (or partially unsatisfied) performance obligations was $226,962 million. We expect to recognize revenue as we satisfy our remaining performance obligations as follows: (1) equipment-related remaining performance obligation of $40,951 million, of which 62%, 82% and 97% is expected to be satisfied within 1, 2 and 5 years, respectively; and (2) services-related remaining performance obligation of $186,012 million, of which 15%, 47%, 67% and 83% is expected to be recognized within 1, 5, 10 and 15 years, respectively, and the remaining thereafter. Contract modifications could affect both the timing to complete as well as the amount to be received as we fulfill the related remaining performance obligations.

2021 1Q FORM 10-Q 37

NOTE 10. CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME
Contract and other deferred assets increased $153 million in the three months ended March 31, 2021 primarily due to the timing of revenue recognition ahead of billing milestones on our long-term equipment contracts. Our long-term service agreements decreased primarily due to billings of $2,232 million, offset by revenues recognized of $2,118 million, a net favorable change in estimated profitability of $31 million at Aviation and a net unfavorable change in estimated profitability of $8 million at Power.
March 31, 2021
Power Aviation Renewable Energy Healthcare Other Total
Revenues in excess of billings $ 5,223  $ 2,911  $ —  $ —  $ —  $ 8,134 
Billings in excess of revenues (1,541) (5,347) —  —  —  (6,888)
Long-term service agreements $ 3,682  $ (2,436) $ —  $ —  $ —  $ 1,246 
Short-term and other service agreements 139  342  109  164  16  769 
Equipment contract revenues 2,024  36  1,239  289  217  3,805 
Current contract assets $ 5,845  $ (2,058) $ 1,348  $ 454  $ 232  $ 5,821 
Nonrecurring engineering costs 13  2,436  33  29  —  2,511 
Customer advances and other 783  2,570  —  122  —  3,474 
Non-current contract and other deferred assets $ 796  $ 5,005  $ 33  $ 151  $ —  $ 5,985 
Total contract and other deferred assets $ 6,641  $ 2,948  $ 1,381  $ 604  $ 233  $ 11,806 
December 31, 2020
Revenues in excess of billings $ 5,282  $ 3,072  $ —  $ —  $ —  $ 8,354 
Billings in excess of revenues (1,640) (5,375) —  —  —  (7,015)
Long-term service agreements $ 3,642  $ (2,304) $ —  $ —  $ —  $ 1,338 
Short-term and other service agreements 129  282  106  173  29  719 
Equipment contract revenues 2,015  59  1,127  306  201  3,707 
Current contract assets $ 5,786  $ (1,963) $ 1,233  $ 479  $ 229  $ 5,764 
Nonrecurring engineering costs 16  2,409  34  31  —  2,490 
Customer advances and other 822  2,481  —  128  (32) 3,398 
Non-current contract and other deferred assets $ 838  $ 4,889  $ 34  $ 159  $ (32) $ 5,888 
Total contract and other deferred assets $ 6,623  $ 2,927  $ 1,268  $ 638  $ 197  $ 11,653 

Progress collections and deferred income decreased $431 million primarily due to the timing of revenue recognition in excess of new collections received, primarily at Aviation and Power. Revenues recognized for contracts included in a liability position at the beginning of the year were $5,909 million and $4,137 million for the three months ended March 31, 2021 and 2020, respectively.
March 31, 2021
Power Aviation Renewable Energy Healthcare Other Total
Progress collections on equipment contracts $ 4,829  $ 197  $ 1,388  $ —  $ —  $ 6,414 
Other progress collections 371  4,483  4,343  416  121  9,735 
Current deferred income 16  122  219  1,392  95  1,844 
Progress collections and deferred income $ 5,217  $ 4,802  $ 5,949  $ 1,808  $ 217  $ 17,993 
Non-current deferred income 118  855  211  555  9  1,748 
Total Progress collections and deferred income $ 5,335  $ 5,657  $ 6,160  $ 2,363  $ 226  $ 19,741 
December 31, 2020
Progress collections on equipment contracts $ 4,918  $ 214  $ 1,229  $ —  $ —  $ 6,362 
Other progress collections 458  4,623  4,604  414  152  10,252 
Current deferred income 17  132  194  1,309  105  1,757 
Progress collections and deferred income $ 5,393  $ 4,969  $ 6,028  $ 1,724  $ 257  $ 18,371 
Non-current deferred income 116  898  214  564  10  1,801 
Total Progress collections and deferred income $ 5,509  $ 5,867  $ 6,241  $ 2,288  $ 267  $ 20,172 

NOTE 11. ALL OTHER ASSETS. All other current assets and All other assets primarily includes equity method and other investments, long-term customer and sundry receivables (see Note 4), cash and cash equivalents in our run-off insurance operations and prepaid taxes and other deferred charges. Consolidated All other non-current assets increased $1,270 million in the three months ended March 31, 2021, primarily due to an increase in Insurance cash and cash equivalents of $1,252 million.
2021 1Q FORM 10-Q 38

NOTE 12. BORROWINGS
March 31, 2021 December 31, 2020
Current portion of long-term borrowings $ 47  $ 36 
Current portion of long-term borrowings assumed by GE Industrial 1,784  2,432 
Other 488  882 
Total GE Industrial short-term borrowings $ 2,318  $ 3,350 
Current portion of long-term borrowings $ 1,743  $ 788 
Intercompany payable to GE Industrial 1,784  2,432 
Non-recourse borrowings of consolidated securitization entities 624  892 
Other 59  283 
Total GE Capital short-term borrowings $ 4,210  $ 4,395 
Eliminations (2,061) (3,033)
Total short-term borrowings $ 4,468  $ 4,713 
Senior notes $ 18,753  $ 18,994 
Senior notes assumed by GE Industrial 17,981  18,178 
Subordinated notes assumed by GE Industrial 1,774  1,779 
Other 422  435 
Total GE Industrial long-term borrowings $ 38,929  $ 39,386 
Senior notes $ 27,292  $ 30,132 
Subordinated notes 148  189 
Intercompany payable to GE Industrial 16,577  16,780 
Non-recourse borrowings of consolidated securitization entities —  — 
Other 521  483 
Total GE Capital long-term borrowings $ 44,539  $ 47,584 
Eliminations (16,577) (16,780)
Total long-term borrowings $ 66,890  $ 70,189 
Total borrowings $ 71,358  $ 74,902 

At March 31, 2021, the outstanding GE Capital borrowings that had been assumed by GE Industrial as part of the GE Capital Exit Plan was $21,538 million ($1,784 million short-term and $19,754 million long-term), for which GE Industrial has an offsetting Receivable from GE Capital of $18,361 million. The difference of $3,177 million in long-term borrowings represents the amount of borrowings GE Capital had funded with available cash to GE Industrial via intercompany loans in lieu of GE Industrial issuing borrowings externally. 

At March 31, 2021, total GE Industrial borrowings of $22,886 million comprised GE Industrial-issued borrowings of $19,709 million and intercompany loans from GE Capital to GE Industrial of $3,177 million as described above.

GE Industrial has provided a full and unconditional guarantee on the payment of the principal and interest on all tradable senior and subordinated outstanding long-term debt securities issued by GE Capital. This guarantee applied to $27,332 million and $28,503 million of GE Capital debt at March 31, 2021 and December 31, 2020, respectively.

See Note 19 for further information about borrowings and associated interest rate swaps.

NOTE 13. INSURANCE LIABILITIES AND ANNUITY BENEFITS. Insurance liabilities and annuity benefits comprise substantially all obligations to annuitants and insureds in our run-off insurance operations. Our insurance operations generated revenues of $775 million and $616 million and profit (loss) of $116 million and $(93) million for the three months ended March 31, 2021 and 2020, respectively. These operations were supported by assets of $50,353 million and $50,824 million at March 31, 2021 and December 31, 2020, respectively. A summary of our insurance contracts is presented below:
March 31, 2021
Long-term care Structured settlement annuities & life Other contracts Other adjustments(a) Total
Future policy benefit reserves
$ 16,997  $ 9,105  $ 183  $ 5,580  $ 31,864 
Claim reserves
4,397  306  1,062  —  5,765 
Investment contracts
—  1,018  1,003  —  2,021 
Unearned premiums and other
16  191  147  —  353 
21,409  10,620  2,395  5,580  40,004 
Eliminations
—  —  (442) —  (442)
Total
$ 21,409  $ 10,620  $ 1,953  $ 5,580  $ 39,562 
2021 1Q FORM 10-Q 39

December 31, 2020
Long-term care Structured settlement annuities & life Other contracts Other adjustments(a) Total
Future policy benefit reserves
$ 16,934  $ 9,207  $ 181  $ 8,160  $ 34,482 
Claim reserves
4,393  275  1,068  —  5,736 
Investment contracts
—  1,034  1,016  —  2,049 
Unearned premiums and other
19  189  89  —  298 
21,346  10,705  2,354  8,160  42,565 
Eliminations
—  —  (374) —  (374)
Total
$ 21,346  $ 10,705  $ 1,980  $ 8,160  $ 42,191 
(a) To the extent that unrealized gains on specific investment securities supporting our insurance contracts would result in a premium deficiency should those gains be realized, an increase in future policy benefit reserves is recorded, with an after-tax reduction of net unrealized gains recognized through Accumulated other comprehensive income (loss) (AOCI) in our consolidated Statement of Earnings (Loss). The decrease in Other adjustments of $2,580 million is a result of the decline in unrealized gains on investment securities.

Claim reserves included incurred claims of $454 million and $507 million, of which insignificant amounts related to the recognition of adjustments to prior year claim reserves arising from our periodic reserve evaluation for the three months ended March 31, 2021 and 2020, respectively. Paid claims were $424 million and $405 million in the three months ended March 31, 2021 and 2020, respectively.

Reinsurance recoverables, net of allowances of $1,540 million and $1,510 million, are included in non-current Other GE Capital receivables in our consolidated Statement of Financial Position, and amounted to $2,592 million and $2,552 million at March 31, 2021 and December 31, 2020, respectively. The vast majority of our remaining net reinsurance recoverables are secured by assets held in a trust for which we are the beneficiary.

NOTE 14. POSTRETIREMENT BENEFIT PLANS. We sponsor a number of pension and retiree health and life insurance benefit plans that we present in three categories, principal pension plans, other pension plans and principal retiree benefit plans. Please refer to Note 13 to the consolidated financial statements of our Annual Report on Form 10-K for the year ended December 31, 2020 for a discussion of our postretirement benefit plans.

The components of benefit plans cost other than the service cost are included in the caption Non-operating benefit costs in our consolidated Statement of Earnings (Loss).
PRINCIPAL PENSION PLANS Three months ended March 31
2021 2020
Service cost for benefits earned $ 64  $ 153 
Prior service cost amortization 7  37 
Expected return on plan assets (763) (748)
Interest cost on benefit obligations 486  587 
Net actuarial loss amortization 864  848 
Benefit plans cost $ 658  $ 877 

Principal retiree benefit plans income was $40 million and $32 million for the three months ended March 31, 2021 and 2020, respectively. Other pension plans was $24 million income and $7 million cost for the three months ended March 31, 2021 and 2020, respectively.

We also have a defined contribution plan for eligible U.S. employees that provides employer contributions. Defined contribution plan costs were $108 million and $95 million for the three months ended March 31, 2021 and 2020, respectively.

NOTE 15. CURRENT AND ALL OTHER LIABILITIES. All other current liabilities and All other liabilities primarily includes liabilities for customer sales allowances, equipment project and commercial liabilities, employee compensation and benefits, income taxes payable and uncertain tax positions, operating lease liabilities (see Note 7), environmental, health and safety remediations and product warranties (see Note 21). GE Industrial All other liabilities decreased $486 million in the three months ended March 31, 2021, primarily due to a decrease in Alstom legacy legal matters of $199 million (see Note 21) and a decrease in interest accruals on assumed debt of $132 million.

NOTE 16. INCOME TAXES. Our consolidated effective income tax rate was 59.7% and 0.9% during the three months ended March 31, 2021 and 2020, respectively. The rate for 2021 is higher than the U.S. statutory rate primarily due to the cost of global activities, including the base erosion and global intangible minimum tax provisions and from tax expense associated with the unrealized gain in our remaining interest in Baker Hughes. This was partially offset by an adjustment to decrease the 2021 three-month tax rate to be in line with the lower expected full-year rate and by U.S. business credits. The rate for 2020 is lower than the U.S. statutory rate primarily due to the lower tax rate on the sale of our BioPharma business. The tax rate on the BioPharma sale was low because the gain outside the U.S. was taxed at lower than 21% and because we recorded $633 million of the tax associated with preparatory steps for the transaction in the fourth quarter of 2019.
2021 1Q FORM 10-Q 40

The Internal Revenue Service (IRS) is currently auditing our consolidated U.S. income tax returns for 2016-2018. The United Kingdom tax authority (the UK Government) disallowed interest deductions claimed by GE Capital for the years 2004-2015 that could result in a potential impact of approximately $1.1 billion, which includes a possible assessment of tax and reduction of deferred tax assets, not including interest and penalties. We are contesting the disallowance. The UK Government is seeking to set aside a 2005 tax settlement agreement, alleging that GE misstated or omitted relevant facts. In October 2019, the UK Government asserted three new claims of fraudulent misrepresentation, one of which the Business and Property Court allowed in a July 2020 decision to go forward. In April 2021, the UK Court of Appeal reversed, holding that the equitable portion of that claim was time barred. The UK Government has petitioned the UK Supreme Court to hear an appeal, and the case remains scheduled for trial this fall in the Business and Property Court and may (depending on the outcome of the trial) be subject to further proceedings in the UK tax tribunal. We comply with all applicable tax laws and judicial doctrines of the United Kingdom and believe that the entire benefit is more likely than not to be sustained on its technical merits.

NOTE 17. SHAREHOLDERS’ EQUITY
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Three months ended March 31
2021 2020
Beginning balance $ 60  $ 61 
AOCI before reclasses – net of taxes of $(7) and $0(a)
(29) 6 
Reclasses from AOCI – net of taxes of $4 and $(12)
11  (47)
AOCI (18) (41)
Less AOCI attributable to noncontrolling interests —  — 
Investment securities AOCI ending balance $ 42  $ 20 
Beginning balance $ (4,386) $ (4,818)
AOCI before reclasses – net of taxes of $(57) and $(5)
110  (554)
Reclasses from AOCI – net of taxes of $0 and $0(b)
—  690 
AOCI 110  135 
Less AOCI attributable to noncontrolling interests 2  2 
Currency translation adjustments AOCI ending balance $ (4,278) $ (4,685)
Beginning balance $ (28) $ 49 
AOCI before reclasses – net of taxes of $4 and $(45)
39  (262)
Reclasses from AOCI – net of taxes of $10 and $8(b)
23  51 
AOCI 62  (211)
Less AOCI attributable to noncontrolling interests —  — 
Cash flow hedges AOCI ending balance $ 34  $ (163)
Beginning balance $ (5,395) $ (7,024)
AOCI before reclasses – net of taxes of $(47) and $30
16  219 
Reclasses from AOCI – net of taxes of $194 and $239(b)
689  817 
AOCI 705  1,035 
Less AOCI attributable to noncontrolling interests 1  3 
Benefit plans AOCI ending balance $ (4,691) $ (5,991)
AOCI at March 31
$ (8,893) $ (10,819)
Dividends declared per common share $ 0.01  $ 0.01 
(a) Included adjustments of $2,038 million and $1,267 million for the three months ended March 31, 2021 and 2020, respectively, related to insurance liabilities and annuity benefits in our run-off insurance operations to reflect the effects that would have been recognized had the related unrealized investment security gains been realized. See Note 13 for further information.
(b) The total reclassification from AOCI included $836 million, including currency translation of $688 million, net of taxes, for the three months ended March 31, 2020, related to the sale of our BioPharma business within our Healthcare segment.

On January 21, 2021, GE Capital Series D preferred stock issued to GE Industrial was converted to GE Capital common stock and GE Capital and GE Industrial also agreed to retire the Series A, B and C GE Capital preferred stock. As a result of these actions, there is no remaining preferred stock between GE Industrial and GE Capital, and accordingly GE Capital will no longer pay preferred dividends to GE Industrial and all preferred stock dividend costs have become a GE Industrial obligation effective January 21, 2021. The exchange of GE Capital Series D preferred stock has no impact on the GE Series D preferred stock, which, effective January 21, 2021 became callable for $5,694 million on dividend payment dates and which dividends converted from 5% fixed rate to 3-month LIBOR plus 3.33%, payable quarterly. Similarly, there were no changes to the GE Series A, B or C preferred stock, which become callable at various dates in 2022 and 2023. The total carrying value of GE preferred stock at March 31, 2021 was $5,930 million and will increase to $5,940 million by the respective call dates through periodic accretion. See our Annual Report on Form 10-K for the year ended December 31, 2020 for further information.

2021 1Q FORM 10-Q 41

Redeemable noncontrolling interests, presented within All other liabilities in our consolidated Statement of Financial Position, include common shares issued by our affiliates that are redeemable at the option of the holder of those interests and amounted to $451 million and $487 million as of March 31, 2021 and December 31, 2020, respectively.

NOTE 18. EARNINGS PER SHARE INFORMATION
Three months ended March 31 2021 2020
(Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic
Earnings from continuing operations
$ 90  $ 92  $ 6,202  $ 6,202 
Preferred stock dividends
(72) (72) (43) (43)
Accretion of redeemable noncontrolling interests, net of tax(a)
2  2  —  — 
Earnings from continuing operations attributable to common shareholders
20  22  6,158  6,158 
Earnings (loss) from discontinued operations
(2,897) (2,894) (19) (19)
Net earnings (loss) attributable to GE common shareholders
(2,874) (2,872) 6,140  6,140 
Shares of GE common stock outstanding
8,772  8,772  8,742  8,742 
Employee compensation-related shares (including stock options)
35  —  7  — 
Total average equivalent shares
8,807  8,772  8,749  8,742 
Earnings per share from continuing operations
$ —  $ —  $ 0.70  $ 0.70 
Earnings (loss) per share from discontinued operations
(0.33) (0.33) 0.00  0.00 
Net earnings (loss) per share
(0.33) (0.33) 0.70  0.70 
Potentially dilutive securities(b) 370  422 
(a) Represents accretion adjustment of redeemable noncontrolling interests in our Additive business within our Aviation segment.
(b) Outstanding stock awards not included in the computation of diluted earnings per share because their effect was antidilutive.

Our unvested restricted stock unit awards that contain non-forfeitable rights to dividends or dividend equivalents are considered participating securities and, therefore, are included in the computation of earnings per share pursuant to the two-class method. For the three months ended March 31, 2021, as a result of excess dividends in respect to the current period earnings, losses were not allocated to the participating securities. For the three months ended March 31, 2020, application of this treatment had an insignificant effect.

NOTE 19. FINANCIAL INSTRUMENTS. The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be Level 3 and the vast majority of our liabilities’ fair value are considered Level 2.
March 31, 2021 December 31, 2020
Carrying
amount
(net) 		Estimated
fair value 		Carrying
amount
(net) 		Estimated
fair value
Assets Loans and other receivables $ 2,901  $ 3,066  $ 2,904  $ 3,125 
Liabilities Borrowings (Note 12) 71,358  81,967  74,902  86,001 
Investment contracts (Note 13) 2,021  2,402  2,049  2,547 

The fair value in relation to carrying value for borrowings at March 31, 2021 compared to December 31, 2020 was unchanged, as an increase in market interest rates was offset by narrowing GE Industrial credit spreads and a decline in fair value adjustments for debt in fair value hedge relationships. Unlike the carrying amount, estimated fair value of borrowings included $1,178 million and $898 million of accrued interest at March 31, 2021 and December 31, 2020, respectively.

Assets and liabilities that are reflected in the accompanying financial statements at fair value are not included in the above disclosures; such items include cash and equivalents, investment securities and derivative financial instruments.

DERIVATIVES AND HEDGING. Our policy requires that derivatives are used solely for managing risks and not for speculative purposes. Total gross notional was $91,921 million ($43,768 million in GE Capital and $48,153 million in GE Industrial) and $95,647 million ($45,445 million in GE Capital and $50,202 million in GE Industrial) at March 31, 2021 and December 31, 2020, respectively. GE Capital notional relates primarily to managing interest rate and currency risk between financial assets and liabilities, and GE Industrial notional relates primarily to managing currency risk.
2021 1Q FORM 10-Q 42

FAIR VALUE OF DERIVATIVES March 31, 2021 December 31, 2020
Gross Notional All other assets All other liabilities Gross Notional All other assets All other liabilities
Interest rate contracts $ 20,395  $ 1,404  $ 16  $ 20,500  $ 1,912  $ 7 
Currency exchange contracts 6,701  193  65  7,387  164  125 
Derivatives accounted for as hedges $ 27,096  $ 1,597  $ 81  $ 27,886  $ 2,076  $ 132 
Interest rate contracts $ 361  $ 14  $ 7  $ 346  $ 8  $ (1)
Currency exchange contracts 62,369  967  911  65,379  767  918 
Other contracts 2,095  322  7  2,036  218  71 
Derivatives not accounted for as hedges $ 64,825  $ 1,302  $ 926  $ 67,761  $ 993  $ 989 
Gross derivatives $ 91,921  $ 2,899  $ 1,007  $ 95,647  $ 3,069  $ 1,121 
Netting and credit adjustments $ (729) $ (729) $ (647) $ (647)
Cash collateral adjustments (1,497) (6) (1,935) (104)
Net derivatives recognized in statement of financial position $ 673  $ 271  $ 487  $ 369 
Net accrued interest $ 24  $ (19) $ —  $ — 
Securities held as collateral (174) —  (2) — 
Net amount $ 522  $ 252  $ 484  $ 369 

It is standard market practice to post or receive cash collateral with our derivative counterparties in order to minimize counterparty exposure. Included in GE Capital Cash, cash equivalents and restricted cash was total net cash collateral received on derivatives of $1,542 million (comprising $2,313 million received and $771 million posted) at March 31, 2021 and $3,289 million (comprising $4,203 million received and $914 million posted) at December 31, 2020. Of these amounts, $584 million and $1,968 million at March 31, 2021 and December 31, 2020, respectively, were received on interest rate derivatives traded through clearing houses, which are recorded as a reduction of derivative assets and net accrued interest.

Also included in total net cash collateral received are amounts presented as cash collateral adjustments in the table above, amounts related to accrued interest on interest rate derivatives presented as a reduction of Net accrued interest of $159 million and $292 million at March 31, 2021 and December 31, 2020, respectively, and excess net cash collateral posted of $693 million (comprising $31 million received and $723 million posted) at March 31, 2021, and $802 million (comprising $3 million received and $805 million posted) at December 31, 2020, which are excluded from cash collateral adjustments in the table above.

Securities held as collateral excluded excess collateral received of $15 million and zero at March 31, 2021 and December 31, 2020, respectively.

Fair value of derivatives in our consolidated Statement of Financial Position excludes accrued interest.

FAIR VALUE HEDGES. We use derivatives to hedge the effects of interest rate and currency exchange rate changes on our borrowings. At March 31, 2021, the cumulative amount of hedging adjustments of $3,826 million (including $2,330 million on discontinued hedging relationships) was included in the carrying amount of the hedged liability of $26,926 million. At March 31, 2020, the cumulative amount of hedging adjustments of $6,527 million (including $2,348 million on discontinued hedging relationships) was included in the carrying amount of the hedged liability of $41,735 million. The cumulative amount of hedging adjustments was primarily recorded in long-term borrowings.

CASH FLOW HEDGES. Changes in the fair value of cash flow hedges are recorded in AOCI and recorded in earnings in the period in which the hedged transaction occurs. The gain (loss) recognized in AOCI was $36 million and $(313) million for the three months ended March 31, 2021 and 2020, respectively. These amounts were primarily related to currency exchange and interest rate contracts.

The total amount in AOCI related to cash flow hedges of forecasted transactions was a $62 million gain at March 31, 2021. We expect to reclassify $4 million of gain to earnings in the next 12 months contemporaneously with the earnings effects of the related forecasted transactions. For the three months ended March 31, 2021 and 2020, we recognized an immaterial amount and $18 million of loss (primarily as a result of the disposition of BioPharma), respectively, related to hedged forecasted transactions and firm commitments that did not occur by the end of the originally specified period. At March 31, 2021 and 2020, the maximum term of derivative instruments that hedge forecasted transactions was 14 years and 15 years, respectively.

NET INVESTMENT HEDGES. For these hedges, the portion of the fair value changes of the derivatives or debt instruments that relates to changes in spot currency exchange rates is recorded in a separate component of AOCI. The portion of the fair value changes of the derivatives related to differences between spot and forward rates is recorded in earnings each period. The amounts recorded in AOCI affect earnings if the hedged investment is sold, substantially liquidated, or control is lost.

The total gain (loss) recognized in AOCI on hedging instruments for the three months ended March 31, 2021 and 2020 was $272 million and $158 million, respectively, predominantly from foreign currency debt. For all periods presented we recognized an immaterial amount excluded from assessment and recognized in earnings.
2021 1Q FORM 10-Q 43

The carrying value of foreign currency debt designated as net investment hedges was $8,106 million and $9,145 million at March 31, 2021 and 2020, respectively. No amount was reclassified from AOCI into earnings for the three months ended March 31, 2021 and 2020, respectively.

EFFECTS OF DERIVATIVES ON EARNINGS. All derivatives are marked to fair value on our consolidated Statement of Financial Position, whether they are designated in a hedging relationship for accounting purposes or are used as economic hedges. For derivatives not designated as hedging instruments, substantially all of the gain or loss recognized in earnings is offset by either the current period change in value of underlying exposures, which is recorded in earnings in the current period or a future period when the recording of the exposures occur.

The table below presents the effect of our derivative financial instruments in the consolidated Statement of Earnings (Loss):
Three months ended March 31, 2021 Three months ended March 31, 2020
Revenues Cost of sales Interest Expense SG&A Other Income Revenues Cost of sales Interest Expense SG&A Other Income
Total amounts presented in the consolidated Statement of Earnings (Loss) $ 17,118  $ 12,538  $ 500  $ 2,891  $ 626  $ 19,490  $ 14,426  $ 561  $ 3,061  $ 6,869 
Total effect of cash flow hedges $ (21) $ (4) $ (8) $ —  $ —  $ (21) $ (25) $ (10) $ (3) $ — 
Hedged items $ 1,843  $ (2,480)
Derivatives designated as hedging instruments (1,899) 2,511 
Total effect of fair value hedges $ (56) $ 31 
Interest rate contracts $ 1  $ —  $ (9) $ —  $ (1) $ (26) $ —  $ (9) $ —  $ — 
Currency exchange contracts 303  —  —  59  38  (521) 13  —  54  11 
Other —  —  —  55  19  —  —  —  (160) (22)
Total effect of derivatives not designated as hedges $ 305  $ —  $ (9) $ 114  $ 56  $ (547) $ 13  $ (9) $ (106) $ (12)
The gain (loss) of amount excluded for cash flow hedges was $(16) million and $15 million for the three months ended March 31, 2021 and 2020, respectively. This amount is recognized primarily in Revenues in our consolidated Statement of Earnings (Loss).

COUNTERPARTY CREDIT RISK. We manage the risk that counterparties will default and not make payments to us according to the terms of our agreements on an individual counterparty basis. Where we have agreed to netting of derivative exposures with a counterparty, we net our exposures with that counterparty and apply the value of collateral posted to us to determine the exposure. We actively monitor these net exposures against defined limits and take appropriate actions in response, including requiring additional collateral. Our exposures to counterparties (including accrued interest), net of collateral we held, was $404 million and $392 million at March 31, 2021 and December 31, 2020, respectively. Counterparties' exposures to our derivative liability (including accrued interest), net of collateral posted by us, was $186 million and $307 million at March 31, 2021 and December 31, 2020, respectively.

NOTE 20. VARIABLE INTEREST ENTITIES. In addition to the three VIEs detailed in Note 4, in our consolidated Statement of Financial Position, we have assets of $1,712 million and $1,733 million and liabilities of $454 million and $657 million, inclusive of intercompany eliminations, at March 31, 2021 and December 31, 2020, respectively, from other consolidated VIEs. These entities were created to help our customers facilitate or finance the purchase of GE goods and services and have no features that could expose us to losses that would significantly exceed the difference between the consolidated assets and liabilities. Substantially all the assets of our consolidated VIEs at March 31, 2021 can only be used to settle the liabilities of those VIEs.

Our investments in unconsolidated VIEs were $3,371 million and $3,230 million at March 31, 2021 and December 31, 2020, respectively. These investments are primarily owned by GE Capital businesses of which $1,120 million and $1,141 million were owned by EFS, comprising equity method investments, primarily renewable energy tax equity investments, at March 31, 2021 and December 31, 2020, respectively. In addition, $2,024 million and $1,833 million were owned by our run-off insurance operations, primarily comprising investment securities at March 31, 2021 and December 31, 2020, respectively. The increase in investments in unconsolidated VIEs in our run-off insurance operations reflects implementation of our revised reinvestment plan, which incorporates the introduction of strategic initiatives to invest in higher-yielding asset classes. Our maximum exposure to loss in respect of unconsolidated VIEs is increased by our commitments to make additional investments in these entities described in Note 21.
2021 1Q FORM 10-Q 44

NOTE 21. COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES
COMMITMENTS. GE Capital had total investment commitments of $2,551 million at March 31, 2021. The commitments primarily comprise project financing investments in thermal and wind energy projects of $769 million and investments by our run-off insurance operations in investment securities and other assets of $1,782 million, and included within these commitments are obligations to make additional investments in unconsolidated VIEs of $447 million and $1,632 million, respectively. See Note 20 for further information.

As of March 31, 2021, in our Aviation segment, we have committed to provide financing assistance of $2,241 million of future customer acquisitions of aircraft equipped with our engines.

Commitments - Discontinued Operations. The GECAS business within discontinued operations has placed multiple-year orders for various Boeing, Airbus and other aircraft manufacturers with list prices approximating $26,118 million, excluding pre-delivery payments made in advance (including 269 new aircraft with estimated delivery dates of 18% in 2021, 18% in 2022 and 64% in 2023 through 2026) and secondary orders with airlines for used aircraft approximating $1,146 million (including 26 used aircraft with estimated delivery dates of 62% in 2021, 27% in 2022 and 11% in 2023) at March 31, 2021. When GECAS purchases aircraft, it is at contractual price, which is usually less than the aircraft manufacturer's list price. As of March 31, 2021, GECAS has made $2,647 million of pre-delivery payments to aircraft manufacturers.

GUARANTEES. Credit Support and Indemnification Agreements - Continuing Operations. For further information on credit support and indemnification agreements for continuing operations, see our Annual Report on Form 10-K for the year ended December 31, 2020.

Indemnification agreements - Discontinued Operations. At March 31, 2021, we have provided specific indemnities to buyers of GE Capital's assets that, in the aggregate, represent a maximum potential claim of $597 million with related reserves of $86 million.

PRODUCT WARRANTIES. We provide for estimated product warranty expenses when we sell the related products. Because warranty estimates are forecasts that are based on the best available information, mostly historical claims experience, claims costs may differ from amounts provided. The liability for product warranties was $1,975 million and $2,054 million at March 31, 2021 and December 31, 2020, respectively.

LEGAL MATTERS. The following information supplements and amends the discussion of Legal Matters in Note 23 to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020; refer to those discussions for information about previously reported legal matters that are not updated below. In the normal course of our business, we are involved from time to time in various arbitrations, class actions, commercial litigation, investigations and other legal, regulatory or governmental actions, including the significant matters described below that could have a material impact on our results of operations. In many proceedings, including the specific matters described below, it is inherently difficult to determine whether any loss is probable or even reasonably possible or to estimate the size or range of the possible loss, and accruals for legal matters are not recorded until a loss for a particular matter is considered probable and reasonably estimable. Given the nature of legal matters and the complexities involved, it is often difficult to predict and determine a meaningful estimate of loss or range of loss until we know, among other factors, the particular claims involved, the likelihood of success of our defenses to those claims, the damages or other relief sought, how discovery or other procedural considerations will affect the outcome, the settlement posture of other parties and other factors that may have a material effect on the outcome. For these matters, unless otherwise specified, we do not believe it is possible to provide a meaningful estimate of loss at this time. Moreover, it is not uncommon for legal matters to be resolved over many years, during which time relevant developments and new information must be continuously evaluated.

Alstom legacy matters. On November 2015, we acquired the Thermal, Renewables and Grid businesses from Alstom. Prior to the acquisition, the seller was the subject of two significant cases involving anti-competitive activities and improper payments: (1) in January 2007, Alstom was fined €65 million by the European Commission for participating in a gas insulated switchgear cartel that operated from 1988 to 2004 (that fine was later reduced to €59 million), and (2) in December 2014, Alstom pled guilty in the United States to multiple violations of the Foreign Corrupt Practices Act and paid a criminal penalty of $772 million. As part of GE’s accounting for the acquisition, we established a reserve amounting to $858 million for legal and compliance matters related to the legacy business practices that were the subject of these and related cases in various jurisdictions, including the previously reported legal proceedings in Slovenia that are described below. The reserve balance was $659 million and $858 million at March 31, 2021 and December 31, 2020, respectively, with the reduction driven primarily by cash payment in connection with the Šoštanj settlement described below.

Regardless of jurisdiction, the allegations relate to claimed anti-competitive conduct or improper payments in the pre-acquisition period as the source of legal violations and/or damages. Given the significant litigation and compliance activity related to these matters and our ongoing efforts to resolve them, it is difficult to assess whether the disbursements will ultimately be consistent with the reserve established. The estimation of this reserve involved significant judgment and may not reflect the full range of uncertainties and unpredictable outcomes inherent in litigation and investigations of this nature, and at this time we are unable to develop a meaningful estimate of the range of reasonably possible additional losses beyond the amount of this reserve. Damages sought may include disgorgement of profits on the underlying business transactions, fines and/or penalties, interest, or other forms of resolution. Factors that can affect the ultimate amount of losses associated with these and related matters include the way cooperation is assessed and valued, prosecutorial discretion in the determination of damages, formulas for determining fines and penalties, the duration and amount of legal and investigative resources applied, political and social influences within each jurisdiction, and tax consequences of any settlements or previous deductions, among other considerations. Actual losses arising from claims in these and related matters could exceed the amount provided.
2021 1Q FORM 10-Q 45

In connection with alleged improper payments by Alstom relating to contracts won in 2006 and 2008 for work on a state-owned power plant in Šoštanj, Slovenia, the power plant owner in January 2017 filed an arbitration claim for damages of approximately $430 million before the International Chamber of Commerce Court of Arbitration in Vienna, Austria. In February 2017, a government investigation in Slovenia of the same underlying conduct proceeded to an investigative phase overseen by a judge of the Celje District Court. In September 2020, the relevant Alstom legacy entity was served with an indictment, which we had anticipated as we are working with the parties to resolve these matters. In March 2021, GE reached a settlement of the arbitration claim with the power plant owner for a mix of cash and services valued by the plant owner at approximately $307 million.

Shareholder and related lawsuits. Since February 2018, multiple shareholder derivative lawsuits have been filed against current and former GE executive officers and members of GE’s Board of Directors and GE (as nominal defendant). Four shareholder derivative lawsuits are currently pending: the Bennett case, which was filed in Massachusetts state court; and the Cuker, Lindsey and Priest/Tola cases, which were filed in New York state court. The Priest and Tola cases were initially filed as separate actions but have now been consolidated into one lawsuit. The Burden case, which was filed in the U.S. District Court for the Southern District of New York, was voluntarily dismissed by the plaintiffs in February 2021. These lawsuits have alleged violations of securities laws, breaches of fiduciary duties, unjust enrichment, waste of corporate assets, abuse of control and gross mismanagement, although the specific matters underlying the allegations in the lawsuits have varied. The allegations in the Bennett, Lindsey and Priest/Tola cases relate to substantially the same facts as those underlying the Hachem securities class action described in our Annual Report on Form 10-K for the year ended December 31, 2020, and the allegations in the Cuker case relate to alleged corruption in China. The plaintiffs seek unspecified damages and improvements in GE’s corporate governance and internal procedures. The Bennett case has been stayed pending final resolution of another shareholder derivative lawsuit (the Gammel case) that was previously dismissed. In August 2019, the Cuker plaintiffs filed an amended complaint, and GE in September 2019 filed a motion to dismiss the amended complaint. The Lindsey case has been stayed by agreement of the parties. GE filed a motion to dismiss the Priest/Tola complaint in March 2021.

In July 2018, a putative class action (the Mahar case) was filed in New York state court naming as defendants GE, former GE executive officers, a former member of GE’s Board of Directors and KPMG. It alleged violations of Sections 11, 12 and 15 of the Securities Act of 1933 based on alleged misstatements related to insurance reserves and performance of GE’s business segments in GE Stock Direct Plan registration statements and documents incorporated therein by reference and seeks damages on behalf of shareholders who acquired GE stock between July 20, 2015 and July 19, 2018 through the GE Stock Direct Plan. In February 2019, this case was dismissed. In March 2019, plaintiffs filed an amended derivative complaint naming the same defendants. In April 2019, GE filed a motion to dismiss the amended complaint. In October 2019, the court denied GE's motion to dismiss and stayed the case pending the outcome of the Hachem case. In November 2019, the plaintiffs moved to re-argue to challenge the stay, and GE cross-moved to re-argue the denial of the motion to dismiss and filed a notice of appeal. The court denied both motions for re-argument, and in November 2020, the Appellate Division First Department affirmed the court's denial of GE's motion to dismiss. In January 2021, GE filed a motion for leave to appeal to the New York Court of Appeals, and that motion was denied in March 2021.
  
In October 2018, a putative class action (the Houston case) was filed in New York state court naming as defendants GE, certain GE subsidiaries and current and former GE executive officers and employees. It alleges violations of Sections 11, 12 and 15 of the Securities Act of 1933 and seeks damages on behalf of purchasers of senior notes issued in 2016 and rescission of transactions involving those notes. This case was stayed pending resolution of the motion to dismiss the Hachem case. In April 2021, the plaintiffs filed an amended complaint.

In February 2019, a securities action (the Touchstone case) was filed in the U.S. District Court for the Southern District of New York naming as defendants GE and current and former GE executive officers. It alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Section 1707.43 of the Ohio Securities Act and common law fraud based on alleged misstatements regarding insurance reserves, GE Power’s revenue recognition practices related to long term service agreements, GE’s acquisition of Alstom, and the goodwill recognized in connection with that transaction. The lawsuit seeks damages on behalf of six institutional investors who purchased GE common stock between August 1, 2014 and October 30, 2018 and rescission of those purchases. This case was stayed pending resolution of the motion to dismiss the Hachem case. In March 2021, the plaintiffs filed an amended complaint.

As previously reported by Baker Hughes, in March 2019, two derivative lawsuits were filed in the Delaware Court of Chancery naming as defendants GE, directors of Baker Hughes (including former members of GE’s Board of Directors and current and former GE executive officers) and Baker Hughes (as nominal defendant), and the court issued an order consolidating these two actions (the Schippnick case). The complaint as amended in May 2019 alleges, among other things, that GE and the Baker Hughes directors breached their fiduciary duties and that GE was unjustly enriched by entering into transactions and agreements related to GE's sales of approximately 12% of its ownership interest in Baker Hughes in November 2018. The complaint seeks declaratory relief, disgorgement of profits, an award of damages, pre- and post-judgment interest and attorneys’ fees and costs. In May 2019, the plaintiffs voluntarily dismissed their claims against the directors who were members of the Baker Hughes Conflicts Committee and a former Baker Hughes director. In October 2019, the Court denied the remaining defendants’ motions to dismiss, except with respect to the unjust enrichment claim against GE, which has been dismissed. In November 2019, the defendants filed their answer to the complaint, and a special litigation committee of the Baker Hughes Board of Directors moved for an order staying all proceedings in this action pending completion of the committee's investigation of the allegations and claims asserted in the complaint. In October 2020, the special litigation committee filed a report with the Court recommending that the derivative action be terminated. In January 2021, the special committee filed a motion to terminate the action.

2021 1Q FORM 10-Q 46

Bank BPH. As previously reported, GE Capital’s subsidiary Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency denominated mortgage loans in various courts throughout Poland. At March 31, 2021, approximately 86% of the Bank BPH portfolio is indexed to or denominated in foreign currencies (primarily Swiss francs), and the total portfolio had a carrying value of $1,986 million. We continue to observe an increase in the number of lawsuits being brought against Bank BPH and other banks in Poland, and we expect this to continue in future reporting periods.

We estimate potential losses for Bank BPH in connection with borrower litigation cases that are pending by recording legal reserves, as well as in connection with potential future cases or other adverse developments as part of our ongoing valuation of the Bank BPH portfolio, which we record at the lower of cost or fair value, less cost to sell. At March 31, 2021, the total amount of such estimated losses was $465 million. We update our assumptions underlying the amount of estimated losses based primarily on the number of lawsuits filed and estimated to be filed in the future, whether liability will be established in lawsuits and the nature of the remedy ordered by courts if liability is established. The increase in the amount of estimated losses during the first quarter of 2021 was driven primarily by increases in the number of lawsuits filed and estimated to be filed in the future. We expect the trends we have previously reported of an increasing number of lawsuits being filed, more findings of liability and more severe remedies being ordered against Polish banks (including Bank BPH) to continue in future reporting periods, although Bank BPH is unable at this time to develop a meaningful estimate of reasonably possible losses associated with active and inactive Bank BPH mortgage loans beyond the amounts currently recorded. Additional factors may also affect our estimated losses over time, including: potentially significant judicial decisions scheduled to be issued in the second quarter of 2021, including a decision by the European Court of Justice (ECJ) on the case involving a Bank BPH mortgage loan that was referred to the ECJ in January 2020 and one or more binding resolutions from the Polish Supreme Court; the impact of any of these or other decisions or binding resolutions on how Polish courts will interpret and apply the law in particular cases and how borrower behavior may change in response, neither or which will be known immediately upon the issuance of a decision or resolution; uncertainty related to a proposal by the Chairman of the Polish Financial Supervisory Authority in December 2020 that banks voluntarily offer borrowers an opportunity to convert their foreign currency denominated mortgage loans to Polish zlotys using an exchange rate applicable at the date of loan origination, and about the approaches that other Polish banks, regulators and other government authorities are adopting or will adopt in response to this proposal; uncertainty arising from investigations of the Polish Office of Competition and Consumer Protection (UOKiK), including a UOKiK decision in December 2020 which found that certain foreign exchange clauses that appear in certain of Bank BPH’s mortgage loan agreements are unfair contractual terms under Polish law. Future adverse developments related to any of the foregoing, or other developments such as actions by regulators or other governmental authorities could have a material adverse effect on Bank BPH and the carrying value of its mortgage loan portfolio and could result in significant losses beyond the amount that we currently estimate.

ENVIRONMENTAL, HEALTH AND SAFETY MATTERS. As previously reported, in 2000, GE and the Environmental Protection Agency (EPA) entered into a consent decree relating to PCB cleanup of the Housatonic River in Massachusetts. Following the EPA’s release in September 2015 of an intended final remediation decision, GE and the EPA engaged in mediation and the first step of the dispute resolution process contemplated by the consent decree. In October 2016, the EPA issued its final decision pursuant to the consent decree, which GE and several other interested parties appealed to the EPA’s Environmental Appeals Board (EAB). The EAB issued its decision in January 2018, affirming parts of the EPA’s decision and granting relief to GE on certain significant elements of its challenge. The EAB remanded the decision back to the EPA to address those elements and reissue a revised final remedy, and the EPA convened a mediation process with GE and interested stakeholders. In February 2020, the EPA announced an agreement between the EPA and many of the mediation stakeholders, including GE, concerning a revised Housatonic River remedy. Based on the mediated resolution, the EPA solicited public comment on a draft permit in July 2020 and issued the final revised permit effective January 4, 2021. In March 2021, two local environmental advocacy groups filed a joint petition to the EAB challenging portions of the revised permit, and EPA and GE are defending that appeal. As of March 31, 2021, and based on its assessment of current facts and circumstances and its defenses, GE believes that it has recorded adequate reserves to cover future obligations associated with the proposed final remedy.

For further information about environmental, health and safety matters, see our Annual Report on Form 10-K for the year ended December 31, 2020.

2021 1Q FORM 10-Q 47

NOTE 22. INTERCOMPANY TRANSACTIONS. Presented below is a walk of intercompany eliminations from the combined GE Industrial and GE Capital totals to the consolidated cash flows for continuing operations.

Three months ended March 31, 2021
Three months ended March 31, 2020
Cash from (used for): Operating activities Investing activities Financing activities Operating activities Investing activities Financing activities
Combined GE Industrial and GE Capital cash flows $ (2,970) $ 1,747  $ (2,178) $ (1,138) $ 20,776  $ (8,494)
  GE Industrial current receivables sold to GE Capital(a) 211  (448) 237  (997) 945  52 
  GE Industrial long-term receivables sold to GE Capital 67  (67) —  135  (135) — 
Supply chain finance programs 120  (120) —  884  (884) — 
  Other reclassifications and eliminations (68) (265) 333  197  (677) 480 
Consolidated cash flows $ (2,640) $ 847  $ (1,608) $ (919) $ 20,025  $ (7,962)
(a)Included the elimination of $3,218 million and $3,972 million payments to GE Industrial for current receivables purchased and retained by GE Capital and the related reclassification to CFOA of $3,429 million and $2,975 million due to GE Capital collections and other activity in our consolidated statement of cash flows for the three months ended March 31, 2021 and 2020, respectively.

Cash payments received on the Receivable facility deferred purchase price are reflected as Cash from investing activities in the GE Capital and Consolidated columns of our consolidated Statement of Cash Flows. Sales of customer receivables from GE Industrial to GE Capital are classified as Cash from operating activities in the GE Industrial column of our Statement of Cash Flows. See Note 4 for further information.

NOTE 23. OTHER INCOME
Three months ended March 31
2021 2020
Purchases and sales of business interests(a) $ 3  $ 12,372 
Licensing and royalty income 48  42 
Associated companies 16  39 
Net interest and investment income (loss)(b) 439  (5,632)
Other items 116  53 
GE Industrial $ 623  $ 6,874 
Eliminations 3  (4)
Total $ 626  $ 6,869 
(a)Included a pre-tax gain of $12,292 million ($11,145 million after-tax) on the sale of BioPharma for the three months ended March 31, 2020. See Note 2 for further information.
(b)Included a pre-tax realized and unrealized gain of $296 million ($188 million after-tax) and a pre-tax unrealized loss of $5,710 million ($4,631 million after-tax) related to our interest in Baker Hughes for the three months ended March 31, 2021 and 2020, respectively.

2021 1Q FORM 10-Q 48

EXHIBITS
Computation of Per Share Earnings. Data is provided in Note 18 of this Report.
Exhibit 101
The following materials from General Electric Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, formatted in XBRL (eXtensible Business Reporting Language); (i) Statement of Earnings (Loss) for the three months ended March 31, 2021 and 2020, (ii) Statement of Financial Position at March 31, 2021 and December 31, 2020, (iii) Statement of Cash Flows for the three months ended March 31, 2021 and 2020, (iv) Consolidated Statement of Comprehensive Income (Loss) for the three months ended March 31, 2021 and 2020, (v) Statement of Changes in Shareholders' Equity for the three months ended March 31, 2021 and 2020, and (vi) Notes to Consolidated Financial Statements.
Exhibit 104
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

FORM 10-Q CROSS REFERENCE INDEX
Item Number Page(s)
Part I – FINANCIAL INFORMATION
Item 1. Financial Statements 24-48
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 4-23
Item 3. Quantitative and Qualitative Disclosures About Market Risk 16-17, 42-44
Item 4. Controls and Procedures 23
Part II – OTHER INFORMATION 
Item 1. Legal Proceedings 45-47
Item 1A. Risk Factors 23
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 23
Item 3. Defaults Upon Senior Securities Not applicable
Item 4. Mine Safety Disclosures Not applicable
Item 5. Other Information Not applicable
Item 6. Exhibits 49
Signatures 49

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

April 27, 2021 /s/ Thomas S. Timko
Date
Thomas S. Timko
Vice President, Chief Accounting Officer and Controller
Principal Accounting Officer
2021 1Q FORM 10-Q 49
        Exhibit 10(a)
IMAGE_01A.JPG         

March 1, 2021 Equity Grant Agreement
GE 2007 Long-Term Incentive Plan
        (as amended and restated April 26, 2017, and as further amended and restated February 15, 2019)

GE Stock Option Grant Agreement “Grant Agreement”
For <<Employee Name>> (“Grantee”)

Grant Date Option Shares Granted Option Exercise Price*
Option
Expiration Date
Vesting Schedule
Number of
Option Shares
Vesting Date
March 1, 2021 <<Granted>> $ March 1, 2031 50% March 1, 2023
50% March 1, 2024
*Exercise price shall be no less than the Fair Market Value of a Share on the Grant Date.
1.Grant. The Management Development and Compensation Committee ("Committee") of the Board of Directors of General Electric Company ("Company") has granted an Option to purchase the above number of Shares to the individual named in this Grant Agreement ("Grantee") subject to the terms of this Grant Agreement. Without limiting any condition of this Option award, the award is subject to cancellation and forfeiture if the Grantee does not confirm acceptance within 45 days of the Grant Date. Once vested, the Option entitles the Grantee to purchase from the Company the vested number of Shares of Company common stock, par value $0.06 per Share, each at the Option Exercise Price provided above, in accordance with the terms of this Grant Agreement, the GE 2007 Long-Term Incentive Plan as amended and restated April 26, 2017 and as further amended and restated February 15, 2019 ("Plan"), and any rules, procedures and sub-plans (including country addenda) adopted by the Committee.

2. Vesting and Expiration Date. In order for all or part of the Option to become vested, the Grantee must be continuously employed by the Company and its Affiliates from the Grant Date through the applicable Vesting Date listed above. The Option shall be cancelled and forfeited on the earlier of the Expiration Date and termination of employment for any reason, except as specifically provided below:

i.Death or Disability. If the Grantee's employment with the Company and its Affiliates terminates prior to the Vesting Date as a result of the Grantee's death or disability, then the Option shall vest and become immediately exercisable as of such

        Exhibit 10(a)
termination and shall remain exercisable until the Expiration Date. For this purpose, “disability” shall have the same definition as provided in the long-term disability plan sponsored by the Company or an Affiliate in which the Grantee is eligible to participate.

ii.Retirement Eligibility. If, on or after the first anniversary of the Grant Date (and prior to the Vesting Date), the Grantee attains age 60 and completes 5 years of continuous employment with the Company and its Affiliates, then the Option shall vest and become immediately exercisable as of such date (the latter of attainment of age 60 and completion of 5 years of continuous employment) and shall remain exercisable until the Expiration Date.

iii.Transfer of Business to Successor Employer. If the Grantee's employment with the Company and its Affiliates terminates prior to the Vesting Date as a result of transferring directly to employment with a successor employer in connection with transfer by the Company or Affiliate of a business operation, then the Option shall vest and become immediately exercisable as of such termination, but shall remain exercisable only until the earlier of (a) 3 months after such termination and (b) the original Expiration Date.

iv.Termination of Employment for Cause. If the Grantee’s employment with the Company and its Affiliates is terminated for Cause (as defined below and determined by the Company in its sole discretion), the Option shall be cancelled immediately (whether vested or unvested) and shall be unexercisable.

For this purpose, “Cause” shall be determined by the Company in its sole discretion and includes: (a) breach of the Employee Innovation and Proprietary Information Agreement or any other confidentiality, non-solicitation, or non-competition agreement with the Company or Affiliate, or breach of a material term of any other agreement with the Company or Affiliate; (b) engagement in conduct that results in, or has the potential to cause, material harm financially, reputationally, or otherwise to the Company; (c) commission of an act of dishonesty, fraud, embezzlement or theft; (d) conviction of, or plea of guilty or no contest to a felony or crime involving moral turpitude; or (e) failure to comply with the Company’s or Affiliate’s policies and procedures, including, but not limited to, The Spirit and Letter.

v.Other Termination of Employment.  If the Grantee’s employment with the Company and its Affiliates terminates prior to the Vesting Date for any reason not described above, then the unvested portion of the Option shall be cancelled as of such termination and the vested portion of the Option shall remain exercisable only until the earlier of (a) 3 months after such termination and (b) the original Expiration Date.

3.     Notice and Manner of Exercise. The Grantee may elect to exercise all or part of the Option (to the extent vested) by notifying the Company (through such administrative procedures as it may establish) of the number of Shares to be purchased (exercised) and the date or Share

        Exhibit 10(a)
price upon which such Options shall be exercised. [The Grantee may choose to exercise either by (i) paying the Option Exercise Price (plus applicable fees and tax withholding) in U.S. dollars (or the currency equivalent thereof) in order to receive the exercised number of Shares or (ii) electing a sell-all “cashless exercise” in which the exercised number of Shares are sold and the cash proceeds (less an amount to cover the Option Exercise Price and applicable tax withholding and fees) are delivered to the Grantee.] Delivery shall be electronic through the brokerage account established by the Company for the Grantee, or in such other medium as is determined by the Company.

The Grantee is ultimately responsible for any and all applicable taxes, regardless of the amount withheld or reported. Notwithstanding the foregoing, the date of issuance or delivery of Shares may be postponed by the Company for such period as may be required for it with reasonable diligence to comply with any applicable listing requirements of any national securities exchange and requirements under any law or regulation applicable to the issuance or transfer of such Shares to the extent such postponement is permissible under Section 409A of the Code. Likewise, the method of exercising Options under this Grant Agreement may be adjusted for compliance with applicable law in the jurisdiction applicable to the Grantee.

4.     Data Security and Privacy.
i.Data Collection, Processing and Usage. Personal data collected, processed and used by the Company in connection with Awards granted under the Plan includes the Grantee’s name, home address, email address, telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all Awards granted, cancelled, exercised, vested, or outstanding. In granting Awards under the Plan, the Company will collect the Grantee’s personal data for purposes of allocating Shares in settlement of the Awards and implementing, administering and managing the Plan. The Company collects, processes and uses the Grantee’s personal data in compliance with GE's Employment Data Protection Standards and the Uses of Employment Data for GE Entities. The Grantee may exercise rights to access, correction, or restriction or deletion where applicable, by contacting the Grantee’s local HR manager or initiating a request through www.onehr.ge.com.

ii.Administrative Service Provider. The Company transfers the Grantee’s personal data to UBS Financial Services, which assists with the implementation, administration and management of the Plan (the “Third-Party Administrator”).  In the future, the Company may select a different Third-Party Administrator and share the Grantee’s personal data with another company that serves in a similar manner. The Third-Party Administrator will open an account for the Grantee to receive and trade Shares acquired under the Plan.  The Grantee will be asked to agree on separate terms and data processing practices with the Third-Party Administrator, which is a condition to the Grantee’s ability to participate in the Plan. The privacy policy of the Third-Party Administrator may be reviewed here.


        Exhibit 10(a)
5.Non-solicitation, Non-competition and Compliance with Agreements. During the Grantee’s employment with the Company or its Affiliate, and for the one-year period following termination of such employment (the “Restriction Period”), the Grantee will not, without prior written approval from the Senior Human Resources Manager of the Grantee’s Company business segment: (a) whether on his or her own behalf or in conjunction with any other person or third party, directly or indirectly solicit or encourage any person who is a Lead Professional Band or higher employee of the Company or any of its Affiliates (a “Restricted Person”) to terminate his or her employment relationship with, or accept any other employment outside of, the Company and its Affiliates; (b) directly hire, or recommend or cause to be hired by an entity for which the Grantee works, or with which the Grantee is otherwise associated or owns more than a 1% ownership interest, any person who is, or was within one year before or after the Grantee’s termination of employment with the Company and its Affiliates, a Restricted Person (this restriction does not apply where legally impermissible, such as California); or (c) provide any non-public information regarding any Restricted Person, including but not limited to, compensation data, performance evaluations, skill sets or qualifications, etc., to any external person in connection with employment outside the Company and its Affiliates, including, but not limited to, recruiters and prospective employers. The above restrictions do not apply once a Restricted Person has been formally notified of his or her impending layoff from the Company or any of its Affiliates.

In addition, the Grantee agrees that during the Restriction Period, the Grantee will not, without prior written approval from the Senior Human Resources Manager of the Grantee’s Company business segment, whether directly or indirectly, perform activities or services in the Restricted Area for any Competitive Company which: (a) are similar in nature to the activities and services the Grantee performed for the Company or its Affiliate (or gained confidential information about, as described in the Employee Innovation and Proprietary Information Agreement or “EIPIA”) during the last two years of Grantee’s employment; and/or (b) will include Grantee working on products or services that are competitive with the products or services the Grantee worked on during the last two years of Grantee’s employment with the Company or its Affiliate. The term “Competitive Company” means any company or other third party that provides products and services that are competitive with the Company or its Affiliates. [The term “Restricted Area” means any area within the country in which the Grantee is based where the Company or its Affiliate has material business operations as of Grantee’s termination of employment and in which the Grantee has provided services, had a material presence or influence, or received confidential information about (as described in the EIPIA) at any time during the last two years of the Grantee’s employment with the Company or its Affiliate. The Grantee understands and agrees that, given the nature of the business of the Company and its Affiliates and the Grantee’s position with the Company or its Affiliate, the foregoing Restriction Period and Restricted Area are reasonable and appropriate to protect the Company’s legitimate business interests and goodwill.] The foregoing restrictions do not apply where legally impermissible (such as California). To the extent the Grantee is subject to an existing non-competition agreement with the Company or any of its affiliates (the “Prior Agreement”), the Prior Agreement shall be incorporated herein by reference and the Prior Agreement and this Grant Agreement shall be read together;

        Exhibit 10(a)
provided, however, that where the provisions are inconsistent, the more restrictive covenant shall apply.
Furthermore, during the Grantee’s employment with the Company or its Affiliate, and for all periods thereafter, the Grantee will not breach his or her EIPIA or otherwise disclose the Company’s or Affiliate’s non-public information.

The Grantee agrees that any breach by him or her of the foregoing obligations inevitably would cause substantial and irreparable damage to the Company and its Affiliates for which money damages may not be an adequate remedy. Accordingly, the Grantee agrees that the Company and its Affiliates will be entitled to an injunction and/or other equitable relief, without the necessity of posting security, to prevent the breach of such obligations. The Grantee also agrees to indemnify and hold the Company and its Affiliates harmless from any loss, claim or damages, including, without limitation, all reasonable attorneys’ fees, costs and expenses incurred in enforcing its rights under this Grant Agreement, as well as repay any payments made hereunder (regardless of whether the Option is vested), except to the extent that such reimbursement is prohibited by law.

The Grantee agrees that the payment and benefits provided for in the Grant Agreement constitute fair and reasonable consideration for Grantee’s compliance with this section.

6.Additional Requirements. The Company reserves the right to impose other requirements on the Award, Shares acquired pursuant to the Award, and the Grantee's participation in the Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law or to facilitate the operation and administration of the Award and the Plan. Without limiting the generality of the foregoing, the Company may require the Grantee to sign any agreements or undertakings that may be necessary to accomplish the foregoing.

7.Alteration/Termination.  Under the express terms of this Grant Agreement, the Committee shall have the right at any time in its sole discretion to amend, alter, suspend, discontinue or terminate the Option without the consent of the Grantee. Furthermore, if the Company determines in its sole discretion that the Grantee has engaged in conduct that (a) constitutes a breach of this Grant Agreement, the EIPIA or any other confidentiality, non-solicitation, or non-competition agreement with the Company or its Affiliates, (b) results in (or has the potential to cause) material harm financially, reputationally, or otherwise to the Company or its Affiliates or (c) occurred prior to the Grantee’s termination of employment and would give rise to a termination for Cause (regardless of whether such conduct is discovered before or after the Grantee’s termination of employment), the unexercised portion of the Option shall be cancelled immediately, and any amounts previously conveyed under this Grant Agreement shall be subject to recoupment. In any event, the Option provided under this Grant Agreement shall be further subject to the Company’s policy with respect to compensation recoupment, as in effect and amended from time to time. The Grantee agrees that the Company may take any such actions as are necessary to effectuate recoupment or applicable law without further consent or action being required by the Grantee, including issuing instructions to any Third-Party Administrator to (i) hold the Grantee’s Shares and other amounts acquired under the Plan and/or (ii) reconvey, transfer, or otherwise return such

        Exhibit 10(a)
Shares and other assets to the Company. Also, the Option shall be null and void to the extent the grant of the Option or the vesting or exercise thereof is prohibited under the laws of the country of residence of the Grantee.

8.Plan Terms and Definitions.  Except to the extent that the context clearly provides otherwise, all terms used in this Grant Agreement have the same meaning as given such terms in the Plan. This Grant Agreement is subject to the terms and provisions of the Plan, which are incorporated by reference. In the event of any conflict between the provisions of this Grant Agreement and those of the Plan, the provisions of the Plan shall control.

9.Interpretation and Construction. This Grant Agreement and the Plan shall be construed and interpreted by the Committee, in its sole discretion. Any interpretation or other determination by Committee (including correction of any defect or omission and reconciliation of any inconsistency) shall be binding and conclusive. All determinations regarding enforcement, waiver or modification of the cancellation and rescission and other provisions of this Grant Agreement shall be made in the Committee’s sole discretion. Determinations made under this Grant Agreement and the Plan need not be uniform and may be made selectively among individuals, whether or not such individuals are similarly situated.

10.Severability. The invalidity or unenforceability of any provision of the Plan or this Grant Agreement will not affect the validity or enforceability of any other provision of the Plan or this Grant Agreement, and each provision of the Plan and this Grant Agreement will be severable and enforceable to the extent permitted by law.

11.Shareholder Rights. The Grantee shall not have any voting or other Shareholder rights unless and until Shares are actually delivered to the Grantee.

12.No Employment Rights. The grant of the Award described in this Grant Agreement does not give the Grantee any rights in respect of employment with the Company or any of its Affiliates.

13.Discretionary Award, Extraordinary Benefit. Awards under the Plan are granted to employees of the Company and its Affiliates in the Committee’s sole discretion. The Award described in this Grant Agreement is a one-time benefit and does not create any contractual or other right to receive other Awards under the Plan or other benefits in lieu thereof. Future grants, if any, will be at the sole discretion of the Committee. The Grantee’s participation in the Plan is voluntary. This Award (and each other Award, if any, granted under the Plan) constitutes an extraordinary item of compensation and is not part of the Grantee’s normal or expected compensation for purposes of calculating any severance, retirement, or other benefit rights (unless otherwise expressly provided in an applicable benefit plan).

14.No Transfer or Assignment. No rights under this Award shall be assignable or transferable by the Grantee, except to the extent expressly permitted by the Plan.


        Exhibit 10(a)
15.Successors and Assigns. The Company may assign any of its rights under this Grant Agreement. This Grant Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Grant Agreement will be binding upon the Grantee and the Grantee's beneficiaries, executors or administrators.

16.Section 409A. To the extent applicable, this Grant Agreement shall be construed and administered consistently with the intent to comply with or be exempt from the requirements of Section 409A of the Code (“Section 409A”) and any state law of similar effect (i.e., applying the exemption for stock rights described in Treas. Reg. § 1.409A-1(b)(5) and/or another exemption).

17.Entire Agreement.  This Grant Agreement, the Plan, and any rules, procedures and sub-plans (including country addenda) adopted by the Committee contain all of the provisions applicable to the Option. No other statements, documents or practices may modify, waive or alter such provisions unless expressly set forth in writing, signed by an authorized officer of the Company and delivered to the Grantee.

By acknowledging this Grant Agreement, the Grantee acknowledges and confirms that the Grantee has read this Grant Agreement and the Plan (including applicable addenda), and the Grantee accepts and agrees to the provisions therein.

18.Electronic Delivery. The Company may, in its sole discretion, decide to deliver any documents related to this or other Awards under the Plan by electronic means. The Grantee hereby consents to receive such documents electronically and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

19.Global Addendum. Notwithstanding any provisions in this document to the contrary, the Option will also be subject to the special terms and conditions set forth on Appendix A for Grantees who reside outside of the United States. Moreover, if a Grantee is not a resident of any of the countries listed on Appendix A as of the Grant Date, but relocates to one of the listed countries at any point thereafter, the special terms and conditions for such country will apply to the Grantee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan. Appendix A constitutes part of this Grant Agreement.

Exhibit 10(b)

IMAGE_01A.JPG     

    March 1, 2021 Equity Grant Agreement
GE 2007 Long-Term Incentive Plan
         (as amended and restated April 26, 2017, and as further amended and restated February 15, 2019)

GE Restricted Stock Unit Grant Agreement (“Grant Agreement”)
For <<Employee Name>> (“Grantee”)


Grant Date RSUs Granted Vesting Schedule
Number of RSUs Vesting Date
March 1, 2021 <<Granted>> 50% March 1, 2023
50% March 1, 2024


1.     Grant. The Management Development and Compensation Committee (“Committee”) of the Board of Directors of General Electric Company (“Company”) has granted the above number of Restricted Stock Units (“RSUs”) to the individual named in this Grant Agreement (“Grantee”), subject to the terms of this Grant Agreement. Without limiting any condition of this RSU award, the award is subject to cancellation and forfeiture if the Grantee does not confirm acceptance within 45 days of the Grant Date. Once vested, each RSU entitles the Grantee to receive from the Company (i) one Share of Company common stock, par value $0.06 per share and (ii) a cash payment in respect of Dividend Equivalents (described below), each in accordance with the terms of this Grant Agreement, the GE 2007 Long-Term Incentive Plan as amended and restated April 26, 2017 and as further amended and restated February 15, 2019 (“Plan”), and any rules, procedures and sub-plans (including country addenda) adopted by the Committee.

2.     Vesting.  In order to vest in an RSU, the Grantee must be continuously employed by the Company and its Affiliates from the Grant Date through the applicable Vesting Date listed above. All unvested RSUs shall be immediately cancelled upon termination of employment for any reason before the Vesting Date, except as specifically provided below:

i.     Death or Disability.  If the Grantee’s employment with the Company and its Affiliates terminates prior to the Vesting Date as a result of the Grantee’s death or disability, then the RSU shall vest as of such date. For this purpose, “disability” shall have the same definition as provided in the long-term disability plan sponsored by the Company or an Affiliate in which the Grantee is eligible to participate.
1

Exhibit 10(b)

ii.    Retirement Eligibility.  If, on or after the first anniversary of the Grant Date (and prior to the Vesting Date), the Grantee attains age 60 and completes 5 years of continuous employment with the Company and its Affiliates, then the RSU shall vest as of such date.

iii.    Transfer of Business to Successor Employer.  If the Grantee’s employment with the Company and its Affiliates terminates prior to the Vesting Date as a result of transferring directly to employment with a successor employer in connection with transfer by the Company or Affiliate of a business operation, then the RSU shall vest as of such date.

3.     Dividend Equivalents. The Company will establish an amount for each RSU equal to the per Share quarterly dividend payments made to Shareholders during the period beginning on the Grant Date and ending on the date that such RSU vests or is cancelled (“Dividend Equivalents”). The Company shall accumulate Dividend Equivalents and, upon vesting of the related RSU, will pay the Grantee a single lump sum cash amount equal to the Dividend Equivalents on the same date that a share is delivered with respect to such RSU, as described in Section 4 of this Grant Agreement. Any accumulated and unpaid Dividend Equivalents attributable to a RSU that is cancelled are immediately forfeited upon cancellation and will not be paid.

4.     Delivery and Tax Withholding.  Within two weeks of the date the RSU vests, the Company shall deliver to the Grantee a number of Shares equal to the number of vested RSUs and the Dividend Equivalent cash amount with respect to each vested RSU (in each case net of applicable tax withholding and fees). Delivery shall be electronic, through the brokerage account established by the Company for the Grantee, or in such other medium as is determined by the Company. The Grantee is ultimately responsible for any and all applicable taxes, regardless of the amount withheld or reported. Notwithstanding the foregoing, the date of issuance or delivery of Shares may be postponed by the Company for such period as may be required for it with reasonable diligence to comply with any applicable listing requirements of any national securities exchange and requirements under any law or regulation applicable to the issuance or transfer of such Shares to the extent such postponement is permissible under Section 409A of the Code.

5.     Data Security and Privacy.

i.     Data Collection, Processing and Usage. Personal data collected, processed and used by the Company in connection with Awards granted under the Plan includes the Grantee’s name, home address, email address, telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all Awards granted, cancelled, exercised, vested, or outstanding. In granting Awards under the Plan, the Company will collect the Grantee’s personal data for purposes of allocating Shares in settlement of the Awards and implementing, administering and managing the Plan. The Company collects, processes and uses the Grantee’s personal data in compliance with GE's Employment Data Protection Standards and the Uses of Employment Data for GE Entities. The Grantee may
2

Exhibit 10(b)

exercise rights to access, correction, or restriction or deletion where applicable, by contacting the Grantee’s local HR manager or initiating a request through www.onehr.ge.com.
ii.    Administrative Service Provider. The Company transfers the Grantee’s personal data to UBS Financial Services, which assists with the implementation, administration and management of the Plan (the “Third-Party Administrator”).  In the future, the Company may select a different Third-Party Administrator and share the Grantee’s personal data with another company that serves in a similar manner. The Third-Party Administrator will open an account for the Grantee to receive and trade Shares acquired under the Plan.  The Grantee will be asked to agree on separate terms and data processing practices with the Third-Party Administrator, which is a condition to the Grantee’s ability to participate in the Plan. The privacy policy of the Third-Party Administrator may be reviewed here.
6.     Non-solicitation, Non-competition and Compliance with Agreements. During the Grantee’s employment with the Company or its Affiliate, and for the one-year period following termination of such employment (the “Restriction Period”), the Grantee will not, without prior written approval from the Senior Human Resources Manager of the Grantee’s Company business segment: (a) whether on his or her own behalf or in conjunction with any other person or third party, directly or indirectly solicit or encourage any person who is a Lead Professional Band or higher employee of the Company or any of its Affiliates (a “Restricted Person”) to terminate his or her employment relationship with, or accept any other employment outside of, the Company and its Affiliates; (b) directly hire, or recommend or cause to be hired by an entity for which the Grantee works, or with which the Grantee is otherwise associated or owns more than a 1% ownership interest, any person who is, or was within one year before or after the Grantee’s termination of employment with the Company and its Affiliates, a Restricted Person (this restriction does not apply where legally impermissible, such as California); or (c) provide any non-public information regarding any Restricted Person, including, but not limited to, compensation data, performance evaluations, skill sets or qualifications, etc., to any external person in connection with employment outside the Company and its Affiliates, including, but not limited to, recruiters and prospective employers. The above restrictions do not apply once a Restricted Person has been formally notified of his or her impending layoff from the Company or any of its Affiliates.

In addition, the Grantee agrees that during the Restriction Period, the Grantee will not, without prior written approval from the Senior Human Resources Manager of the Grantee’s Company business segment, whether directly or indirectly, perform activities or services in the Restricted Area for any Competitive Company which: (a) are similar in nature to the activities and services the Grantee performed for the Company or its Affiliate (or gained confidential information about, as described in the Employee Innovation and Proprietary Information Agreement or “EIPIA”) during the last two years of Grantee’s employment; and/or (b) will include Grantee working on products or services that are competitive with the products or services the Grantee worked on during the last two years of Grantee’s employment with the Company or its Affiliate. The term “Competitive Company” means any company or other third party that provides products and services that are competitive with the
3

Exhibit 10(b)

Company or its Affiliates. [The term “Restricted Area” means any area within the country in which the Grantee is based where the Company or its Affiliate has material business operations as of Grantee’s termination of employment and in which the Grantee has provided services, had a material presence or influence, or received confidential information about (as described in the EIPIA) at any time during the last two years of the Grantee’s employment with the Company or its Affiliate. The Grantee understands and agrees that, given the nature of the business of the Company and its Affiliates and the Grantee’s position with the Company or its Affiliate, the foregoing Restriction Period and Restricted Area are reasonable and appropriate to protect the Company’s legitimate business interests and goodwill.] The foregoing restrictions do not apply where legally impermissible (such as California). To the extent the Grantee is subject to an existing non-competition agreement with the Company or any of its affiliates (the “Prior Agreement”), the Prior Agreement shall be incorporated herein by reference and the Prior Agreement and this Grant Agreement shall be read together; provided, however, that where the provisions are inconsistent, the more restrictive covenant shall apply.

Furthermore, during the Grantee’s employment with the Company or its Affiliate, and for all periods thereafter, the Grantee will not breach his or her EIPIA or otherwise disclose the Company’s or Affiliate’s non-public information.

The Grantee agrees that any breach by him or her of the foregoing obligations inevitably would cause substantial and irreparable damage to the Company and its Affiliates for which money damages may not be an adequate remedy. Accordingly, the Grantee agrees that the Company and its Affiliates will be entitled to an injunction and/or other equitable relief, without the necessity of posting security, to prevent the breach of such obligations. The Grantee also agrees to indemnify and hold the Company and its Affiliates harmless from any loss, claim or damages, including, without limitation, all reasonable attorneys’ fees, costs and expenses incurred in enforcing its rights under this Grant Agreement, as well as repay any payments made hereunder (regardless of whether the RSUs are vested), except to the extent that such reimbursement is prohibited by law.

The Grantee agrees that the payment and benefits provided for in the Grant Agreement constitute fair and reasonable consideration for Grantee’s compliance with this section.

7.     Additional Requirements. The Company reserves the right to impose other requirements on the Award, Shares acquired pursuant to the Award, and the Grantee's participation in the Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law or to facilitate the operation and administration of the Award and the Plan. Without limiting the generality of the foregoing, the Company may require the Grantee to sign any agreements or undertakings that may be necessary to accomplish the foregoing.

8.     Alteration/Termination.  Under the express terms of this Grant Agreement, the Committee shall have the right at any time in its sole discretion to amend, alter, suspend, discontinue or terminate any RSUs without the consent of the Grantee. Furthermore, if the Company determines in its sole discretion that the Grantee has engaged in conduct that (a) constitutes a
4

Exhibit 10(b)

breach of this Grant Agreement, the EIPIA or any other confidentiality, non-solicitation, or non-competition agreement with the Company or its Affiliates, (b) results in (or has the potential to cause) material harm financially, reputationally, or otherwise to the Company or its Affiliates or (c) occurred prior to the Grantee’s termination of employment and would give rise to a termination for Cause (regardless of whether such conduct is discovered before or after the Grantee’s termination of employment), any unvested RSUs shall be cancelled immediately, and any amounts previously conveyed under this Grant Agreement shall be subject to recoupment. In any event, the RSUs provided under this Grant Agreement shall be further subject to the Company’s policy with respect to compensation recoupment, as in effect and amended from time to time. The Grantee agrees that the Company may take any such actions as are necessary to effectuate recoupment or applicable law without further consent or action being required by the Grantee, including issuing instructions to any Third-Party Administrator to (i) hold the Grantee’s Shares and other amounts acquired under the Plan and/or (ii) reconvey, transfer, or otherwise return such Shares and other assets to the Company. Also, the RSUs shall be null and void to the extent the grant of RSUs or the vesting thereof is prohibited under the laws of the country of residence of the Grantee.

For this purpose, “Cause” shall be determined by the Company in its sole discretion and includes: (a) breach of the Employee Innovation and Proprietary Information Agreement or any other confidentiality, non-solicitation, or non-competition agreement with the Company or Affiliate, or breach of a material term of any other agreement with the Company or Affiliate; (b) engagement in conduct that results in, or has the potential to cause, material harm financially, reputationally, or otherwise to the Company or its Affiliate; (c) commission of an act of dishonesty, fraud, embezzlement or theft; (d) conviction of, or plea of guilty or no contest to a felony or crime involving moral turpitude; or (e) failure to comply with the Company’s or Affiliate’s policies and procedures, including, but not limited to, The Spirit and Letter.

9.     Plan Terms and Definitions.  Except to the extent that the context clearly provides otherwise, all terms used in this Grant Agreement have the same meaning as given such terms in the Plan. This Grant Agreement is subject to the terms and provisions of the Plan, which are incorporated by reference. In the event of any conflict between the provisions of this Grant Agreement and those of the Plan, the provisions of the Plan shall control.

10.    Interpretation and Construction. This Grant Agreement and the Plan shall be construed and interpreted by the Committee, in its sole discretion. Any interpretation or other determination by Committee (including correction of any defect or omission and reconciliation of any inconsistency) shall be binding and conclusive. All determinations regarding enforcement, waiver or modification of the cancellation and rescission and other provisions of this Grant Agreement shall be made in the Committee’s sole discretion. Determinations made under this Grant Agreement and the Plan need not be uniform and may be made selectively among individuals, whether or not such individuals are similarly situated.

11.    Severability. The invalidity or unenforceability of any provision of the Plan or this Grant Agreement will not affect the validity or enforceability of any other provision of the Plan or
5

Exhibit 10(b)

this Grant Agreement, and each provision of the Plan and this Grant Agreement will be severable and enforceable to the extent permitted by law.

12.    Shareholder Rights. The Grantee shall not have any voting or other Shareholder rights unless and until Shares are actually delivered to the Grantee.

13.    No Employment Rights. The grant of the Award described in this Grant Agreement does not give the Grantee any rights in respect of employment with the Company or any of its Affiliates.

14.    Discretionary Award, Extraordinary Benefit. Awards under the Plan are granted to employees of the Company and its Affiliates in the Committee’s sole discretion. The Award described in this Grant Agreement is a one-time benefit and does not create any contractual or other right to receive other Awards under the Plan or other benefits in lieu thereof. Future grants, if any, will be at the sole discretion of the Committee. The Grantee’s participation in the Plan is voluntary. This Award (and each other Award, if any, granted under the Plan) constitutes an extraordinary item of compensation and is not part of the Grantee’s normal or expected compensation for purposes of calculating any severance, retirement, or other benefit rights (unless otherwise expressly provided in an applicable benefit plan).

15.    No Transfer or Assignment. No rights under this Award shall be assignable or transferable by the Grantee, except to the extent expressly permitted by the Plan.

16.    Successors and Assigns. The Company may assign any of its rights under this Grant Agreement. This Grant Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Grant Agreement will be binding upon the Grantee and the Grantee's beneficiaries, executors or administrators.

17.    Section 409A. To the extent applicable, this Grant Agreement shall be construed and administered consistently with the intent to comply with or be exempt from the requirements of Section 409A of the Code (“Section 409A”) and any state law of similar effect (i.e., applying the “short-term deferral” rule described in Treas. Reg. § 1.409A-1(b)(4) and/or another exemption). Where the Grant Agreement specifies a window during which a payment may be made, the payment date within such window shall be determined by the Company in its sole discretion.

18.    Entire Agreement.  This Grant Agreement, the Plan, and any rules, procedures and sub-plans (including country addenda) adopted by the Committee contain all of the provisions applicable to the RSUs. No other statements, documents or practices may modify, waive or alter such provisions unless expressly set forth in writing, signed by an authorized officer of the Company and delivered to the Grantee.

By acknowledging this Grant Agreement, the Grantee acknowledges and confirms that the Grantee has read this Grant Agreement and the Plan (including applicable addenda), and the Grantee accepts and agrees to the provisions therein.

6

Exhibit 10(b)

19.    Electronic Delivery. The Company may, in its sole discretion, decide to deliver any documents related to this or other Awards under the Plan by electronic means. The Grantee hereby consents to receive such documents electronically and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

20.    Global Addendum. Notwithstanding any provisions in this document to the contrary, the RSUs will also be subject to the special terms and conditions set forth on Appendix A for Grantees who reside outside of the United States. Moreover, if a Grantee is not a resident of any of the countries listed on Appendix A as of the Grant Date, but relocates to one of the listed countries at any point thereafter, the special terms and conditions for such country will apply to the Grantee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan. Appendix A constitutes part of this Grant Agreement.


7

Exhibit 10(c)
IMAGE_01A.JPG
March 1, 2021 Equity Grant Agreement
GE 2007 Long-Term Incentive Plan
(as amended and restated April 26, 2017, and as further amended and restated February 15, 2019)

GE Performance Stock Unit Grant Agreement (“Grant Agreement”)
For <<Employee Name>> (“Grantee”)

Grant Date
PSUs Granted
Vesting Date
March 1, 2021
<<number>>*
(target)
March 1, 2024
*Actual number of Shares delivered to be between 0% and 175% of target
based on performance as defined below.

1.Grant. The Management Development and Compensation Committee (“Committee”) of the Board of Directors of General Electric Company (“Company”) has granted the above number of Performance Stock Units (“PSUs”) to the individual named in this Grant Agreement (“Grantee”), subject to the terms of this Grant Agreement. Without limiting any condition of this PSU award, the award is subject to cancellation and forfeiture if the Grantee does not confirm acceptance within 45 days of the Grant Date. Once vested, each PSU entitles the Grantee to receive from the Company (i) one Share of Company common stock, par value $0.06 per share and (ii) a cash payment in respect of Dividend Equivalents (described below), each in accordance with the terms of this Grant Agreement, the GE 2007 Long-Term Incentive Plan as amended and restated April 26, 2017 and as further amended and restated February 15, 2019 (“Plan”), and any rules, procedures and sub-plans (including country addenda) adopted by the Committee.

2.Vesting. A PSU shall become vested only upon satisfaction of the performance criteria described in Section 2(a) and the employment criteria described in Section 2(b).

a.Performance Criteria. Subject to satisfying the employment criteria, the number of PSUs to be vested shall be a percentage of the number of PSUs Granted (as shown above), determined as follows:

i.Financial Goals Percentage. A percentage based on 2021 performance against the Earnings Per Share and Free Cash Flow targets shown below (the “Financial Goals Percentage”) shall be calculated. The Financial Goals Percentage equals the sum of the Earnings Per Share Factor plus the Free Cash Flow Factor, with each such Factor weighted 50% of the total as shown in the table below. If performance for a Factor is below the threshold level, that factor will be 0%. If performance for a Factor is above
    1

Exhibit 10(c)
the maximum level, that Factor will be capped at 50% of 175%, or 87.5%. If performance is between the threshold and target, or between the target and maximum, the percentage will be determined by interpolation.

Factor Weight Threshold Target Maximum
Earnings Per Share 50% $0.17 $0.21 $0.25
Free Cash Flow ($MM) 50% $2,880 $3,600 $4,320
Percentage 25% 100% 175%

ii.TSR Adjustment. The Financial Goals Percentage shall be adjusted based on relative Total Shareholder Return for the three-year period of 2021-2023 (the “TSR Adjustment”) as follows:

A.If the Company’s Total Shareholder Return (“Company TSR”) is equal to or below the 35th percentile (“threshold”) of the Total Shareholder Return for the S&P 500 Industrial Index Companies (“S&P Industrials TSR”), then the Financial Goals Percentage will be multiplied by 80%.

B.If the Company TSR is equal to the 55th percentile (“target”) of the S&P Industrials TSR, then the Financial Goals Percentage will be multiplied by 100%.

C.If the Company TSR is equal to or exceeds the 80th percentile (“maximum”) of the S&P Industrials TSR, then the Financial Goals Percentage will be multiplied by 120%.

If the Company TSR is between the threshold and target, or between the target and maximum, TSR Adjustment shall be determined by interpolation. However, in no event will the PSUs be adjusted to provide more than 175% of the PSUs Granted in total.

All determinations regarding performance (both for the Financial Goals Percentage and TSR Adjustment) shall be made solely by the Committee in accordance with the customary accounting and financial reporting practices used by the Company for external reporting, and shall include adjustment for any recapitalization, split-up, spinoff, reorganization, restructuring or other similar corporate transaction as determined by the Committee to prevent dilution or enlargement of intended benefits.

b.Employment Criteria. In order to vest in a PSU with respect to which the performance criteria are satisfied, the Grantee must be continuously employed by the Company and its Affiliates from the Grant Date through the Vesting Date listed above.  All unvested PSUs shall be immediately cancelled upon termination of employment for any reason before the Vesting Date, except as specifically provided below:

    2

Exhibit 10(c)
i.Death or Disability.  If the Grantee’s employment with the Company and its Affiliates terminates prior to the Vesting Date as a result of the Grantee’s death or disability, then the employment criteria shall be deemed satisfied. For this purpose, “disability” shall have the same definition as provided in the long-term disability plan sponsored by the Company or an Affiliate in which the Grantee is eligible to participate.

ii.Retirement Eligibility.  If, on or after the first anniversary of the Grant Date (and prior to the Vesting Date), the Grantee attains age 60 and completes 5 years of continuous employment with the Company and its Affiliates, then the employment criteria shall be deemed satisfied.

3.Dividend Equivalents. The Company will establish an amount for each PSU equal to the per Share quarterly dividend payments made to Shareholders during the period beginning on the Grant Date and ending on the date that such PSU vests or is cancelled (“Dividend Equivalents”). The Company shall accumulate Dividend Equivalents and, upon vesting of the related PSU, will pay the Grantee a single lump sum cash amount equal to the Dividend Equivalents on the same date that Shares are delivered with respect to such PSU, as described in Section 4 of this Grant Agreement. Any accumulated and unpaid Dividend Equivalents attributable to a PSU that is cancelled are immediately forfeited upon cancellation and will not be paid.

4.Delivery and Tax Withholding.  As soon as practicable after the Vesting Date and during the 2024 calendar year, the Company shall deliver to the Grantee a number of Shares equal to the number of vested PSUs and the Dividend Equivalent cash amount with respect to each vested PSU (in each case net of applicable tax withholding and fees). Delivery shall be electronic, through the brokerage account established by the Company for the Grantee, or in such other medium as is determined by the Company. The Grantee is ultimately responsible for any and all applicable taxes, regardless of the amount withheld or reported. Notwithstanding the foregoing, the date of issuance or delivery of Shares may be postponed by the Company for such period as may be required for it with reasonable diligence to comply with any applicable listing requirements of any national securities exchange and requirements under any law or regulation applicable to the issuance or transfer of such Shares to the extent such postponement is permissible under Section 409A of the Code.

5.Holding Period. Shares paid to the Grantee pursuant to this Grant Agreement must be held for at least one year following the delivery date (except for such Shares used to satisfy any tax withholding obligation or fees) and may be used to satisfy any Company stock ownership requirements imposed by the Company.

6.Data Security and Privacy.

a.Data Collection, Processing and Usage. Personal data collected, processed and used by the Company in connection with Awards granted under the Plan includes the Grantee’s name, home address, email address, telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or
    3

Exhibit 10(c)
directorships held in the Company, and details of all Awards granted, cancelled, exercised, vested, or outstanding. In granting Awards under the Plan, the Company will collect the Grantee’s personal data for purposes of allocating Shares in settlement of the Awards and implementing, administering and managing the Plan. The Company collects, processes and uses the Grantee’s personal data in compliance with GE's Employment Data Protection Standards and the Uses of Employment Data for GE Entities. The Grantee may exercise rights to access, correction, or restriction or deletion where applicable, by contacting the Grantee’s local HR manager or initiating a request through www.onehr.ge.com.
b.Administrative Service Provider. The Company transfers the Grantee’s personal data to UBS Financial Services, which assists with the implementation, administration and management of the Plan (the “Third-Party Administrator”).  In the future, the Company may select a different Third-Party Administrator and share the Grantee’s personal data with another company that serves in a similar manner. The Third-Party Administrator will open an account for the Grantee to receive and trade Shares acquired under the Plan.  The Grantee will be asked to agree on separate terms and data processing practices with the Third-Party Administrator, which is a condition to the Grantee’s ability to participate in the Plan. The privacy policy of the Third-Party Administrator may be reviewed here.
7.Non-solicitation, Non-competition and Compliance with Agreements. During the Grantee’s employment with the Company or its Affiliate, and for the one-year period following termination of such employment (the “Restriction Period”), the Grantee will not, without prior written approval from the Senior Human Resources Manager of the Grantee’s Company business segment: (a) whether on his or her own behalf or in conjunction with any other person or third party, directly or indirectly solicit or encourage any person who is a Lead Professional Band or higher employee of the Company or any of its Affiliates (a “Restricted Person”) to terminate his or her employment relationship with, or accept any other employment outside of, the Company and its Affiliates; (b) directly hire, or recommend or cause to be hired by an entity for which the Grantee works, or with which the Grantee is otherwise associated or owns more than a 1% ownership interest, any person who is, or was within one year before or after the Grantee’s termination of employment with the Company and its Affiliates, a Restricted Person (this restriction does not apply where legally impermissible, such as California); or (c) provide any non-public information regarding any Restricted Person, including, but not limited to, compensation data, performance evaluations, skill sets or qualifications, etc., to any external person in connection with employment outside the Company and its Affiliates, including, but not limited to, recruiters and prospective employers. The above restrictions do not apply once a Restricted Person has been formally notified of his or her impending layoff from the Company or any of its Affiliates.

In addition, the Grantee agrees that during the Restriction Period, the Grantee will not, without prior written approval from the Senior Human Resources Manager of the Grantee’s Company business segment, whether directly or indirectly, perform activities or services in the Restricted Area for any Competitive Company which: (a) are similar in nature to the activities and services the Grantee performed for the Company or its Affiliate (or gained
    4

Exhibit 10(c)
confidential information about, as described in the Employee Innovation and Proprietary Information Agreement or “EIPIA”) during the last two years of Grantee’s employment; and/or (b) will include Grantee working on products or services that are competitive with the products or services the Grantee worked on during the last two years of Grantee’s employment with the Company or its Affiliate. The term “Competitive Company” means any company or other third party that provides products and services that are competitive with the Company or its Affiliates. [The term “Restricted Area” means any area within the country in which the Grantee is based where the Company or its Affiliate has material business operations as of Grantee’s termination of employment and in which the Grantee has provided services, had a material presence or influence, or received confidential information about (as described in the EIPIA) at any time during the last two years of the Grantee’s employment with the Company or its Affiliate. The Grantee understands and agrees that, given the nature of the business of the Company and its Affiliates and the Grantee’s position with the Company or its Affiliate, the foregoing Restriction Period and Restricted Area are reasonable and appropriate to protect the Company’s legitimate business interests and goodwill.] The foregoing restrictions do not apply where legally impermissible (such as California). To the extent the Grantee is subject to an existing non-competition agreement with the Company or any of its affiliates (the “Prior Agreement”), the Prior Agreement shall be incorporated herein by reference and the Prior Agreement and this Grant Agreement shall be read together; provided, however, that where the provisions are inconsistent, the more restrictive covenant shall apply.

Furthermore, during the Grantee’s employment with the Company or its Affiliate, and for all periods thereafter, the Grantee will not breach his or her EIPIA or otherwise disclose the Company’s or Affiliate’s non-public information.

The Grantee agrees that any breach by him or her of the foregoing obligations inevitably would cause substantial and irreparable damage to the Company and its Affiliates for which money damages may not be an adequate remedy. Accordingly, the Grantee agrees that the Company and its Affiliates will be entitled to an injunction and/or other equitable relief, without the necessity of posting security, to prevent the breach of such obligations. The Grantee also agrees to indemnify and hold the Company and its Affiliates harmless from any loss, claim or damages, including, without limitation, all reasonable attorneys’ fees, costs and expenses incurred in enforcing its rights under this Grant Agreement, as well as repay any payments made hereunder (regardless of whether the PSUs are vested), except to the extent that such reimbursement is prohibited by law.

The Grantee agrees that the payment and benefits provided for in the Grant Agreement constitute fair and reasonable consideration for Grantee’s compliance with this section.

8.Additional Requirements. The Company reserves the right to impose other requirements on the Award, Shares acquired pursuant to the Award, and the Grantee's participation in the Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law or to facilitate the operation and administration of the Award and the Plan. Without limiting the generality of
    5

Exhibit 10(c)
the foregoing, the Company may require the Grantee to sign any agreements or undertakings that may be necessary to accomplish the foregoing.

9.Alteration/Termination.  Under the express terms of this Grant Agreement, the Committee shall have the right at any time in its sole discretion to amend, alter, suspend, discontinue or terminate any PSUs without the consent of the Grantee. Furthermore, if the Company determines in its sole discretion that the Grantee has engaged in conduct that (a) constitutes a breach of this Grant Agreement, the EIPIA or any other confidentiality, non-solicitation, or non-competition agreement with the Company or its Affiliates, (b) results in (or has the potential to cause) material harm financially, reputationally, or otherwise to the Company or its Affiliates or (c) occurred prior to the Grantee’s termination of employment and would give rise to a termination for Cause (regardless of whether such conduct is discovered before or after the Grantee’s termination of employment), any unvested PSUs shall be cancelled immediately, and any amounts previously conveyed under this Grant Agreement shall be subject to recoupment. In any event, the PSUs provided under this Grant Agreement shall be further subject to the Company’s policy with respect to compensation recoupment, as in effect and amended from time to time. The Grantee agrees that the Company may take any such actions as are necessary to effectuate recoupment or applicable law without further consent or action being required by the Grantee, including issuing instructions to any Third-Party Administrator to (i) hold the Grantee’s Shares and other amounts acquired under the Plan and/or (ii) reconvey, transfer, or otherwise return such Shares and other assets to the Company. Also, the PSUs shall be null and void to the extent the grant of PSUs or the vesting thereof is prohibited under the laws of the country of residence of the Grantee.

For this purpose, “Cause” shall be determined by the Company in its sole discretion and includes: (a) breach of the Employee Innovation and Proprietary Information Agreement or any other confidentiality, non-solicitation, or non-competition agreement with the Company or Affiliate, or breach of a material term of any other agreement with the Company or Affiliate; (b) engagement in conduct that results in, or has the potential to cause, material harm financially, reputationally, or otherwise to the Company or its Affiliate; (c) commission of an act of dishonesty, fraud, embezzlement or theft; (d) conviction of, or plea of guilty or no contest to a felony or crime involving moral turpitude; or (e) failure to comply with the Company’s or Affiliate’s policies and procedures, including, but not limited to, The Spirit and Letter.

10.Plan Terms and Definitions.  Except to the extent that the context clearly provides otherwise, all terms used in this Grant Agreement have the same meaning as given such terms in the Plan. This Grant Agreement is subject to the terms and provisions of the Plan, which are incorporated by reference. In the event of any conflict between the provisions of this Grant Agreement and those of the Plan, the provisions of the Plan shall control.

11.Interpretation and Construction. This Grant Agreement and the Plan shall be construed and interpreted by the Committee, in its sole discretion. Any interpretation or other determination by Committee (including correction of any defect or omission and reconciliation of any inconsistency) shall be binding and conclusive. All determinations regarding enforcement, waiver or modification of the cancellation and rescission and other
    6

Exhibit 10(c)
provisions of this Grant Agreement shall be made in the Committee’s sole discretion. Determinations made under this Grant Agreement and the Plan need not be uniform and may be made selectively among individuals, whether or not such individuals are similarly situated.

12.Severability. The invalidity or unenforceability of any provision of the Plan or this Grant Agreement will not affect the validity or enforceability of any other provision of the Plan or this Grant Agreement, and each provision of the Plan and this Grant Agreement will be severable and enforceable to the extent permitted by law.

13.Shareholder Rights. The Grantee shall not have any voting or other Shareholder rights unless and until Shares are actually delivered to the Grantee.

14.No Employment Rights. The grant of the Award described in this Grant Agreement does not give the Grantee any rights in respect of employment with the Company or any of its Affiliates.

15.Discretionary Award, Extraordinary Benefit. Awards under the Plan are granted to employees of the Company and its Affiliates in the Committee’s sole discretion. The Award described in this Grant Agreement is a one-time benefit and does not create any contractual or other right to receive other Awards under the Plan or other benefits in lieu thereof. Future grants, if any, will be at the sole discretion of the Committee. The Grantee’s participation in the Plan is voluntary. This Award (and each other Award, if any, granted under the Plan) constitutes an extraordinary item of compensation and is not part of the Grantee’s normal or expected compensation for purposes of calculating any severance, retirement, or other benefit rights (unless otherwise expressly provided in an applicable benefit plan).

16.No Transfer or Assignment. No rights under this Award shall be assignable or transferable by the Grantee, except to the extent expressly permitted by the Plan.

17.Successors and Assigns. The Company may assign any of its rights under this Grant Agreement. This Grant Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Grant Agreement will be binding upon the Grantee and the Grantee's beneficiaries, executors or administrators.

18.Section 409A. To the extent applicable, this Grant Agreement shall be construed and administered consistently with the intent to comply with or be exempt from the requirements of Section 409A of the Code (“Section 409A”) and any state law of similar effect (i.e., applying the “short-term deferral” rule described in Treas. Reg. § 1.409A-1(b)(4) and/or another exemption). Where the Grant Agreement specifies a window during which a payment may be made, the payment date within such window shall be determined by the Company in its sole discretion.

19.Entire Agreement.  This Grant Agreement, the Plan, and any rules, procedures and sub-plans (including country addenda) adopted by the Committee contain all of the provisions applicable to the PSUs. No other statements, documents or practices may modify, waive or
    7

Exhibit 10(c)
alter such provisions unless expressly set forth in writing, signed by an authorized officer of the Company and delivered to the Grantee.

By acknowledging this Grant Agreement, the Grantee acknowledges and confirms that the Grantee has read this Grant Agreement and the Plan (including applicable addenda), and the Grantee accepts and agrees to the provisions therein.

20.Electronic Delivery. The Company may, in its sole discretion, decide to deliver any documents related to this or other Awards under the Plan by electronic means. The Grantee hereby consents to receive such documents electronically and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

21.Global Addendum. Notwithstanding any provisions in this document to the contrary, the PSUs will also be subject to the special terms and conditions set forth on Appendix A for Grantees who reside outside of the United States. Moreover, if a Grantee is not a resident of any of the countries listed on Appendix A as of the Grant Date, but relocates to one of the listed countries at any point thereafter, the special terms and conditions for such country will apply to the Grantee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan. Appendix A constitutes part of this Grant Agreement.

    8

Exhibit 10(d)












GELOGO1A.JPG
GE Corporate
Kevin Cox
Chief Human Resources Officer
GE Corporate
5 Necco Street
Boston, MA 02210
USA
June 10, 2020


Mr. John S. Slattery



Dear John:

We are pleased to offer you the position of President & Chief Executive Officer of GE Aviation. The details of this offer, which is contingent upon your successful completion of a drug test, are as set forth below.

Position Details Effective July 13, 2020, you will begin your employment with the Company as President & Chief Executive Officer of GE Aviation, reporting directly to the Company’s Chief Executive Officer. Your principal office will be in Cincinnati, Ohio, but you will travel to other locations as necessary to fulfill your responsibilities of the role.

Compensation As full compensation for all services provided and duties performed, you will receive the following:

(a)Base Salary. You will receive an annual base salary of $1,250,000 (“Base Salary”), payable by the Company in accordance with its normal payroll practices.

(b)Annual Incentive Bonus. You will be eligible to receive an annual incentive bonus, under the Company’s Annual Executive Incentive Program or any successor or replacement program, with each year’s Annual Bonus having a target of 100% of your Base Salary (“AEIP Target”), which shall be determined and paid in accordance with the Company’s normal procedures. For the 2020 performance year, you will be eligible for a pro-rated bonus, payable based on Aviation’s actual results relative to the established metrics.

(c)Long Term Incentive Award (“LTIP Award”). You will be eligible to participate in the Company’s annual long-term incentive equity grant program with a targeted grant fair value of $6,000,000. For the performance year 2020, you will receive a pro-rated targeted grant fair value of $3,000,000, which will be approved and granted at the first meeting of the Management Development and Compensation Committee after the Effective Date, and will be delivered 50% in Performance Stock Units (based on a Monte Carlo calculation), 30% in Stock Options (based on a Black Scholes methodology), and 20% in Restricted Stock Units ( based on the 30 day average prior to and including the grant date). All LTIP Awards will be
governed by the terms and conditions consistent with awards made to other similarly situated officers of the Company.

(d)Sign-On Award. As further consideration for your joining the Company, and in recognition of the value of the long-term incentive and bonus you stand to forfeit with your current employer, you will be provided (i) a cash payment in the gross amount of $1,000,000, which will be paid as soon as practical following the start of your employment, and (ii) an award of stock options with a grant date fair market value of $1,500,000 (as determined using standard Black-Scholes methodologies and otherwise in accordance with normal Company procedures for options granted to C-suite executives). The stock award will be granted as soon as practical following the start of your employment and will vest ratably one-third each year over three years. The terms and conditions for this award shall be in accordance with the Company’s standard grant provisions for similarly situated officers.


(e)Employee Benefits. You will be eligible to participate in all employee benefit plans generally available to similarly situated officers of the Company. All aspects of these benefits will be governed by GE plans and policies, a summary of which is included as a reference. In addition, you will receive:

i.Relocation benefits consisting of a one-time cash payment in the net amount of $2,500,000 (provided in lieu of a housing allowance). In addition, the company will provide you destination services to find suitable housing, a temporary living allowance for a maximum duration of six months, and will arrange for the movement of household goods and personal effects. If you voluntarily terminate employment within two (2) years of the physical relocation, or obtaining work authorization, whichever comes sooner, GE reserves the right to seek full repayment of all paid or reimbursed relocation costs including any applicable tax gross-up.

ii. Given your role, it is optimal for you to obtain a US passport, which you have agreed to pursue. The Company will pay for any costs associated with obtaining such a passport for you and your family members who will be accompanying you to the US.

iii.    Children’s educational support (i.e., tuition reimbursement up to a net total of $60,000 annually) through the completion of high school for your school-age children.

iv.    Tax planning and preparation services (including host country tax orientation and home and host country income tax preparation), for a period of 3 years following the commencement of your employment.

iii. Tax protection on select elements of company source income and private source income, up to US $300,000 of worldwide tax for a period of 3 years following the commencement of your employment.

Severance Payment If your employment with GE is terminated for reasons other than cause, death or disability, you will receive the Company’s standard Officer Severance package, which includes a lump sum payment equal to 12 months of base salary and, assuming you remain employed through the first quarter of the year in which your employment terminates, a pro-rated AEIP payment.
2


Restrictive Covenants During your employment, and for the 12 month period following your termination of employment, you will not directly or indirectly: (i) provide services to a competitor of the Company’s Aviation division in a position in which your duties will be substantially similar to the duties you performed for the Company and/or will require you to work on products or services that are competitive with the products or services you worked on during the two years prior to your termination, or (ii) solicit the employment of, hire, or encourage any Senior Professional Band employee or above to leave his/her position or accept employment outside of the Company, including in any company with which you may subsequently become involved (in accordance with the Company’s standard non-solicit agreement which you agree to sign in connection with the on-boarding process).

Confidentiality You acknowledge that you will have access to and become acquainted with proprietary and confidential information, which may include trade secrets, regarding the Company and its customers that constitutes a valuable asset of the Company and that is not available to the public. You agree that you will not use or disclose the Company’s Confidential Information, either during or after the termination of your employment, for any reason other than in the performance of your job and for the benefit of the Company. You further agree that you will sign the Company’s Employee Invention and Proprietary Information Agreement (“EIPIA”) as part of the on-boarding process and will abide by the terms of that Agreement.


John, I am incredibly excited about the prospect of your joining our team. We look forward to your acceptance of this offer and response by email by Friday June 12, 2020.

If you have any questions, please don’t hesitate to contact me directly.

Sincerely,

/s/ Kevin Cox
Kevin Cox




Please signify your acceptance of this offer letter:


/s/ John S. Slattery    June 12, 2020
Signature Date
3

Exhibit 31(a)
Certification Pursuant to
Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended

I, H. Lawrence Culp, Jr., certify that:

1.I have reviewed this quarterly report on Form 10-Q of General Electric Company;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: April 27, 2021
/s/ H. Lawrence Culp, Jr.
H. Lawrence Culp, Jr.
Chairman & Chief Executive Officer


Exhibit 31(b)
Certification Pursuant to
Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended

I, Carolina Dybeck Happe, certify that:

1.I have reviewed this quarterly report on Form 10-Q of General Electric Company;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: April 27, 2021
/s/ Carolina Dybeck Happe
Carolina Dybeck Happe
Chief Financial Officer

Exhibit 32
Certification Pursuant to
18 U.S.C. Section 1350

In connection with the Quarterly Report of General Electric Company (the “registrant”) on Form 10-Q for the period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “report”), we, H. Lawrence Culp, Jr. and Carolina Dybeck Happe, Chief Executive Officer and Chief Financial Officer, respectively, of the registrant, certify, pursuant to 18 U.S.C. § 1350, that to our knowledge:
(1)The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2)The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the registrant.

April 27, 2021
 
/s/ H. Lawrence Culp, Jr.
H. Lawrence Culp, Jr.
Chairman & Chief Executive Officer
/s/ Carolina Dybeck Happe
Carolina Dybeck Happe
Chief Financial Officer